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ABSTRACT 
The heat shock response (HSR) is the cell’s molecular reaction to protein damaging stress 
and is critical in the management of denatured proteins.  Activation of HSF1, the master 
transcriptional regulator of the HSR, results in the induction of molecular chaperones 
called heat shock proteins (HSPs).  Transcription of hsp genes is promoted by the 
hyperphosphorylation of HSF1, while the attenuation of the HSR is regulated by a dual 
mechanism involving negative feedback inhibition from HSPs and acetylation at a critical 
lysine residue within the DNA binding domain of HSF1, which results in a loss of 
affinity for DNA.  SIRT1 is a NAD+-dependent histone deacetylase that has been 
reported to deacetylate HSF1, thus promoting stress-induced HSF1 DNA binding ability 
and increasing HSP expression (Westerheide, Anckar et al. 2009). While an abundance of 
research is aimed to investigate SIRT1 substrate regulation, the mechanism in which 
SIRT1 itself is regulated is less understood (Haigis and Sinclair 2010).  Positive and 
negative modulators of SIRT1 include AROS and DBC1, respectively, and have yet to be 
investigated in relation to SIRT1-dependent regulation of the HSR.  In addition, 
metabolic stress such as caloric restriction has been shown to modulate SIRT1 activity in 
yeast (Rahat, Maoz et al. 2011), but the effect of caloric restriction on the HSR is 
unknown.  
Using cell-based assays, we have investigated how the HSR may be controlled by factors 
influencing SIRT1 activity.  We found that heat shock results in an increase in the 
cellular NAD+/NADH ratio and an increase in recruitment of SIRT1 to the hsp70 
promoter.  Furthermore, we found that the SIRT1 modulators, AROS and DBC1, impact 
hsp70 transcription, HSF1 acetylation status, and HSF1 recruitment to the hsp70 
promoter.  The nematode Caenorhabditis elegans is a useful model organism for testing 
the relationship between the HSR and metabolism, as these animals can easily be 
  xii 
calorically-restricted via bacterial limitation and possess the mammalian SIRT1 homolog, 
Sir2.1.  Using C. elegans, we demonstrate that caloric restriction and heat shock have a 
synergistic effect on the HSR in a sir2.1-dependent manner.  We show that caloric 
restriction increases the ability of heat shock to promote thermotolerance and fitness in 
wild-type animals and to preserve movement in a polyglutamine toxicity 
neurodegenerative disease model and that this effect is dependent on sir2.1.  These 
studies provide insight into SIRT1-dependent regulation of the HSR and the impact of 
metabolism on this response.  We highlight the SIRT1 modulators AROS and DBC1 as 
two new targets available for therapeutic regulation of the HSR and add caloric 
restriction as another HSR activator that can synergize with heat shock. 
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CHAPTER 1. INTRODUCTION 
The Discovery of the Heat Shock Response 
The heat shock response (HSR) was discovered serendipitously in the 1960’s by an 
Italian geneticist named Ferruccio Ritossa.  While working at the Genetic Institute in 
Pavia, Ritossa designed a project to study the nucleic acids that were synthesized in the 
chromosomal puffs observed in Drosophila salivary glands at active sites of transcription.  
Sometime throughout his research, one of Ritossa’s colleagues increased the temperature 
of his incubator and consequently changed the puffing pattern he observed.  After 
determining the optimal temperature for this shift, Ritossa observed new RNA synthesis 
within 2-3 minutes of thermal stress (Ritossa 1962; Ritossa 1996).  He observed the rapid 
induction of new RNA across different tissues, developmental times, and species of 
Drosophila and eventually published his work in Experientia in 1962 (Ritossa 1962). 
The work was not well received and it wasn’t until several years later that the heat shock 
response became an established field.  In the late 1970’s it was discovered that an 
elevation in temperature resulted in a change of the total protein profile for the cell.  
Pulse radiolabeling of mRNA and proteins indicated that production of the aptly named 
heat shock proteins (HSPs) increased upon thermal stress, while the production of other 
constitutively expressed proteins decreased (Tissiere.A, Mitchell et al. 1974; Lewis, 
Helmsing et al. 1975; Spradling, Pardue et al. 1977).   The cloning of a rapidly inducible 
HSP known as hsp70 and the subsequent analysis of the hsp70 promoter lead to the 
identification of an evolutionarily conserved heat shock element (HSE) that is found 
upstream of HSP genes.  Through the use of affinity chromatography with 
HSE-oligonucleotide-sepharose beads, the biochemical purification and characterization 
of the HSE-binding protein resulted in the identification of the Heat Shock Factor 1 
(HSF1) transcription factor for S. cerevisiae, Drosophila, and human cell culture (Parker 
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and Topol 1984; Wiederrecht, Shuey et al. 1987; Wu, Wilson et al. 1987; Goldenberg, 
Luo et al. 1988).  These studies lead to the establishment of the HSR field that is now 
recognized to have a vital role in the regulation of protein homeostasis.   
HSF1 Regulation of the Heat Shock Response 
The HSR is an ancient inducible state designed to allow a cell to manage denaturing 
stress and promote organismal survival.  Stressors that perturb the HSR include, but are 
not limited to, heat, heavy metals, oxygen-free radicals, cancer, aging, infection, protein 
misfolding diseases, and the presence of various growth factors (Morimoto, Westerheide 
et al. 2009).  Initiation of the HSR results in transcriptional upregulation of molecular 
chaperones known as heat shock proteins (HSPs).  The elevated level of HSPs allows a 
cell to manage stress and obtain protein homeostasis.  Once a stressor triggers the HSR, 
HSF1 trimerizes and translocates to the nucleus (Figure 1.1).   
 
Figure 1.1.  HSF1 regulation of the heat shock response (HSR).   
HSF1 exists as an inactive monomer in the cytoplasm.  Upon induction of the HSR, it 
trimerizes and translocates to the nucleus where it binds to heat shock elements (HSEs) 
found in the promoter region of HSP genes.  Transcription is induced when HSF1 is 
  3 
hyperphosphorylated.  Upon acetylation, HSF1 loses affinity for the DNA.  SIRT1 is a 
deacetylase that promotes HSF1 DNA binding. 
Upon translocation into the nucleus, HSF1 binds conserved regulatory upstream promoter 
elements known as heat shock elements (HSEs).  The HSEs consists of several inverted 
repeats of the pentamer sequence nGAAn (Sorger and Pelham 1987; Amin, Ananthan et 
al. 1988).  Each DNA-binding foot of the HSF1 trimer is capable of binding to an 
inverted repeat of the HSE, therefore the transcription binding site is typically a region of 
contiguous repeats with the sequence TTCnnGAAnnTTC (Amin, Ananthan et al. 1988; 
Xiao and Lis 1988; Perisic, Xiao et al. 1989).  Many HSP genes have several regions of 
HSE repeats resulting in the binding of multiple HSF1 transcription factors.  This binding 
occurs in a cooperative manner in which the binding of one HSF1 facilitates the binding 
of the next one (Xiao, Perisic et al. 1991).  This cooperativity may account for the 
differential expression of heat shock genes, whereby the number of HSEs impacts the 
level of gene induction.  Interestingly, the C. elegans hsp70 family member, F44E5.5, 
possesses four regions of HSE clusters (Figure 1.2A), while C12C8.1 possesses one 
region of HSE clusters  (Figure 1.2B).  The integrity or stringency of an HSE may also 
vary as demonstrated by the mouse hsp70.1 gene, which contains two regions of HSEs, 
each containing typical and atypical groupings of the nGAAn inverted pentamer 
(Christians, Michel et al. 1997) (Figure 1.2C).  
While trimerization is all that is necessary for HSF1 to bind to DNA, activation of 
transcription only occurs upon HSF1 hyperphosphorylation.  As an example, the 
anti-inflammatory agent sodium salicylate is capable of inducing HSF1 to bind to the 
DNA, but does not cause the phosphorylation required for initiation of transcription 
which would result in upregulation of HSPs (Jurivich, Sistonen et al. 1992).  
Phosphorylation of HSF1 is promiscuous as several protein kinase families including 
MAPK, PKC, and CAMKII are reported to phosphorylate HSF1 at various residues 
(Westerheide, Raynes et al. 2012). 
Attenuation of the HSR is regulated by a dual mechanism involving negative feedback 
inhibition from HSPs (Shi, Mosser et al. 1998) and acetylation at a critical lysine residue  
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within the DNA binding domain of HSF1 causing loss of affinity for DNA (Westerheide, 
Anckar et al. 2009).  It is not clear if multiple histone acetyl transferases (HATs) are 
involved in the HSR, but p300 has been shown to acetylate HSF1 when overexpressed 
(Westerheide, Anckar et al. 2009) and to interact with HSF1 in vivo (Zhang, Murshid et 
al. 2011).  SIRT1 is a NAD+-dependent histone deacetylase that deacetylates HSF1, thus 
promoting stress-induced HSF1 DNA binding ability and increased HSP expression 
(Westerheide, Anckar et al. 2009).  The end result of the HSR is the upregulation of 
HSPs, thus promoting the cell’s ability to cope with denaturing stress. 
 
Figure 1.2.  Representation of the HSE elements found in hsp70 family genes for 
C. elegans and M. musculus.  
The hsp70 gene family is highly inducible and is frequently used as a marker for 
initiation of the HSR.  Two hsp70 family genes in C. elegans, (A) F44E5.5 and (B) 
C12C8.1, vary in the number of HSEs found in the promoter region of each gene.  
(C) HSE sequences may be atypical as demonstrated by the M. musculus hsp70.1 gene.  
HSEs that differ from the standard nGAAn sequence appear underlined.  The numbers 
A)  C. elegans: F44E5.5       B) C elegans: C12C8.1   
!
taacttcTTCtaGAAgcTTCtgGAAtaTTCcactgca ! ! !aattgtaGAAggTTCtaGAAgatgcca!
!
!
ccagccaTTCgaGAAcgTTCtaGAAccTTCcattata !!
!
!
gattgttGGAgGAAatGGAatgTTCgaGAAaaaGAAagaggga !!
!
!
tgcagtgGAAtatTCCaGAAgcTTCtaGAAgatgtta !!
!!
-294 
-177 
-88 
-26 +1 
-55 
-150 
-222 -113 -96 
HSE HSE 
-190 -110 +1 
caGAAacCTCtgGAGagTTCtg ! gcGAAacTGCtgGAAgaTTCct   !
C) M. musculus: Hsp70.1 
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below each sequence mark the residue distance from the ATG site.  Figure 1.2C is 
adapted from Christians, et al. (1997).  
Nuclear Stress Bodies 
In addition to canonical HSEs being found in all eukaryotic heat shock-responsive genes, 
degenerate HSEs also compose structures in the nucleus called nuclear stress bodies 
(nSBs) (Sarge, Murphy et al. 1993; Biamonti and Vourc'h 2010).  Several nuclear factors 
that are distributed throughout the nucleoplasm can accumulate in nuclear 
subcompartments such as nucleoli, nuclear speckles, Cajal bodies, promyelocytic 
leukaemia (PML) bodies, and the perinucleolar compartment (PNC) [reviewed by 
(Spector 2001; Lamond and Spector 2003)]. nSBs are transient subnuclear structures that 
are distinct from other nuclear bodies, such as PML and Cajal bodies (Cotto, Fox et al. 
1997; Chiodi, Biggiogera et al. 2000). Very little is known regarding the function of 
nSB’s since their discovery in the late 1980’s and their subsequent association with the 
HSR.   
In 1989, it was first demonstrated that HS resulted in the recruitment of heterogeneous 
ribonucleoprotein particles (hnRNPs) to distinct perichromatin granules (PGs), now 
known as nSBs (Mahl, Lutz et al. 1989).  Subsequently, immunofluorescence indicated 
that HSF1 also translocates to these nuclear bodies upon HS stress (Sarge, Murphy et al. 
1993) (Figure 1.3).  The kinetics of nSB formation is dependent on the nature and 
duration of the stressor, but is consistent with HSF1 activation of HSP transcription.  
However, classical heat-induced HSPs do not colocalize to the nSB structures (Leroy, 
Perrin et al. 1997).  Interestingly, the cycling of nSB assembly/disassembly upon 
successive rounds of short HS treatments results in their formation at the same positions 
on the chromatin (Jolly, Usson et al. 1999).  Investigation of these nuclear positions led to 
the finding that upon HS, HSF1 binds to the pericentric heterochromatic 9qh region of 
the human chromosome (Jolly, Konecny et al. 2002), which is a block of heterochromatin 
composed of satellite III repeats (Jones, Prosser et al. 1973).  The transcriptional 
activation of these sites results in the production of non-coding RNA molecules that 
remain fixed at the transcription site and are composed of multiple repeats of the 
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sequence (GGAAT)nCAACCCGAGT (Valgardsdottir, Chiodi et al. 2005).  Therefore, 
while this sequence is not a canonical HSE, this degenerate nGAAn motif may be 
responsible for recruiting HSF1 specifically to the genomic satellite III fragments, as 
other satellite sequences such as Sat II and α-satellite do not recruit HSF1 (Grady, Ratliff 
et al. 1992; Jolly, Metz et al. 2004).  
 
Figure 1.3. HSF1 localizes to nuclear stress bodies upon HS.   
HeLa cells were fixed in formaldehyde and blocked in FBS.  Immunocytochemistry was 
performed using an anti-HSF1 primary antibody (Stressgen cat#SPA-901) detected by an 
RFP secondary antibody (Invitrogen Alexa-Fluor #555) and the cells were Dapi stained.  
A 42°C HS results in localization of HSF1 (RFP) to nuclear stress bodies (nSBs).   
While the function of nSBs is unknown, the accumulation of satellite III transcripts 
results in the recruitment of several RNA-processing proteins and splicing factors 
[reviewed by (Sandqvist and Sistonen 2004)].  This sequestration of RNA maturation 
factors may hypothetically aid in the global decrease in translation observed at the onset 
of the HSR.  Conversely, translation of HSPs is maximized upon HS activation of HSF1. 
The rapid increase in HSPs may be facilitated by HSF1 forming a protein interaction with 
symplekin, a protein subunit found in a CstF/CPSF polyadenylation factor complex 
responsible for RNA maturation (Xing, Mayhew et al. 2004).  Thus HSF1 may directly 
enhance the production of mature HSP transcripts by acting as a polyadenylation 
stimulatory factor.   
Interestingly, nSBs are only found in human and monkey cell lines and have not been 
discovered in any other eukaryote, including rodents (Denegri, Moralli et al. 2002).  
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However, recent characterization of a transgenic C. elegans strain expressing tagged 
HSF-1::GFP at physiological levels has demonstrated localization of HSF-1 to subnuclear 
compartments that are reminiscent of primate nSBs (Morton and Lamitina 2012).  Like 
nSBs, the induced C. elegans stress granules are transient and recruit HSF1 with rapid 
kinetics and reformation of these bodies upon subsequent HS occurs in approximately the 
same nuclear positions.  Further research is necessary to determine if nSBs are an 
evolutionarily conserved mechanism of HSR regulation of proteostasis.     
Molecular Chaperones and Heat Shock Proteins 
The unifying characteristic of molecular chaperones is the ability to bind to denatured 
proteins.  Molecular chaperones are proteins that non-covalently bind and form stable 
complexes with non-native proteins.  Disassociation of a chaperone and its substrate most 
often requires the binding and subsequent hydrolysis of adenine triphosphate (ATP) (Fink 
1999).  Chaperones are ubiquitous and assist in the folding, assembly, transport, and 
degradation of proteins (Saibil, Zheng et al. 1993).  Although their assistance is critical in 
these processes, chaperones do not contribute to the final protein conformation or 
activity.   
As a nascent polypeptide chain emerges from the ribosome, highly interactive 
hydrophobic regions of the chain will tend to self-aggregate.  Protein aggregation is an 
immediate impediment to successful folding and the achievement of a native state.  It is 
not clear what percentage of proteins can successfully self-assemble into an active 
conformation.  In vitro experiments indicate that small proteins have the ability to 
assemble in a few tens of milliseconds without ever achieving an intermediate folding 
conformation (Hartl 1996; Fink 1999).  But for most proteins, the binding of chaperones 
to these interactive regions is imperative to successful folding.  
In addition to assisting in the prevention of nascent protein aggregation, chaperones may 
act as holdases for some intermediate stages of protein folding (Hoffmann, Linke et al. 
2004).  This role contributes to the correct folding pathway of the protein, but also acts as 
a method to prevent inappropriate folding.  Macromolecular crowding in the cellular 
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environment often leads to the restriction of available free water.  Cytoskeletal elements, 
organelles, membranes, and a high concentration of other proteins all contribute to the 
crowded environment (Ellis 2001).  Intracellular crowding leads to a general increase in 
reaction efficiencies.  Without the mechanism of chaperone control, proteins may attain 
conformation prematurely, which may interfere with transcriptional regulation, cell 
signaling, and translocation of the protein (Zhou, Rivas et al. 2008).   
Premature folding is specifically problematic in protein recruitment to cellular 
membranes and translocation.  In order for translocation to occur, a protein must pass 
through intermembrane channels.  Native proteins may be too large or bulky to pass 
through such narrow conduits.  Thus, a chaperone may be necessary to act as a holdase to 
regulate protein folding and the subsequent transport of the protein to the appropriate 
membrane for translocation.  Once past the membrane, additional chaperones may 
contribute to the folding of the protein into its active conformation (Ambjornsson and 
Metzler 2004). 
In addition to binding to newly formed polypeptides, molecular chaperones are also 
responsible for managing proteins that have undergone denaturing stress.  Denaturation 
may occur due to exposure of the protein to extreme pH, heat, organic solvents, high 
concentrations of inorganic salts, and other factors not conducive to the cellular 
environment (Hartl 1996).  Upon encountering a denatured protein, molecular chaperones 
perform triage, either directing the protein into the correct folding pathway or shuttling 
the damaged protein to the proteasome for destruction (Roelofs, Park et al. 2009).  Many 
molecular chaperones that are important in protein folding have also been shown to have 
roles in maintaining protein homeostasis such as the HSR.  Molecular chaperones that are 
inducible in this manner are called heat shock proteins (HSPs) and make up the majority 
of the classes of chaperones.  Progressively as research contributes to what is known 
about the HSR, several chaperones reported to assist in protein folding have been 
reclassified as HSPs.    
While chaperone families are not stringently classified and often overlap, there are five 
families of HSPs commonly discussed in the literature: small HSPs, HSP40, HSP70, 
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HSP90, and HSP100.  Several HSP chaperone families have members that are 
constitutive and do not have a role in the HSR.  For instance, HSP70 is a highly inducible 
molecular chaperone that is often used as a sensor of the HSR, but the constitutive Hsc70 
is maintained at a constant level in the cell and is not induced by stress (Takayama, Xie et 
al. 1999).  The unifying characteristic of the HSP family of proteins is their inducibility 
by the master transcriptional regulator, HSF1. 
Domains of HSF11 
Similar to many eukaryotic transcription factors, HSF1 possesses a complex modular 
structure with several functional domains that have been mapped by mutational analyses 
(Wiederrecht, Seto et al. 1988; Sorger and Nelson 1989; Green, Schuetz et al. 1995; 
Newton, Knauf et al. 1996).  Approximately 90% of eukaryotic transcription factors 
possess long regions of intrinsic disorder, which may contribute to their flexibility and 
allow protein interaction with multiple cellular partners (Liu, Perumal et al. 2006).  More 
than half of the HSF1 protein is predicted to be disordered (Westerheide, Raynes et al. 
2012). In fact, only two of the HSF1 functional domains, the DNA-binding domain 
(DBD, residues 15-120) and the hydrophobic repeat HR-A/B domain (residues 130-203), 
are predicted to be ordered.  The HR region C, which is located at the beginning of the 
transactivation domain (TAD, residues 384-409), is predicted to be partially ordered. The 
DBD and HR-A/B domains are connected by a flexible linker and the remainder of the 
protein, including two important functional domains, the regulatory domain (RD, 
residues 221-310) and the TAD (residues 371-529) and their linker, is mostly disordered.   
DNA binding domain (DBD) 
The DBD is the most conserved domain of HSF1 from C. elegans to humans 
(Figure 1.4).  Both the crystal structure of the DBD for Kluyveromyces lactis HSF and the 
solution structure of the DBDs for K. lactis and D. melanogaster HSF1 show that the 
DBD is a helix-turn-helix motif (Damberger, Pelton et al. 1994; Harrison, Bohm et al. 
                                                
1 Portions of this section have been previously published by the author (Westerheide, Raynes, et al 2012) 
and is utilized with permission of the publisher.  See Appendix E. 
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1994; Vuister, Kim et al. 1994).  The helix-turn-helix structure contains 3 alpha helices, 4 
beta strands, and an exposed loop.  Upon trimerization, the DBD of each HSF1 monomer 
recognizes an inverted nGAAn repeat of the HSE (Fernandes, Xiao et al. 1994).  The 
domains make contact with the major groove and with the DNA phosphate backbone by 
helix 3 (Vuister, Kim et al. 1994; Littlefield and Nelson 1999).  Helix 3 is a region rich in 
positive charge and is the most conserved region of the DBD.  Unlike other helix-
turn-helix proteins, the loop in the HSF1 DBD does not bind DNA.  Instead, the loop 
forms an interaction with the surface between adjacent HSF monomers (Littlefield and 
Nelson 1999). 
Trimerization domains 
The HSF1 trimerization domain is composed of three arrays of hydrophobic heptad 
repeats (HR-A/B) (Sorger and Nelson 1989).  HSF1 trimerization is unusual in that when 
the monomers come together, they form a leucine zipper, an artifact typically seen in 
dimerization.  Trimerization is constitutive and is actively suppressed by the hydrophobic 
heptad repeat HR-C (Rabindran, Haroun et al. 1993; Zuo, Baler et al. 1994).  When a 
mutation is introduced into the HR-C domain, trimerization and binding to the DNA is 
able to persist. S. cerevisiae and K. lactis HSFs have constitutive DNA-binding activity. 
In these HSFs, the HR-C is poorly conserved and does not actively suppress 
trimerization. Mutating the HR-C does not affect the oligomerization status of HSF in 
these organisms (Chen, Barlev et al. 1993).  
Transactivation domains (TAD) 
Transcriptional elongation of hsp genes is regulated by the transactivation domains 
(TAD) of HSF1.  In the absence of HSF1, RNA polymerase pauses at 46-49 bases 
downstream from the transcription start site even in the presence of excess free 
nucleotides (Brown, Imbalzano et al. 1996).  The HSF1 transactivation domain can be 
divided into two distinct regions rich in hydrophobic and acidic residues: activation 
domain I and activation domain II, spanning amino acids 371-430 and 431-505, 
respectively (Green, Schuetz et al. 1995; Shi, Kroeger et al. 1995; Zuo, Rungger et al. 
A. 
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1995).  These domains have been shown to equivalently stimulate both initiation and 
elongation of transcription (Brown, Weirich et al. 1998).  This redundancy may be in 
effect due to the importance of HSPs in maintaining protein homeostasis.   
Regulatory domain (RD) 
The regulatory activity of HSF1 is located between amino acids 221 and 310 and is 
functionally conserved between mammalian hsf1 genes, but not between other members 
of the HSF family (Green, Schuetz et al. 1995).  Upon non-stress conditions in which 
protein homeostasis is preserved, the transactivator activity of TAD I and TAD II is 
repressed by the regulatory domain and an exposure to stress leads to a reversal of this 
repression (Green, Schuetz et al. 1995; Newton, Knauf et al. 1996).    The regulatory 
domain of HSF1 contains several serine residues that are responsive to protein kinases 
and lead to repression of the TADs upon phosphorylation.  Phosphorylation by the MAP 
kinase ERK is responsible for this transactivator repression and mutation of these 
phosphorylation sites abolishes the suppression of the transactivation domains even in the 
absence of stress (Chu, Soncin et al. 1996).  
Post-translational Modification Regulation of HSF12  
HSF1 is extensively modified by post-translational modifications including 
phosphorylation, sumoylation, and acetylation (Figure 1.5).  This extensive modification 
may form a code to allow fine-tuning of the activity of HSF1 to the precise needs of the 
cell. 
Phosphorylation 
HSF is phosphorylated at several residues in order to promote or inhibit transactivation.  
HSF was first reported to display a reduction in electrophoretic mobility as a result of
                                                
2 Portions of this section have been previously published by the author (Westerheide, Raynes, et al 2012) 
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Figure 1.4. Amino acid sequence alignment of HSFs (with highlighted DBD) from different organisms using BLAST analysis.  
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Figure 1.5. Commonly discussed post‐translational modification sites for HSF1.  
In addition to these sites, Guettouche, et al. (2005) have indicated phosphorylation sites 
on serine residues 97, 230, 292, 314, 319, 344, and 363. While K80 is a critical lysine 
residue that when acetylated will cause a loss of affinity for DNA, other uncharacterized 
sites for acetylation include lysine residues 116, 118, 126, 148, 157, 208, 224, 298, 208, 
and 224 (Westerheide, Anckar et al. 2009). 
phosphorylation in S. cerevisiae (Sorger and Pelham 1988).  Mammalian HSF1 also 
exhibits a similar electrophoretic shift due to hyperphosphorylation upon activation of the 
heat shock response.  Phosphorylation regulates transcriptional activity and not DNA 
binding, as some inducers of HS, such as the anti-inflammatory agent sodium salicylate, 
are capable of inducing HSF1 to bind to the DNA, but do not cause hyperphosphorylation 
(Jurivich, Sistonen et al. 1992).  Another example of the distinction between these two 
activities is observed in yeast.  In S. cerevisiae, HSF exists as a trimer with constitutive 
DNA-binding activity.  However, transcriptional activation only occurs in the presence of 
increased phosphorylation (Sorger, Lewis et al. 1987; Sorger and Pelham 1988; Sorger 
1990).    
Through phosphoamino acid analyses and mass spectrometry, several phosphorylation 
sites within HSF1 have been mapped.  While phosphorylation has been primarily mapped 
to serine residues, a low level of threonine phosphorylation has also been detected (Chu, 
Soncin et al. 1996; Cotto, Kline et al. 1996; Kline and Morimoto 1997; Xia and Voellmy 
1997; Holmberg, Hietakangas et al. 2001).  Of the first phosphorylation sites to be 
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characterized are serine residues S303, S307, and S363 located within the C-terminal 
region of the regulatory domain.  These sites are proline-directed and typically 
experience phosphorylation in the absence of stress.  Upon stress, the repressive activity 
of these residues is superseded by the activation of HSF1 (Chu, Soncin et al. 1996; 
Knauf, Newton et al. 1996; Kline and Morimoto 1997).     An HSF1 phosphorylation site 
that leads to transcriptional activation is serine residue 230, located within the N-terminal 
region of the regulatory domain (Holmberg, Hietakangas et al. 2001).  Many sites within 
HSF1 can be phosphorylated, and a mass spectrometry analysis of HSF1 activated by 
heat shock found phosphorylation on Ser121, Ser230, Ser292, Ser303, Ser307, Ser314, 
Ser319, Ser326, Ser344, Ser363, Ser419, and Ser444 (Guettouche, Boellmann et al. 
2005). Phosphorylation of Ser326, but none of the other serine residues, was found to 
contribute significantly to activation of HSF1 upon stress in this study (Guettouche, 
Boellmann et al. 2005). While the implications of HSF1 phosphorylation have yet to be 
fully characterized, it is clear that dynamic phosphorylation modulates HSF1 activity in 
both a positive and negative manner.   
HSF1 phosphorylation is regulated by a number of kinases with several of the residues 
suspected to undergo modification by more than one kinase.  MAP kinases have been 
shown to negatively regulate HSF1 activity and the HSF1 Serine residues S303, 307 and 
363 have been found to be MAP kinase targets.  The MAP kinase ERK1 has been shown 
to phosphorylate S307, after which S303 is receptive to phosphorylation by glycogen 
synthase-3 kinase (GSK-3) (Chu, Soncin et al. 1996; Knauf, Newton et al. 1996; Kline 
and Morimoto 1997).  The MAP kinase p38 has also been reported to phosphorylate 
S303 and/or S307, resulting in basal repression of HSF1 (Knauf, Newton et al. 1996).  
JNK, another MAP kinase family member, and the PKC isoforms alpha and zeta have 
been suggested to phosphorylate S363, thereby contributing to the maintenance of HSF1 
in an inert state (Chu, Zhong et al. 1998; Dai, Frejtag et al. 2000).  Inhibition has also 
been shown to occur through the phosphorylation of S121 by the proinflammatory 
protein kinase MK2, which may lead to an increase in affinity for Hsp90 (Wang, 
Khaleque et al. 2006).  Various kinases suspected of activating HSF1 have also been 
discovered. For instance, the Ca2+/calmodulin-dependent kinase II (CaMK II) 
phosphorylates S230 and promotes transcriptional activity (Holmberg, Hietakangas et al. 
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2001).  Given the broad range of stimuli that induce the HSR and the vast number of 
HSF1 phosphorylation sites, it may be that different kinases regulate HSF1 depending on 
the nature of the stress.  As an example, in yeast, Snf1 protein kinase has been shown to 
regulate HSF1 in low glucose conditions, but does not phosphorylate HSF upon 
temperature heat shock (Hahn and Thiele 2004).   
Sumoylation  
Upon stress, HSF1 is modified by SUMO-1 at the well-conserved lysine residue 298 
within the N-terminal region of the regulatory domain (Hietakangas, Ahlskog et al. 
2003).  In order for K298 to become sumoylated, S303 must first undergo 
phosphorylation, which has a repressive effect on HSF1 activation (Hietakangas, Ahlskog 
et al. 2003).   There may be a regulatory interplay of modifications at this residue as 
residue K298 is also an acetylation site (Westerheide, Anckar et al. 2009). 
Acetylation 
While the kinetics of phosphorylation and sumoylation are brought on rapidly upon 
stress, acetylation is delayed and coincides with a reduction of HSF1 DNA-binding 
activity at the decline of the HSR (Westerheide, Anckar et al. 2009).  Acetylation of 
HSF1 by the histone acetyltransferase p300 occurs to diminish HSF1 binding to the 
DNA.  The deacetylation of HSF1 is regulated by the NAD+-dependent deacetylase 
SIRT1. When SIRT1 is inhibited by siRNA, not only are the levels of heat shock-induced 
hsp70 mRNA significantly decreased, but the ability of HSF1 to bind to the hsp70 
promoter region is also greatly reduced (Westerheide, Anckar et al. 2009).   
Other Heat Shock Transcription Factors3 
The mammalian HSF family is composed of HSF1, 2, 3, 4, 5, Y and X (Fujimoto and 
Nakai 2010).  While there is some redundancy, the HSF family members maintain 
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different functionalities.  Mammalian HSF1 is the ortholog of the single, essential HSF 
that is present in S. cerevisiae, C. elegans, and D. melanogaster.  HSF1 is the best-
characterized member of the HSF family and the factor responsible for the HSR.   HSF2 
and HSF4 have various roles in development and differentiation (Pirkkala, Nykanen et al. 
2001).  Mammalian HSF3, 5, Y and X have not yet been well characterized. 
HSF2 
HSF2 has been shown to recruit to satellite III repeats in nuclear stress bodies (NSBs) 
along with HSF1 (Alastalo, Hellesuo et al. 2003). At this colocalization site, HSF2 has 
been indicated to play a role in the HSR by modulating HSF1 in a heterocomplex 
formation (Ostling, Bjork et al. 2007).  HSF2 was originally discovered in tandem with 
HSF1 and similarly was shown to stimulate HSE-dependent transcription in vitro (Sarge, 
Zimarino et al. 1991; Schuetz, Gallo et al. 1991).  While HSF2 is capable of inducing the 
transcription of HSPs, it is not activated by heat and therefore has not been associated 
with the induction of the HSR (Sarge, Zimarino et al. 1991; Sistonen, Sarge et al. 1992).  
However, HSF2 has been shown to be involved in development and cellular 
differentiation (Sistonen, Sarge et al. 1992; Mezger, Rallu et al. 1994; Murphy, 
Gorzowski et al. 1994; Sarge, Park-Sarge et al. 1994; Rallu, Loones et al. 1997).   
Despite low amino acid sequence homology between HSF1 and HSF2, the DNA binding 
domain, as well as the N-terminal and C-terminal trimerization domains, are conserved. 
Similar to human HSF1, more than half of HSF2 is predicted to be disordered.  In 
addition, HSF2 possesses several ordered functional domains including a DBD (residues 
7-112), a HR-A/B domain (residues 119-192), and a HR-C domain (residues 360-385). 
The remainder of HSF2 is mostly disordered. However, the manner of DNA-binding 
differs between the two proteins.  HSF2 appears to regulate a different set of target genes 
compared to HSF1 and also experiences variable expression patterns in different tissues 
and cell types (Sistonen, Sarge et al. 1992; Rallu, Loones et al. 1997).  The DNA 
binding-specificity of HSF1 is determined by the loop within the DNA binding domain.  
Chimeric HSF2 containing the HSF1 DBD loop is capable of binding to HSF1 target 
genes upon HS stress (Ahn, Liu et al. 2001).  In addition, the transactivation activity of 
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HSF2 is considerably weaker than HSF1, possibly as a result of a dispersed AD 
(Yoshima, Yura et al. 1998).  In addition to the role of HSF2 in development, evidence 
has indicated that HSF2 may act as a modulator of HSF1 transcription.  While HSF2 has 
not been shown to directly regulate the HSR, HSF2 has been shown to interact with 
HSF1, is recruited to nuclear stress bodies along with HSF1, and has been shown to 
stimulate HSF1-mediated transcription upon heat shock stress (He, Soncin et al. 2003).   
HSF4 
HSF4 exhibits limited sequence homology to the other HSF family members, but regions 
of similarity correspond to the DNA binding domain and the N-terminal hydrophobic 
repeats (HR-A/B).  Like other HSF family members, HSF4 is able to bind to HSEs.  
However, when HSF4 is co-transfected into Cos7 cells along with a transcriptional 
HSE-reporter construct, HSF4 is unable to induce transcription and is therefore not a 
typical activator for the transcription of hsp genes (Nakai, Tanabe et al. 1997).  In 
addition, HSF4 lacks a cis-regulatory domain that represses HSF1 under non-stress 
conditions (Green, Schuetz et al. 1995). 
HSF4 has also been shown to exhibit crosstalk with HSF1.  Together, HSF1 and HSF4 
are involved in the maintenance of sensory organs and are critical during lens 
development (Fujimoto, Oshima et al. 2008).  HSF4 expression is specific to the brain 
and lungs and has been indicated to play a role in protein quality control (Tanabe, Sasai 
et al. 1999; Fujimoto, Izu et al. 2004). Mutations of HSF4 have been shown to lead to 
cataractogenesis and the breakdown of the lens microarchitecture (Bu, Jin et al. 2002; 
Smaoui, Beltaief et al. 2004).  Two HSF4 missense mutations have been identified by 
screening age-related cataract patients (Shi, Shi et al. 2008).  These mutations appear to 
have an effect on HSF4 DNA-binding to HSEs resulting in an under-expression of heat 
shock proteins in the lens, which consequently lead to an increase in protein aggregates 
that cause cataracts. 
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HSF3, 5, X and Y 
HSF3 was first identified in chicken, where it is the HSF that is essential for activation of 
the HSR in this species (Nakai and Morimoto 1993).  Mammalian HSF3 has only 
recently been identified in mouse, and is capable of activating non-classical heat 
inducible genes during HS by binding to the PDZ domain-containing 3 (Pdzk3) promoter 
(Sistonen, Sarge et al. 1992).  Although sequences related to HSF3 have also been found 
in the orthologous region of the human genome, this sequence is thought to be a 
pseudogene as no transcripts corresponding to this gene have been found (Fujimoto and 
Nakai 2010). 
HSF5 has recently been discovered as part of a large gene characterization project (Ahn, 
Liu et al. 2001) and has been identified as a potential transcription factor within the HSF 
family, but has not undergone characterization.  HSFY and HSFX are the only members 
of the HSF family found on the sex chromosomes.  HSFY is present on the human 
Y chromosome as well as murine chromosome 2.  It is predominantly expressed in the 
testes and may potentially have a role in spermatogenesis (Shinka, Sato et al. 2004; 
Tessari, Salata et al. 2004; Bhowmick, Takahata et al. 2006).  Even less has been 
characterized regarding HSFX, but both HSFs have been found to exist as two identical 
copies (Bhowmick, Takahata et al. 2006).   
Sensory Regulation of HSF1 and the Heat Shock Response 
Due to the importance of HSF1 as a regulator of protein homeostasis, the activation and 
disengagement of transcriptional activity is a finely tuned process.  While many studies 
have focused on the function of HSF1 as the master regulator of cytoprotective genes, 
little work has focused on the manner in which HSF1 senses proteotoxic stress and 
mounts or attenuates a response.  The triggering of HSF1 by temperature sensitive RNAs 
and negative feedback by HSPs are two mechanisms of HSF1 control. 
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Activation of HSF1 by Temperature Sensitive RNA 
In E. coli, the HSR is regulated by an alternative sigma factor known as σ32, which 
recruits RNA polymerase to transcribe HSPs (Grossman, Erickson et al. 1984; Taylor, 
Straus et al. 1984).  Upon thermal stress, HSP transcription is rapidly induced, then 
declines as the cells adapt to the stress, and finally reaches an equilibrium that is typically 
observed in high temperature bacteria (Straus, Walter et al. 1987).  Once the cells reach 
homeostatic conditions, excess HSPs are diluted out of the cells as they divide.  An 
upshift in temperature results in the translation of σ32, which is encoded by the rpoH 
gene.  One of the hallmarks of translational control of σ32 is the ability of the rpoH 
mRNA to react to changes in temperature.  At 30°C, rpoH mRNA undergoes a structural 
transition that results in base-pairing that occludes the Shine-Dalgarno sequence 
(Figure 1.6), thus inhibiting translation.  However, at high temperatures the rpoH RNA 
secondary structure is resolved and translation of σ32 is no longer inhibited (Morita, 
Kanemori et al. 1999; Morita, Tanaka et al. 1999).  Therefore, rpoH mRNA acts as a 
thermosensor to regulate the abundance of the HSR sigma factor, σ32, and thus it’s ability 
to mount and attenuate a response to denaturing stress.  
In eukaryotes, temperature-sensing RNA has also been indicated to play a regulatory role 
in the HSR.  In a study to identify putative HSF1 interacting partners, fractionation of 
lysate from HS-treated HeLa or hamster BHK-21 cells on an HSF1-Sepharose column 
and subsequent mass spectrometry analysis resulted in the identification of an 
aminoacyl-tRNA-binding translation elongation factor known as eEF1A (Shamovsky, 
Ivannikov et al. 2006).  Co-immunoprecipitation of eEF1A from BHK-21 cells indicated 
an increase in eEF1A-bound HSF1 upon HS, but exogenous eEF1A was unable to 
activate HSF1 in vitro (Shamovsky, Ivannikov et al. 2006).  Further analysis indicated 
that the presence of a specific non-coding RNA (ncRNA), subsequently named Heat 
Shock RNA-1 (HSR-1), was required to mediate eEF1A conversion of HSF1 into its 
trimeric DNA-bound state (Shamovsky and Nudler 2009).  While little is know regarding 
HSR-1 RNA, it is a proposed thermosensor that may undergo structural changes 
resembling the mechanism of translational control in the bacterial rpoH RNA 
thermometer.    
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Figure 1.6.  Secondary RNA structure for the bacterial rpoH mRNA.   
The rpoH RNA undergoes a secondary structure upon homeostatic conditions that blocks 
translational access of the ribosomal subunits to the Shine-Dalgarno sequence.  Induction 
of thermal stress results in the melting of the rpoH RNA structure and allows the 
ribosome to translate sigma factor 32 (Johansson and Cossart 2003).  
Negative feedback of HSF1 by Heat Shock Proteins 
During the recovery phase of the HSR, an accumulation of HSPs corresponds to a 
reduction of hsp transcription, therefore attenuating the response.  Perturbation of HSP 
translation or functionality results in a prolonged HSR in which hsp transcription does 
not abate, indicating a self-regulating mechanism for transcriptional control of HSF1 
(Didomenico, Bugaisky et al. 1982).  HSP regulation of HSF1 is present in homeostatic 
conditions, whereby HSP90 sequesters the inactive HSF1 monomer in the cytoplasm; 
upon activation of HSF1 by denaturing stress, the HSP90-HSF1 interaction is greatly 
diminished (Zou, Guo et al. 1998).  Furthermore, inhibition of HSP90 by geldanamycin 
in Xenopus oocytes results in the conversion of HSF1 to an active trimer (Ali, Bharadwaj 
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et al. 1998).  In addition to releasing the monomeric HSF1 for trimeric activation in the 
cytoplasm, HSP90 may play a role in inactivation of HSF1 in the nucleus.  An 
HSP90-FKBP52-p23 complex binds to the HSF1 regulatory domain (RD) and disruption 
of this complex promotes HSF1 DNA-binding at hsp promoters (Ali, Bharadwaj et al. 
1998; Bharadwaj, Ali et al. 1999; Guo, Guettouche et al. 2001). 
In addition to HSP90 regulation, the robust increase of HSP70 levels that accrue 
throughout the HSR also play a role in the negative feedback of HSF1.  HSP70, along 
with co-chaperone HSP40, bind to the HSF1 activation domain (AD) and inhibit HSF1 
transactivation (Shi, Mosser et al. 1998).  This model is a method to sequester monomeric 
HSF1 in the cytoplasm during unstressed conditions.  HSP70/HSP40 is then titrated away 
from HSF1 upon the presence of misfolded proteins, thus allowing the transactivation of 
HSF1. Moreover, accumulation of HSP chaperones and the unavailability of denatured 
proteins causes HSP70/HSP40 to disassociate HSF1 trimers (Morimoto, Sarge et al. 
1992; Shi, Mosser et al. 1998).  However, the robust molar excess of HSP70 in heat 
shocked cells would presumably make fine-tuning of HSF1 activity problematic 
(Shamovsky and Nudler 2008).  Therefore, negative feedback by the HSP70/HSP40 
complex may be a passive mode of control compared to HSP90 regulation.  Additionally, 
post-translational acetylation of the HSF1 DBD is a more rapid measure to repress HSF1, 
with SIRT1 acting as an inhibitor of HSF1 repression. 
An Introduction to Sirtuins 
The sirtuin family is evolutionarily conserved from prokaryotes to eukaryotes 
(Brachmann, Sherman et al. 1995).  Sir2 (silent information regulator 2) is the original 
sirtuin and was first observed in yeast during an extensive screen for silencing factors 
(Rine, Strathern et al. 1979).  Sir2 is a Class III NAD+-dependent histone deacetylase that 
possesses transcriptional silencing activity due to the removal of histone acetyl groups 
resulting in the tighter packaging of chromatin (Fritze, Verschueren et al. 1997).  The 
mechanism of sirtuin deacetylation is unique, in which the SIRT protein binds to a NAD+ 
molecule, thus cleaving nicotinamide and transferring the acetyl group from a substrate 
protein onto the NAD+ backbone.  The result is a 1:1:1 ratio of nicotinamide, O-acetyl-
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ADP-ribose, and the deacetylated substrate protein as measured by HPLC quantification.  
In the absence of enzyme or acetylation of the substrate protein, no ADP-ribose or 
nicotinamide is generated from available NAD+, thus establishing the necessity of NAD+ 
hydrolysis in the catalysis of SIRT1 deacetylation activity (Landry, Slama et al. 2000).  
Additionally, some sirtuin family members, such as SIRT4 and SIRT6, possess 
ADP-ribosyltransferase activity capable of transferring the O-acetyl-ADP-ribose onto 
acceptor protein residues (Haigis and Sinclair 2010). ADP-ribosyltransferase activity 
occurs most often in the presence of proteins containing acetyl-lysines and is not specific 
to sirtuin deacetylation of threonine and serine residues (Landry, Sutton et al. 2000).   
Interest in sirtuins has grown with their association with longevity. It was found that an 
extra copy of Sir2 transformed into yeast resulted in a reduction in recombination of 
ribosomal DNA and a subsequent 30% increase in lifespan of the yeast mother cell 
(Kaeberlein, McVey et al. 2001).  The Sir2 homolog Sir2.1 was later discovered to 
extend lifespan in C. elegans, suggesting that Sir2 homologs and the NAD+/NADH ratio 
may also be responsible for extending lifespan in higher eukaryotes, such as mammals 
(Tissenbaum and Guarente 2001).  While several studies have supported the role of Sir2 
in longevity, recently the impact of sirtuins in fly and worm lifespan extension has been 
questioned on the basis that several aging studies did not utilize the appropriate controls.  
By outcrossing Sir2 overexpression transgenic animals to wild-type animals, the intensity 
observed in previous lifespan studies was diminished, thus bringing to light that differing 
genetic backgrounds related to transgene insertion must be a measure controlled in 
experimental design (Burnett, Valentini et al. 2011).  Recent experiments to address this 
issue in C. elegans with identical genetic backgrounds now show that while the original 
effect on lifespan by Sir2 overexpression was overestimated, there is still a 10–14% 
lifespan extension (Viswanathan and Guarente 2011). 
Modulators of SIRT1 
While evidence has emerged that the NAD+/NADH ratio plays a critical role in SIRT1 
regulation, until recently little investigation had been done concerning proteins that may 
play a role in regulating the function of SIRT1.  Two potentially significant modulators 
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of SIRT1 activity include the positive and negative regulators AROS and DBC1, 
respectively.  AROS, an alias for Active Regulator of SIRT1, is a nuclear protein also 
referred to as ribosomal protein S19 binding protein 1 (RPS19bp1).  Mutations in 
Ribosomal protein S19 (RPS19) are found in patients diagnosed with a type of aplastic 
iron deficiency known as Diamond-Blackfan anemia (DBA) (Draptchinskaia, Gustavsson 
et al. 1999) and RPS19bp1 was discovered as a result of a study investigating the role of 
RPS19 in erythropoiesis (Maeda, Toku et al. 2006).  AROS has been shown to enhance 
SIRT1-mediated deacetylation of p53, thus inhibiting p53-mediated transcriptional 
activity and promoting cell survival.  In addition, AROS activity is abrogated by SIRT1 
inhibitors and SIRT1 siRNA (Kim, Kho et al. 2007). 
DBC1, an alias for Deleted in Breast Cancer 1, was initially cloned from a region (8p21) 
homozygously deleted in 3.5% of breast cancers (Hamaguchi, Meth et al. 2002).  DBC1 
has been found to directly interact with SIRT1 and inhibit deacetylase activity both 
in vivo and in vitro (Kim, Chen et al. 2008).  DBC-1 mediated down-regulation of SIRT1 
has an effect on the transcriptional activity of other sirtuin substrates, such as p53.  The 
repression of SIRT1 by DBC1 leads to an increase in p53 acetylation, and therefore an 
upregulation of p53 apoptotic activity.  Likewise, the RNA interference of DBC1 results 
in an increase of SIRT1-mediated deacetylation thus inhibiting p53-dependent apoptosis 
(Zhao, Kruse et al. 2008). In a similar manner, DBC1 has also been shown to regulate the 
acetylation status of the nuclear receptor PPARγ (Santagata, Hu et al. 2011).   Both 
AROS and DBC-1 have yet to be investigated in relation to SIRT1 and the HSR.     
Molecular function of SIRT1 
The deacetylase activity of SIRT1 has been well documented in the regulation of several 
stress-induced transcription factors including p53 (Luo, Nikolaev et al. 2001; Vaziri, 
Dessain et al. 2001), NF-κB (Yeung, Hoberg et al. 2004; Salminen, Huuskonen et al. 
2008; Jung, Lee et al. 2009), PGC-1α (Rodgers, Lerin et al. 2005; Rodgers, Lerin et al. 
2008), HIV Tat (Chen, Zhou et al. 2005; Pagans, Pedal et al. 2005), and the FOXO 
family of transcription factors (Brunet, Sweeney et al. 2004; Motta, Divecha et al. 2004; 
Viswanathan, Kim et al. 2005). Research has highlighted SIRT1 as a potential oncogene 
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based on its ability to deacetylate p53, thus resulting in cell survival (Vaziri, Dessain et 
al. 2001).  SIRT1 deacetylation of transcription factors may result in their activation or 
inactivation.  For instance, SIRT1 deacetylation of the FOXO family of transcription 
factors activates genes that are important for gluconeogenesis (Brunet, Sweeney et al. 
2004; Giannakou and Partridge 2004), while deacetylation of NF-κB results in the 
suppression of inflammatory responses (Yang, Zhang et al. 2012).  In addition, SIRT1 
deacetylation of Tat, the viral trans-activating regulatory protein, has been shown to 
increase HIV expression (Pagans, Pedal et al. 2005).  Most recently, SIRT1 has been 
shown to be an HSF1 deacetylase, indicating SIRT1 as a regulator of protein homeostasis 
(Westerheide, Anckar et al. 2009).  The activation of SIRT1 upon stress may be an 
evolutionarily conserved role to drive cellular homeostasis by invoking a variety of stress 
response pathways.   
SIRT1 and Metabolic Stress 
Caloric restriction (CR) is a 30-40% decrease in dietary intake with maintained nutrition 
that has been shown to increase longevity and protect against age-related disease (Bishop 
and Guarente 2007). The life extension effects of CR were first established as early as 
1935 using calorically-restricted rats (McCay, Crowell et al. 1989) and have now been 
extended to yeast (Fabrizio, Pozza et al. 2001; Kaeberlein, Powers et al. 2005), 
nematodes (Johnson 2008; Greer and Brunet 2009), flies (Giannakou, Goss et al. 2008; 
Min, Yamamoto et al. 2008), and mice (Anderson, Shanmuganayagam et al. 2009).   
Sirtuins are linked to metabolism based on their unique ability to breakdown NAD+ 
during protein deacetylation, resulting in the formation of nicotinamide and 
O-acetyl-ADP-ribose (Denu 2003).  Nicotinamide phosphoribosyltransferase (NAMPT) 
is an important component in the NAD+ synthesis pathway that converts nicotinamide to 
NAD+ and has been shown to regulate the transcriptional function of Sir2α in mammalian 
cells (Revollo, Grimm et al. 2004).  In fasted mice, an increase in NAMPT activity 
correlated with an increase in NAD+ levels and enhanced SIRT1 transcriptional activity 
(Hayashida, Arimoto et al. 2010) (Figure 1.7).  Interestingly, it has been reported that a 
10-fold change in cellular NAD+ concentration is required to affect Sir2 activity 
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(Anderson, Latorre-Esteves et al. 2003).  However, CR studies in yeast have shown that 
Sir2 activity is also regulated by a reduction of NADH, a competitive inhibitor of Sir2 
(Lin, Ford et al. 2004; Rahat, Maoz et al. 2011).  CR was found to increase the replicative 
lifespan of budding yeast by Sir2 activation due to decreasing the NADH levels resulting 
in an increase in the NAD+/NADH ratio (Lin, Ford et al. 2004).  In both calorically 
restricted rats and human cell culture treated with serum from these animals, CR results 
in an increase of SIRT1 expression (Cohen, Miller et al. 2004).   
  
Figure 1.7.  Model of sirtuin deacetylation. 
Sirtuins bind to NAD+ and an acetylated substrate protein in order to catalyze the transfer 
of the acetyl group to the NAD+-backbone, thus resulting in the deacetylated substrate 
protein, nicotinamide, and O-acetyl-ADP-ribose in a 1:1:1 ratio.  Nicotinamide, a SIRT 
inhibitor, is converted back to NAD+ upon CR induction of the NAD+ biogenesis 
pathway through NAMPT.   
Furthermore, while SIRT1 is regulated in part by metabolism, SIRT1 is also required for 
the CR phenotype.  In yeast, the deletion of Sir2 blocks the beneficial effects of CR on 
yeast lifespan (Lin, Kaeberlein et al. 2002).  In mammals, CR produces complex 
behavioral changes, including increased physical activity and an increase in distance 
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coverage, which is most likely associated with foraging behavior (Weed, Lane et al. 
1997).  Moreover, wild-type mice and SIRT1 knockout (KO) mice demonstrate vastly 
different phenotypes upon CR, with the SIRT1 KO mice exhibiting traits very similar to 
wild-type control mice that are not on a restricted diet (Chen, Steele et al. 2005).  
Metabolism and the Heat Shock Response 
Overnutrition is a major health concern in developed countries and is the result of an 
unbalanced lifestyle in which energy consumption surpasses energy expenditure.  This 
imbalance can lead to the development of a condition known as metabolic syndrome that 
is characterized by insulin resistance, hypertension, obesity, and type 2 diabetes (Zimmet, 
Magliano et al. 2005).  The metabolic dysfunction characterized by diabetes can lead to a 
loss of protein homeostasis that impacts a number of biological systems.  For example, 
post-translational glycation of the small HSP α-crystallin in the lens leads to a decrease in 
chaperone activity that contributes to the formation of cataracts (Kumar, Kumar et al. 
2007).  Diabetic patients exhibit decreased expression of HSP70 in skeletal muscle 
(Kurucz, Morva et al. 2002) and diabetic monkeys display a significant decline of both 
HSP70 and HSP90 in the blood and liver (Kavanagh, Zhang et al. 2009).  While an 
impaired HSR is a hallmark of diabetic disease, induction of the HSR can rescue 
metabolic distress.  For instance, physical exercise has been shown to induce the HSR 
resulting in the upregulation of HSPs (Smolka, Zoppi et al. 2000; McArdle, Pattwell et al. 
2001; Milne and Noble 2002).  Furthermore, streptozotocin-induced diabetic rats have 
impaired HSP72 expression in the heart, liver, and muscles, but 8 weeks of endurance 
training increased HSP72 expression and compensated for some of the deleterious effects 
associated with diabetes (Atalay, Oksala et al. 2004; Lappalainen, Lappalainen et al. 
2010).  Interestingly, rats on a high-fat diet that were treated weekly with a 20 min HS at 
41° C for 12 weeks have improved glucose tolerance, increased insulin signaling, and 
increased expression of HSP72 and HSP25 (Gupte, Bomhoff et al. 2009).   
Due to the fact that overnutrition leads to proteotoxic stress, it stands to reason that 
caloric restriction has a positive impact on protein homeostasis.  CR reverses the 
age-related decline of HSP70 in rat hepatocytes (Heydari, Wu et al. 1993).  Moreover, 
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CR promotes cytoprotection to thermal stress allowing for 100% survival compared to 
50% survival of old rats on an ad libitum diet (Hall, Oberley et al. 2000).  Other forms of 
diet restriction including glucose restriction with 2-deoxy-D-glucose (DOG), a 
nonmetabolizable glucose analog, have been shown to increase HSP70 levels in the 
striatum, hippocampus, and synaptic terminals of rat brains (Duan and Mattson 1999; 
Lee, Bruce-Keller et al. 1999; Yu and Mattson 1999; Guo and Mattson 2000).  
DOG-treated animals experienced cytoprotection from oxidative damage and 
mitochondrial dysfunction upon exposure to amyloid beta-peptide (Guo and Mattson 
2000).  However, the cytoprotective nature of a restricted diet appears to be due to a 
number of protective mechanisms that overlap with the HSR.  In C. elegans, HSF-1 is 
required for longevity (Morley and Morimoto 2004), but glucose restriction via 
DOG-treatment results in lifespan extension that is independent of the HSF-1 regulator, 
Sir2.1 (Schulz, Zarse et al. 2007).  There are several methods to induce dietary restriction 
that differentially invoke a number of cytoprotective pathways including the forkhead 
transcription factor FOXO, the AMP-dependent protein kinase AMPK, and the oxidative 
stress inducible Nrf2, in addition to HSF1 [reviewed in (Dancso, Spiro et al. 2010)].  
Regardless of the crosstalk between these various pathways, it is evident that the HSR 
and metabolism are linked and dynamically impact organismal health. 
SIRT1 Regulation of HSF1 
SIRT1 regulates the HSR in an HSF1-dependent manner.  In cell culture, SIRT1 siRNA 
inhibition results in a significant reduction of HSF1 recruitment to the hsp70 promoter 
and a drastic decline of hsp70 mRNA levels upon HS (Westerheide, Anckar et al. 2009).  
Moreover, only wild-type SIRT1, and not a catalytic mutant, is capable of deacetylating 
HSF1 in an in vivo acetylation assay (Westerheide, Anckar et al. 2009).  Recently, SIRT1 
has also been shown to deacetylate HSF1 in neurons stressed by mutated α-synuclein.   
SIRT1 activated the HSR in an HSF1-dependent manner, thereby increasing hsp70 
transcription resulting in a reduction of α-synuclein aggregation and conferring 
neuroprotection (Donmez, Arun et al. 2012). 
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Since the initial finding that SIRT1 regulates the HSR in an HSF1-dependent manner, 
little work has been done to understand the role of SIRT1 on the HSR.  This dissertation 
aims to elucidate the role of SIRT1 on the heat shock response and the impact of 
metabolism.   
Specific Aims 
The objective of this study is to investigate the mechanism by which SIRT1 regulates 
HSF1 activity and the impact of caloric restriction.  The hypothesis of this proposal is 
that SIRT1 undergoes a change in activity upon stress, including heat and caloric 
restriction, resulting in the modulation of the heat shock response.  The following 
specific aims are designed to test this hypothesis. 
Investigate the Mechanism of SIRT1 regulation of the Heat Shock Response 
(Chapter 2) 
Aim 1: Determine the mechanism of SIRT1 activity regulation upon initiation of the heat 
shock response. 
1.1: Determine whether sirt1 mRNA or protein levels change upon initiation of the 
HSR. 
1.2: Investigate how heat shock influences the cellular NAD+/NADH ratio. 
1.3: Determine if initiation of the HSR alters SIRT1 recruitment to the hsp70 
promoter. 
1.4: Investigate whether AROS and DBC1 impact SIRT1 deacetylation of HSF1. 
Aim 2: Investigate the role of AROS and DBC1 in SIRT1 regulation of the HSR in an 
HSF1 dependent manner. 
2.1: Determine if AROS and DBC1 mRNA or protein levels vary throughout a heat 
shock time course. 
2.2: Determine if AROS and DBC1 have a positive and negative impact, 
respectively, on the HSR. 
2.3: Determine if AROS and DBC1 alter HSF1 recruitment to and activity at the 
hsp70 promoter. 
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Evaluate the Impact of Caloric Restriction on Sir2.1 Regulation of the Heat Shock 
Response and the Effect on Cytoprotection in a C. elegans model (Chapter 3) 
Aim 1: Investigate the effect of metabolism on Sir2.1-regulation of the heat shock 
response. 
1.1: Determine if heat shock and metabolism have the same effect on the HSR using 
a strain of C. elegans possessing GFP integrated with a heat inducible promoter. 
1.2: Determine whether a synergistic effect between elevated temperature and 
caloric restriction is observed at the transcriptional level for multiple members of 
the hsp70 family. 
1.3: Investigate whether a synergistic effect between elevated temperature and 
caloric restriction is dependent on Sir2.1, specifically. 
Aim 2: Investigate the functional effects of synergy between elevated temperature and 
caloric restriction. 
2.1: Investigate the biological significance of synergy between elevated temperature 
and caloric restriction by evaluating organismal cytoprotection. 
2.2: Investigate the impact of synergy between elevated temperature and caloric 
restriction using a neurodegenerative disease model. 
Studies 
The first two chapters consist of published manuscripts designed to address the Specific 
Aims (pages 28-29).  Chapter 1 evaluates the roles of AROS and DBC1 in regulation of 
the heat shock response. Chapter 2 evaluates the capacity for caloric restriction and 
temperature heat shock to synergize to promote the induction of the heat shock response 
and cytoprotection in the Caenorhabditis elegans model organism.  Chapter 3 consists of 
unpublished data supporting the hypothesis that RPS19, an AROS-interacting protein, is 
a transcriptional target of HSF1. 
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CHAPTER 2: THE SIRT1 MODULATORS AROS AND DBC1 REGULATE 
HSF1 ACTIVITY AND THE HEAT SHOCK RESPONSE 
Authored by Rachel Raynes, Kathleen M. Pombier, Kevin Nguyen, Jessica Brunquell, 
Jamie E. Mendez, and Sandy D. Westerheide. 
Published in PLoS ONE 8(1): e54364. doi:10.1371/journal.pone.0054364. January 18, 
2013. 
Experiments were designed, performed, and analyzed by R. Raynes or performed under 
the direction of R. Raynes.  K. Pombier performed overexpression transfection in 
Figure 2.4B,C. K. Nguyen performed qPCR replicates for Figures 2.5C,D.  J. Brunquell 
and R. Raynes measured cell viability in Figure 2.5B and 2.6C.  J. Mendez and R. Raynes 
measured luciferase activity in Figure 2.4C.      
All data analysis and figures were generated by R. Raynes.  The manuscript was written 
by R. Raynes and S.D. Westerheide.  See Appendix E for copyright permission. 
Abstract 
The heat shock response, the cellular response to protein damaging stress, is critical in 
maintaining proteostasis.  The heat shock response is regulated by the transcription factor 
HSF1, which is activated upon heat shock and other stresses to induce the expression of 
molecular chaperones. SIRT1 has previously been shown to activate HSF1 by 
deacetylating it, leading to increased DNA binding ability.  We have investigated how the 
heat shock response may be controlled by factors influencing SIRT1 activity.  We found 
that heat shock results in an increase in the cellular NAD+/NADH ratio and an increase in 
recruitment of SIRT1 to the hsp70 promoter. Furthermore, we found that the SIRT1 
modulators AROS and DBC1 have an impact on hsp70 transcription, HSF1 acetylation 
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status, and HSF1 recruitment to the hsp70 promoter.  Therefore, AROS and DBC1 are 
now two new targets available for therapeutic regulation of the heat shock response. 
Introduction 
The heat shock response (HSR) is a cellular response to diverse stressors that results in 
the induction of genes encoding molecular chaperones essential for protection and 
recovery from cellular damage (Anckar and Sistonen 2011). The stressors that activate 
transcription of these heat shock genes include elevated temperature, heavy metals, 
chemical toxicants, and oxidative stress. Heat shock proteins function to guide protein 
folding and protect cells against a wide array of stress conditions (Morimoto, 
Westerheide et al. 2009). The HSR is regulated at the transcriptional level by the heat 
shock transcription factor 1 (HSF1). 
SIRT1 is a NAD+-dependent deacetylase that regulates a number of target proteins, 
including p53 (Luo, Nikolaev et al. 2001; Vaziri, Dessain et al. 2001), PGC-1α (Rodgers, 
Lerin et al. 2005; Rodgers, Lerin et al. 2008), HIV Tat (Chen, Zhou et al. 2005; Pagans, 
Pedal et al. 2005), NF-κB (Yeung, Hoberg et al. 2004; Salminen, Huuskonen et al. 2008; 
Jung, Lee et al. 2009), and the FOXO family of transcription factors (Brunet, Sweeney et 
al. 2004; Motta, Divecha et al. 2004; Viswanathan, Kim et al. 2005). We have previously 
shown that SIRT1 also impacts the HSR by deacetylation of the transcription factor 
HSF1 (Westerheide, Anckar et al. 2009).  However, the mechanism by which heat shock 
(HS) may regulate SIRT1 is still unknown.   
SIRT1 has been shown to be regulated by diverse mechanisms.  SIRT1 mRNA levels are 
stabilized by HuR, a ubiquitously expressed RNA binding protein, and oxidative stress 
has been reported to dissociate the HuR-sirt1 mRNA complex allowing for sirt1 mRNA 
decay (Abdelmohsen, Pullmann et al. 2007).  SIRT1 enzymatic activity can be regulated 
by the cellular NAD+/NADH ratio, as the hydrolysis of NAD+ is necessary to drive 
SIRT1 enzymatic activity (Borra, Langer et al. 2004).  Caloric restriction (CR) was 
shown to increase the replicative lifespan of yeast by activating Sir2, the yeast SIRT1 
homolog, due to decreasing NADH levels (Lin, Ford et al. 2004).  Interestingly, CR 
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induces the expression of NAMPT, which triggers the NAD+ salvage pathway converting 
nicotinamide (NAM) to NAD+ (Menssen, Hydbring et al. 2012).   
Recently, DBC1 and AROS have been indicated to have a role in SIRT1 regulation.  
DBC1, identified as a SIRT1 interactor via co-purification, was found to inhibit the 
deacetylase activity of SIRT1, resulting in increased p53 acetylation and the upregulation 
of p53 function and p21 gene expression (Kim, Chen et al. 2008; Zhao, Kruse et al. 
2008).  Conversely, AROS, identified as a SIRT1 interactor via a yeast two-hybrid 
screen, was found to activate SIRT1, promoting the deacetylation of p53 and leading to 
the downregulation of p53 function (Kim, Kho et al. 2007).  The impact of SIRT1 
expression levels, changes in the cellular NAD+/NADH ratio, and the SIRT1 modulators 
DBC1 and AROS have yet to be investigated as they relate to the regulation of the HSR.   
Here we further investigate the mechanism of SIRT1 regulation of the HSR. Previously, 
HSF1 has been shown to interact with SIRT1 via co-immunoprecipitation, indicating that 
HSF1 and SIRT1 interact, but not indicating whether or not the interaction is direct 
(Westerheide, Anckar et al. 2009; Donmez, Arun et al. 2012).  We now show with a GST 
pull-down assay that the HSF1-SIRT1 interaction is direct.  We report that induction of 
the HSR correlates with an increase in the cellular NAD+/NADH ratio and with an 
increase in recruitment of SIRT1 to the hsp70 promoter. Additionally, we find that the 
SIRT1 modulators AROS and DBC1 have an impact on hsp70 transcription, HSF1 
acetylation status, and HSF1 recruitment to the hsp70 promoter.   
Methods 
Cell culture and heat shock 
HeLa, HEK293, and HeLa hsp70.1 promoter-luciferase reporter cells (Westerheide, 
Bosman et al. 2004) were utilized in this study.  All cell lines were cultured in DMEM 
media (CellGro cat#15-017-CV) supplemented with 10% fetal bovine serum (GIBCO 
cat#10437-028) and 1% Pen-Strep-Glutamine (CellGro cat#30-0090CI) at 37° C with 
5% CO2.  HS was induced as previously described (Westerheide, Anckar et al. 2009).  
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Briefly, plates were wrapped in parafilm and submerged in a water bath set to 42°C for 
the designated times prior to collection with 1X PBS. 
Plasmids 
Plasmids used in this study include expression vectors for SIRT-MYC (Langley, Pearson 
et al. 2002), p300 (Eckner, Ewen et al. 1994), DBC1-HA (Kim, Chen et al. 2008), AROS 
(Kim, Kho et al. 2007), Flag-HSF1, and Myc-HSF1 (Cotto, Fox et al. 1997; Holmberg, 
Hietakangas et al. 2001).   
NAD+/NADH quantification 
HeLa cells were exposed to control conditions or a 2 hour HS in a 42°C water bath.  The 
cells were collected in 1X PBS and NAD+/NADH extracted using the FluoroNAD™ 
Fluorescent NAD/NADH Detection Kit by Cell Technology, Inc (cat#FLNADH 100-2), 
according to the manufacturer’s instructions.  The concentration readings were applied to 
a NADH standard curve and the NAD+/NADH ratio was determined. 
Chromatin immunoprecipitation 
HEK293 cells were fixed in 1% formaldehyde and neutralized in 125 mM glycine.  The 
cells were collected in 1X PBS, lysed in Cell Lysis Buffer (5 mM PIPES pH 8.0, 85 mM 
KCl, 0.5% NP40) with the addition of Halt™ Protease Inhibitors (Thermo Scientific 
cat#78430), and then centrifuged, with the resulting pellet resuspended in Nuclei Lysis 
Buffer (50 mM Tris-HCl pH 8.1, 10 mM EDTA, 1% SDS) with the addition of Halt™ 
Protease Inhibitors.  Chromatin shearing was preformed for 45 minutes, cycling on and 
off for 30 seconds each using the Diagenode Bioruptor 300.  Immunoselection and 
immunoprecipitation were performed essentially as previously described (Beresford and 
Boss 2001) using 5 µL of HSF1 (Enzo cat#ADI-SPA-901), SIRT1 (Millipore cat 
#07-131), or IgG (Cell Signaling Technology cat#2729S) antibody. The DNA was 
purified using phenol/chloroform/isoamyl alcohol (25:24:1) by standard procedure.  
qPCR was performed on the ChIP DNA with ABI’s Step One Plus Real-time PCR 
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system using BioRad’s iTaq™ Fast SYBR® Green Supermix with ROX (cat#172-5101) 
according to manufacturer’s protocol using primers to the hsp70 promoter-proximal HSE 
site, an upstream hsp70 promoter site, and the gapdh promoter (Table 1).  Statistical data 
analysis and determination of relative fold increase from control samples without HS was 
performed according to standard protocol (Bookout and Mangelsdorf 2003). 
Transient transfection and siRNA knockdown 
Transfections were performed with Polyfect® Transfection Reagent (Qiagen cat#301107) 
according to the manufacturer’s protocol.  HeLa hsp70.1 promoter-luciferase reporter and 
HEK293 cells were transfected with DharmaFECT transfection reagent (Thermo) 
according to the manufacturer’s protocol, using 50 nM of Dharmacon SmartPool DBC1, 
AROS, HSF1, or non-targeting (NT) control siRNA.  RNA was isolated using Trizol 
48 hours after transfection.  Knockdown was confirmed via qRT-PCR.   
Cell viability assay 
Cell viability was measured 48 hours after treatment with siRNA or expression plasmids 
using PrestoBlue (Life Technologies Ltd. cat#A13262) according to the manufacturer’s 
instructions.  Briefly, HEK293 cells were seeded in a 96 well plate and transfected as 
described above.  After 48 hours of treatment, PrestoBlue was added to each well at a 
final concentration of 10%.  After a 10 minute incubation at 37°C, total fluorescence was 
measured at excitation 525+/-20 nm and emission 590+/-35 nm.   
HSF1 acetylation assay 
HEK293 cells were transfected with expression plasmids Flag-HSF1 and p300, and either 
SIRT1-MYC, DBC1-HA, or AROS.  Cell lysates were subjected to immunoprecipitation 
with Flag beads, and acetylated HSF1 was detected by Western blotting with an antibody 
that recognizes acetylated lysines (Cell Signaling Technology cat#9441).  
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Luciferase assay 
HeLa hsp70.1 promoter-luciferase reporter cells were seeded in a 96 well plate at a 
density of 7.5 x 103 cells per well.  All transfections were performed 24 hours after 
plating.  24 hours post-transfection cells were treated with or without 5 µM celastrol.  
Luciferase assays were performed 24 hours post-treatment with Promega’s Bright-Glo 
Luciferase Assay (cat#E2620) according to manufacturer’s instructions and as previously 
described (Westerheide, Kawahara et al. 2006).  
Quantitative RT-PCR 
qRT-PCR was performed to quantify mRNA levels for aros, dbc1, hsp27, hsp70, hsp90, 
sirt1, and gapdh using gene-specific primers (Table 1).  Cells were collected in PBS and 
RNA was extracted using Trizol per standard protocol. RNA was reverse transcribed 
using Applied Biosystem’s High Capacity cDNA Reverse Transcription Kit 
(cat#4368814) according to the manufacturer’s protocol.  The samples were diluted to 50 
ng/µL and used as a template for qRT-PCR. qRT-PCR was performed with Applied 
Biosystem’s Step One Plus Real-time PCR system using BioRad’s iTaq™ Fast SYBR® 
Green Supermix with ROX (cat#172-5101) according to manufacturer’s protocol.  
Statistical data analysis and determination of relative fold increase from control samples 
was performed according to standard calculations (Bookout and Mangelsdorf 2003). 
Immunoblotting analysis 
The cells were collected in 1X PBS and then extracted using M-PER (Thermo Scientific 
cat#78503) with the addition of Halt™ Protease Inhibitors (Thermo Scientific 
cat#78430).  Protein was quantified with Biorad Protein Assay (cat#500-0006) and 20 µg 
of protein was run on 10% SDS-PAGE gels.  Gels were stained with 1% Ponceau in 10% 
glacial acetic acid for visualization of normalized protein levels before being blotted to 
nitrocellulose and immunostained with primary antibody in 5% milk.  Primary antibodies 
used include ACTIN (Santa Cruz cat#sc-1616-r), AROS (Santa Cruz cat#sc-86210), 
β-tubulin (Cell Technology cat#2128), DBC1 (Abcam cat#ab70242), HA (Convance  
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cat#MMS-101P), c-MYC (Sigma cat#M4439), HSF1 (Assay Design cat#SPA-950), 
SIRT1 (Abcam cat#ab 32441), Acetylated-Lysine (Cell Signaling Technology cat#9441).  
HRP-conjugated secondary antibodies were from Millipore (cat#12-349 and 12-348) and 
Jackson ImmunoResearch (cat#112-035-062).  ECL Plus Western Blotting Detection 
System (Amersham™ cat#RPN2132) was used to incubate blots prior to film exposure 
(Kodak ClinicSelect Blue X-ray film cat#604-1768). 
Results 
SIRT1 is not regulated by a change in expression upon HS 
We sought to determine if HS might regulate the activity of SIRT1 through changes in 
SIRT1 expression levels.  HeLa cells were treated with a 42°C HS from 0 to 6 hours and, 
as expected, hsp70 mRNA levels increased substantially by 2 hours of HS and then began 
to decline by 6 hours of treatment correlating with the attenuation phase of the HSR 
(Figure 2.1A).  The mRNA levels for hsp27 and hsp90 were also quantified, 
demonstrating that HS induces the transcription of multiple HSPs (Figure 2.1B,C).  
Conversely, sirt1 mRNA levels were not altered during the initial 2 hours of HS 
treatment (Figure 2.1D).  While sirt1 mRNA levels did begin to decline by 4 hours of HS 
treatment, Western blot analysis shows that SIRT1 protein levels remained constant 
throughout the 6 hour HS time course, while HSP70 and HSP27 protein levels were 
increased at the 4 and 6 hour timepoints as expected (Figure 2.1E,F).  HSP90 protein 
levels did not show a significant increase over this time course, likely due to the 
abundance and stability of this protein (data not shown) (Ethridge, Hellmich et al. 1998). 
Therefore, we conclude that the regulation of SIRT1 abundance is likely not a major 
mechanism by which HS controls SIRT1 activity, at least during the initial phases of the 
HSR. 
Heat shock induces an increase in the cellular NAD+/NADH ratio 
We next investigated whether HS could induce a change in the cellular NAD+/NADH 
ratio, as SIRT1 is well-documented as an NAD+-dependent deacetylase (Blander and 
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Guarente 2004; Baur, Pearson et al. 2006; Lavu, Boss et al. 2008; Zschoernig and 
Mahlknecht 2008).  The cellular NAD+ and NADH levels from whole cell extracts were 
quantified for HEK293 cells that were treated with HS at 42°C for 2 hours and the levels 
compared to unstressed cells.  HS did not induce a significant increase in the cellular 
NAD+ levels (Figure 2.2A), but did significantly decrease the cellular NADH levels by 
approximately 2-fold (Figure 2.2B).   Overall, HS resulted in an increase of the 
NAD+/NADH ratio from 2.5 to 6.5 (Figure 2.2C). HS may therefore have a positive 
impact on SIRT1 activity due to an increase in available NAD+ and a reduction of 
NADH.  We note that as SIRT1 is a nuclear protein, a more relevant measurement may 
be of the nuclear (instead of the whole cell) NAD+/NADH ratio.  Future studies will be 
required to determine if the nuclear NAD+/NADH ratio is altered upon HS.  
SIRT1 recruitment to the hsp70 promoter increases upon heat shock 
 We then tested SIRT1 recruitment to the hsp70 promoter over a HS time course to see if 
SIRT1 may be recruited to DNA with the same kinetics as HSF1.  HEK293 cells were 
treated with HS at 42°C for 0, 2, 4, and 6 hours followed by chromatin 
immunoprecipitation (ChIP) using an antibody to SIRT1.  We found that upon a 2 hour 
HS, there was a 4-fold increase of SIRT1 recruitment to the hsp70 promoter 
(Figure 2.3B). After 6 hours of HS, recruitment of SIRT1 to the hsp70 promoter was 
reduced to a 2-fold increase as compared to unstressed cells.  These kinetics correspond 
to what has previously been reported for HSF1 DNA recruitment (Westerheide, Anckar 
et al. 2009) and also correlates with our HSF1 recruitment results in Figure 2.6D.  
Therefore, it is likely that SIRT1 has the ability to regulate HSF1 while it is on the 
promoter. Recruitment was also evaluated at an upstream non-specific site of the hsp70 
promoter and at the gapdh promoter.  We found that SIRT1 recruitment to these sites do 
not increase upon HS (Figure 2.3C,D).  Therefore, increased recruitment of SIRT1 is 
specific to the HSE-binding site within the hsp70 promoter.   
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AROS and DBC1 expression have an impact on the HSR 
As SIRT1 activity is positively regulated by AROS and negatively regulated by DBC1, 
we next sought to determine the impact of these proteins on the HSR.  While aros and 
dbc1 mRNA levels do not change upon 0-3 hours of HS and show only  minimal change 
between 3-6 hours of HS (Figure 2.4A), AROS and DBC1 overexpression have 
significant effects on hsp70 transcription (Figure 2.4 B,C).  AROS, DBC1, or empty 
vector was overexpressed in HEK293 cells and the induction of the HSR was assessed 
using the transcription of hsp70 as a marker throughout a 6 hour HS time course.  We 
found that AROS overexpression resulted in a striking increase in HS-induced hsp70 
mRNA levels (Figure 2.4B).  Conversely, DBC1 overexpression resulted in a decrease in 
HS-induced hsp70 mRNA levels (Figure 2.4C).   
Next, we investigated the impact of AROS and DBC1 siRNA knockdown on the HSR.  
We transfected HEK293 cells with AROS, DBC1, or a non-targeting (NT) siRNA and 
treated the cells with either DMSO (mock) or celastrol (5 µM), a potent inducer of the 
HSR (Westerheide, Bosman et al. 2004).  Transfection with siRNA resulted in significant 
knockdown of aros and dbc1, which did not impact cell viability compared to the NT 
control (Figure 2.5A,B).  Cells transfected with AROS siRNA displayed a decrease in 
hsp70 induction by celastrol (Figure 2.5C), while conversely cells transfected with DBC1 
siRNA displayed an increase in hsp70 induction by celastrol (Figure 2.5D).  Therefore, 
we conclude from these experiments that AROS and DBC1 may be significant regulators 
of the HSR, with AROS having a positive effect on the HSR and DBC1 having a 
negative effect. 
AROS and DBC1 affect HSF1 acetylation 
We next examined the impact of AROS and DBC1 on HSF1 acetylation status using an 
in vivo acetylation assay.  Cells were transfected with Flag-HSF1 and p300 together with 
SIRT1, DBC1, AROS, or empty vector expression plasmids prior to treatment with or 
without HS (Figure 2.6A).  HS led to HSF1 acetylation (lane 2), while the overexpression 
of SIRT1 inhibited HS-induced HSF1 acetylation (lane 4), consistent with previous  
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results (Westerheide, Anckar et al. 2009).  Interestingly, the overexpression of DBC1, the 
SIRT1 inhibitor, enhanced HSF1 acetylation under both non-stress and stress conditions 
(lanes 5 and 6), while the overexpression of the SIRT1 activator AROS reduced 
HS-induced HSF1 acetylation to a similar degree as SIRT1 itself (compare lanes 4 and 
8).  Western blot analysis was used to verify the overexpression of SIRT1, DBC1 and 
AROS (Figure 2.6B), and cell viability results show that the overexpression of these 
factors does not affect overall cellular fitness (Figure 2.6C). We therefore conclude that 
AROS and DBC1 can modulate the acetylation status of HSF1.  We would like to point 
out that while it is likely that the effects of AROS and DBC1 on HSF1 deacetylation are 
occurring through SIRT1, we have not demonstrated this here and it could be possible 
that other deacetylases are involved. 
AROS and DBC1 impact HSF1 DNA binding  
As HSF1 acetylation status has previously been shown to affect DNA binding ability 
(Westerheide, Anckar et al. 2009), we investigated the effect of AROS and DBC1 
expression on HSF1 binding to the hsp70 promoter.  HEK293 cells were transfected with 
AROS, DBC1, or empty vector and then treated with HS over a 6 hour time course 
followed by ChIP using an antibody to HSF1.  As expected, a 2 hour HS resulted in 
recruitment of HSF1 to the hsp70 promoter, and this binding decreased by 6 hours of 
continuous HS (Figure 2.6D). AROS overexpression enhanced HS-induced recruitment 
of HSF1 to the hsp70 promoter.  Conversely, DBC1 overexpression led to the inhibition 
of HS-induced HSF1 recruitment.  Thus, AROS and DBC1 can modulate both HSF1 
acetylation status as well as HS-induced binding of HSF1 to target DNA sites. 
We next evaluated the effect of AROS and DBC1 knockdown on the activation of an hsp 
promoter reporter.  HeLa cells expressing a stable hsp70.1 promoter-luciferase reporter 
were transfected with siRNA to HSF1, AROS, DBC1, or a non-targeting (NT) siRNA 
control. Cells were treated with either DMSO (mock) or celastrol (5 µM) 24 hours post-
transfection and luciferase activity was measured 24 hours post-treatment.  We found that 
knockdown of AROS resulted in a 2-fold reduction of celastrol-induced luciferase 
activity compared to the NT siRNA control (Figure 2.6E).  This result is similar to the 
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result produced with HSF1 siRNA treatment.  Conversely, DBC1 knockdown resulted in 
an approximate 2.3-fold increase in celastrol-induced luciferase activity compared to the 
non-targeting siRNA control (Figure 2.6E).   This data provides further support that 
AROS and DBC1 positively and negatively impact expression from the hsp70 promoter, 
respectively. 
Discussion 
HSF1, the master regulator of genes involved in protein quality control, is highly 
post-translationally modified (Anckar and Sistonen 2011).  These modifications are 
hypothesized to allow fine-tuning of the transcriptional activity of HSF1 in order to 
respond to the precise needs of the cell.  We have previously shown that HSF1 is 
acetylated and SIRT1 activates HSF1 through deacetylation at a key lysine residue within 
the DNA binding domain, thereby promoting DNA binding (Westerheide, Anckar et al. 
2009).  With this study, we have expanded our analysis of the regulation of HSF1 by 
SIRT1 and find that AROS and DBC1, two SIRT1 modulators, can regulate HSF1’s 
acetylation status and thus control the HSR. 
SIRT1 and the HSR 
Prior work by us and others has established a connection between SIRT1 and the HSR in 
mammalian tissue culture cells, mice, and C. elegans (Westerheide, Anckar et al. 2009; 
Donmez, Arun et al. 2012; Raynes, Leckey et al. 2012).  We have shown that SIRT1 
prolongs HSF1 DNA binding, thus serving to enhance the HSR by increasing 
HS-induced chaperone expression (Westerheide, Anckar et al. 2009).  The connection 
between SIRT1 and the HSR has been further established with an α-synuclein mouse 
model (Donmez, Arun et al. 2012).  In these mice, SIRT1 was shown to deacetylate 
HSF1 and increase HSP70 levels in the brain, leading to α-synuclein aggregate 
suppression and an overall greater survival (Donmez, Arun et al. 2012).  We have also 
recently shown that the C. elegans SIRT1 homolog Sir2.1 is linked to the HSR (Raynes, 
Leckey et al. 2012).  Caloric restriction was found to synergize with HS to induce hsp70 
gene expression in the worm, and this effect was dependent on Sir2.1 (Raynes, Leckey et 
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al. 2012). Our finding here that DBC1 and AROS, two modulators of SIRT1 activity, can 
regulate the HSR provides yet further support for a role of SIRT1 in the HSR. 
The regulation of SIRT1 during heat shock 
We sought to discover how HS may regulate SIRT1 activity.  We first tested whether 
SIRT1 may be regulated at the transcription or translation level during HS.  However, we 
did not find major changes in SIRT1 abundance throughout a HS time course.  SIRT1 is a 
NAD+ binding protein and has been shown to be activated by an increase in the cellular 
NAD+/NADH ratio (Borra, Langer et al. 2004).  Previous studies have indicated that a 
10-fold change in NAD+ concentration was required to affect Sir2 activity (Anderson, 
Latorre-Esteves et al. 2003).  However, a decrease in NADH, a competitive inhibitor of 
SIRT1 that is present at much lower levels in the cell compared to NAD+, may have a 
greater impact on SIRT1 activity.  Caloric restriction studies in yeast have shown that 
Sir2 activity is regulated by a reduction of NADH resulting in an increase in the 
NAD+/NADH ratio (Lin, Ford et al. 2004; Rahat, Maoz et al. 2011). We demonstrate in 
this study that cellular NADH levels decrease upon HS resulting in an increase in the 
NAD+/NADH ratio and therefore this may be one mechanism by which HS regulates 
HSF1 activity.  These results suggest that the HS-induced increase in the NAD+/NADH 
ratio may be an important factor in SIRT1 regulation of the HSR.   
While SIRT1 is not a DNA binding protein, it can be recruited to promoters through 
association with other DNA binding proteins.  For instance, BCL11A, a zinc finger 
transcription factor that functions as a myeloid and B-cell proto-oncogene, has been 
shown to recruit SIRT1 to a promoter template (Senawong, Peterson et al. 2005).   
Furthermore, SIRT1 converges to the same DNA regulatory elements as its transcription 
factor substrate CLOCK, indicating that these proteins operate on circadian promoters in 
a chromatin regulatory complex (Nakahata, Kaluzova et al. 2008).  We sought to 
investigate whether SIRT1 was recruited to the hsp70 promoter with similar kinetics as 
HSF1 upon HS and found that it is.   Therefore, SIRT1 may be in a chromatin-bound 
complex together with HSF1 on target promoters, leading to enhanced HSF1 activity. 
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AROS and DBC1 regulate HSF1 
AROS and DBC1 are two regulators of SIRT1 activity.  DBC1 has been shown to form a 
stable complex with SIRT1 by binding to its catalytic domain and inhibiting its activity 
by blocking substrate access (Kim, Chen et al. 2008; Zhao, Kruse et al. 2008).  While 
AROS regulation of SIRT1 has been comparatively understudied, it is a SIRT1 binding 
partner that positively regulates SIRT1 deacetylase activity (Kim, Kho et al. 2007).  
AROS and DBC1 were first characterized to affect SIRT1 regulation of p53-mediated 
apoptosis through alteration of the p53 acetylation status.  DBC1 has also recently been 
characterized to regulate the acetylation status of the nuclear receptor PPARγ (Santagata, 
Hu et al. 2011).    
We show here that the overexpression and knockdown of AROS and DBC1 have a 
striking impact on hsp70 transcription.  Overexpression of DBC1 results in a decrease in 
hsp70 transcription, while knockdown with DBC1 siRNA results in an increase in HSR 
induction.  Conversely, overexpression of AROS results in an increase in hsp70 
transcription, while knockdown with AROS siRNA results in a decrease in HSR 
induction.   In an acetylation assay, AROS is able to completely deacetylate HSF1 in a 
manner similar to SIRT1, while DBC1 increases HSF1 acetylation.  Given that AROS 
and DBC1 were found to regulate HSF1 acetylation, and HSF1 acetylation can affect 
DNA binding ability, we sought to investigate whether AROS and DBC1 expression 
could affect HSF1 DNA binding.  As expected, we found that overexpression of AROS 
led to an increase in HSF1 recruitment to the hsp70 promoter and that, conversely, 
overexpression of DBC1 led to a decrease in HSF1 recruitment to the promoter. Thus, we 
have now added HSF1 to the list of SIRT1 target proteins that are modulated at the 
acetylation status level by AROS and DBC1.  This work expands our knowledge of the 
control of the HSR and provides AROS and DBC1 as new therapeutic targets for 
modulating this response. 
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Table 2.1.  List of qRT-PCR primers used in this study. 
Gene name Sequence* Amplicon (bp) 
   
aros F: 5’- GAAGGCAATTCAGGCCCAGAAACT- 3’ 
R: 5’- TCGTCCTGGTCAGAAACTTCAGGT- 3’ 
 
131 
dbc1 Primer mix from GeneCopoeia, Inc. 
Cat # HQP015872 (KIAA1967) 
 
Not provided 
gapdh F: 5’- CCACTCCTCCACTTTGAC - 3’ 
R: 5’- ACCCTGTTGCTGTAGCCA - 3’ 
 
102 
gapdh promoter1 F: 5’- TACTAGCGGTTTTACGGGCG - 3’ 
R: 5’- TCGAACAGGAGGAGCAGAGAGCGA - 3’ 
 
166 
hsp272 F: 5’- CAAGTTTCCTCCTCCCTGTC - 3’ 
R: 5’- GGCAGTCTCATCGGATTTTG - 3’ 
 
156 
hsp703 F: 5’- AGAGCGGAGCCGACAGAG - 3’ 
R: 5’- CACCTTGCCGTGTTGGAAC - 3’ 
 
110 
hsp70  promoter 13 
(HSE site) 
 
F: 5’- GGCGAAACCCCTGGAATATTCCCGA - 3’ 
F: 5’- AGCCTTGGGACAACGGGAG - 3’ 
 
191 
hsp70  promoter 2 
(NS site) 
 
F: 5’- CCTCCCGAGGAGCTGGGACT - 3’ 
R: 5’- CGAGGCGGGCGGATCACTTA - 3’ 
 
134 
hsp904 F: 5’- GGCAGTCAAGCACTTTTCTGTAG - 3’ 
R: 5’- GTCAACCACACCACGGATAAA - 3’ 
 
199 
sirt13 F: 5’- TCCTGGACAATTCGAGCCATCTCT - 3’ 
R: 5’- TTCCAGCGTGTCTATGTTCTGGGT - 3’ 
103 
 
*F: forward, R: reverse 
1Primers from Folz et al. Am. J. Respir. Cell Mol. Biol. 2008 39:2, 243 
2Primers from Yao et al. Journal of Biomedical Science 2010 17:30. 
3Primers from Westerheide et al. Science 2009 323, 1063. 
4Primers from McLean et al. Biochemical and Biophysical Research Communications 
2006 351:3. 
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Figure 2.1.  SIRT1 is not regulated by a change in expression upon HS.   
(A-C) hsp70, hsp27, and hsp90 mRNA expression levels are induced during a HS time 
course.  HeLa cells were exposed to a 42°C HS from 0 to 6 hours and mRNA levels were 
determined by qRT-PCR. (D) sirt1 mRNA expression levels are not altered in the early 
stages of HS.  HeLa cells were exposed to a 42°C HS from 0 to 6 hours and mRNA 
levels were determined qRT-PCR.  Results for A-D are in technical triplicates and are 
representative of biological duplicates.  Statistical significance was measured by 
Student’s t test as compared to 0 hr HS (*P<0.05; ** P<0.01).  (E) SIRT1 protein levels 
are not altered during a HS time course.  HeLa cells were treated with a HS time course 
and SIRT1, HSP70, HSP27, and β-tubulin protein levels were determined by Western 
analysis.   (F) Protein levels from E were quantified and plotted using ImageJ. 
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Figure 2.2.  HS induces an increase in the NAD+/NADH ratio.   
(A) NAD+ and (B) NADH concentrations were determined for HeLa cells exposed to 
either control conditions or a 42°C HS for 2 hours.  (C) HS induces an increase in the 
NAD+/NADH ratio as a result of decreased NADH levels.  Mean values of the 
NAD+/NADH ratios from (A) and (B) are plotted. Results in A-C are in technical 
triplicates and are representative of biological duplicates.  Statistical significance was 
measured by Student’s t test as compared to - HS (*P<0.05; ** P<0.01; ***P<0.001).  
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Figure 2.3.  HS results in an increase in SIRT1 recruitment that is specific to the 
HSE within the hsp70 promoter.   
(A) Schematic representation of primers designed to amplify the HSE site and a 
nonspecific (NS) site at the hsp70 promoter.  (B) SIRT1 is recruited to the hsp70 
promoter HSE site during HS.  HEK293 cells were exposed to a 42°C HS from 0 to 6 
hours prior to chromatin immunoprecipitation (ChIP) with a SIRT1 antibody.  SIRT1 is 
not recruited upon HS to a non-specific (NS) upstream hsp70 promoter site (C) or to the 
gapdh promoter (D).  Results in B-D are in technical triplicates and are representative of 
biological duplicates.  Statistical significance was measured by Student’s t test as 
compared to - HS (*P<0.05; ** P<0.01; ***P<0.001).  
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Figure 2.4.  AROS and DBC1 overexpression impacts the transcription of hsp70 and 
initiation of the HSR.   
(A) aros and dbc1 mRNA expression levels do not undergo a significant change upon 0-3 
hours of HS, while small changes in levels are observed between 3-6 hours of HS.  
HEK293 cells were exposed to a 42°C HS from 0 to 6 hours and mRNA levels were 
determined by qRT-PCR. (B) AROS overexpression enhances HS induction of hsp70 
mRNA, while (C) DBC1 overexpression inhibits HS induction of hsp70 mRNA.  For B 
and C, HEK293 cells were transfected with empty vector (EV), AROS, or DBC1 and 
then exposed to a 42°C HS from 0 to 6 hours.  The mRNA levels were determined for 
hsp70 by qRT-PCR.  Results in A-C are in technical triplicates and are representative of 
biological duplicates.  Statistical significance was measured by Student’s t test as 
compared to 0 hr HS (*P<0.05; **P<0.01; ***P<0.001). 
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Figure 2.5.  AROS and DBC1 knockdown impact the transcription of hsp70 and 
initiation of the HSR.  
(A) AROS and DBC1 siRNA is able to knockdown gene expression. HEK293 cells were 
transfected with siRNA for DBC1, AROS, or a non-targeting (NT) control and aros and 
dbc1 gene expression was assessed by qRT-PCR.  (B) AROS, DBC1, and HSF1 siRNA 
do not significantly impact cell viability compared to the NT siRNA control as measured 
by a PrestoBlue assay.  Cell viability assay was performed in biological and technical 
triplicates and statistical significance was measured by Student’s t test compared to NT 
siRNA control.  (C) AROS knockdown decreases the induction of hsp70 by celastrol.  
HEK293 cells were transfected with AROS or NT control siRNA and treated with and 
without celastrol (5 µM).  The mRNA levels were determined for hsp70 by qRT-PCR.  
(D) DBC1 knockdown increases the induction of hsp70 by celastrol.  HEK293 cells were 
transfected with DBC1 or NT control siRNA and treated with and without celastrol 
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(5 µM).  The mRNA levels were determined for hsp70 by qRT-PCR. Results in A, C, 
and D are in technical triplicates and are representative of biological duplicates. 
Statistical significance was measured by Student’s t test as compared to control 
(*P<0.05; ** P<0.01;  ***P<0.001). 
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Figure 2.6.  AROS and DBC1 impact HSF1 acetylation, DNA recruitment, and 
activity at the hsp70 promoter.   
(A) AROS and DBC1 overexpression impact HSF1 acetylation. HEK293 cells were 
transfected with p300 and FLAG-HSF1 as well as empty vector, SIRT1-MYC, DBC1-
HA, or AROS as indicated and exposed to 0 or 2 hours of HS at 42°C.  A FLAG 
immunoprecipitation was run on an SDS-PAGE gel and the acetylation status of HSF1 
was determined using an acetyl-lysine antibody.  Results are representative of biological 
triplicates.  (B) The expression of transfected SIRT1-MYC, DBC1-HA, and AROS was 
verified by Western analysis. (C) Overexpression of HSF1, DBC1, and AROS do not 
significantly impact cell viability compared to the empty vector (EV) control as measured 
by PrestoBlue.  The cell viability assay was performed in biological and technical 
triplicates and statistical significance was measured by Student’s t test compared to EV.  
(D) AROS and DBC1 overexpression impact HSF1 recruitment to the hsp70 promoter.  
AROS, DBC1, or empty vector (EV) was overexpressed in HEK293 cells prior to HS for 
0, 2, or 6 hours and chromatin immunoprecipitation (ChIP) was performed with an HSF1 
antibody.  The purified DNA was then analyzed by qPCR and DNA levels were 
determined for the hsp70 promoter.  The qPCR results are in technical triplicates and 
statistical significance was measured by Student’s t test as compared to EV at 0 hr HS 
(*P<0.05; ** P<0.01).  ChIP was performed in biological duplicates. (E) AROS and 
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DBC1 knockdown impact hsp70.1 promoter-luciferase reporter activity. HeLa hsp70.1 
promoter-luciferase reporter cells were transfected with 50 nM of Dharmacon SmartPool 
DBC1, AROS, HSF1, or non-targeting (NT) control siRNA and HS was induced with 
celastrol (5 µM).  Luciferase activity was measured and compared to that of the NT 
control.  Luciferase assays were performed in biological triplicate.  Statistical 
significance was measured by Student’s t test as compared to the NT siRNA control with 
celastrol (5 µM) treatment (*P<0.05).  
 
  52 
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Summary 
The heat shock response (HSR) is responsible for maintaining cellular and organismal 
health through the regulation of proteostasis.  Recent data demonstrating that the 
mammalian HSR is regulated by SIRT1 suggests that this response may be under 
metabolic control.  To test this hypothesis, we have determined the effect of caloric 
restriction in C. elegans on the activation of the HSR and have found a synergistic effect 
on the induction of hsp70 gene expression. The homolog of mammalian SIRT1 in 
C. elegans is Sir2.1. Using a mutated C. elegans strain with a sir2.1 deletion, we show 
that heat shock and caloric restriction cooperate to promote increased survivability and 
fitness in a sir2.1-dependent manner.  Finally, we show that caloric restriction increases 
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the ability of heat shock to preserve movement in a polyglutamine toxicity 
neurodegenerative disease model and that this effect is dependent on sir2.1.   
Introduction 
The heat shock response (HSR) is a cytoprotective response that increases longevity and 
protects against diseases of aging in model organisms (Akerfelt, Morimoto et al. 2010; 
Anckar and Sistonen 2011).  This response enables an organism to manage protein 
damaging stress through the activation of the transcription factor HSF1.  HSF1 is 
responsible for transcriptionally upregulating the heat shock protein genes (HSPs).   In 
mammalian cells, flies, nematodes, and plants, this transcription factor exists as an 
inactive monomer, however in response to denaturing stress will trimerize and bind to 
heat shock elements (HSEs) located in the promoter regions of the hsp genes (Sarge, 
Murphy et al. 1993; Yao, Munson et al. 2006; von Koskull-Doring, Scharf et al. 2007; 
Chiang, Ching et al. 2012).  Increased expression of HSPs, such as HSP70 family 
members, results in cellular protection from a variety of stressors including elevated 
temperatures, oxidative stress, heavy metals, proteasome inhibitors, and infection 
(Westerheide and Morimoto 2005). 
A characteristic of many HSR activators is the ability to elicit hormesis, a biological 
process that occurs when a low level stress is applied that promotes cytoprotection 
against a subsequent exposure to a more severe stress (Cypser and Johnson 2002).  For 
instance, exposure to a moderate heat shock (HS) can protect against exposure to a 
subsequent high-temperature HS in Caenorhabditis elegans (Lithgow, White et al. 1995).  
Hormesis occurs, in part, through the upregulation of molecular chaperones during the 
first mild stress treatment, which then protect cells from subsequent acute protein 
damage.  
Caloric restriction (CR), a 30-40% decrease in dietary intake, increases longevity and 
protects against diseases of aging (Bishop and Guarente 2007).  An association between 
CR and longevity was established as early as 1935 through studies with 
calorically-restricted rats (McCay, Crowell et al. 1989).  CR has now been shown to 
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increase longevity in many other models including S. cerevisiae (Fabrizio, Pozza et al. 
2001; Kaeberlein, Powers et al. 2005), C. elegans (Johnson 2008; Greer and Brunet 
2009), D. melanogaster (Giannakou, Goss et al. 2008; Min, Yamamoto et al. 2008), and 
M. musculus (Anderson, Shanmuganayagam et al. 2009).  In addition to increasing 
longevity, CR slows the progression of many age-related diseases including 
neurodegenerative diseases (Bishop and Guarente 2007).  For instance, in various 
C. elegans models of protein aggregation diseases, CR has been shown to protect against 
age-associated paralysis (Steinkraus, Smith et al. 2008).   Genetic experiments in model 
organisms have implicated that CR mediates its effects through a number of genes, 
including the sirtuins (Donmez and Guarente 2010).   
The sirtuins are a family of NAD+-dependent deacetylases that have been characterized 
to play a role in a number of biological processes.  The first family member identified 
was the yeast Sir2α , based on its responsibility for establishing transcriptional silencing 
of mating-type loci (Laurenson and Rine 1992).  The mammalian homolog to yeast Sir2a, 
SIRT1 deacetylates histones and many stress-inducible transcription factors including 
p53, FOXO and NF-kB (Luo, Nikolaev et al. 2001; Brunet, Sweeney et al. 2004; Yeung, 
Hoberg et al. 2004). Recent findings have indicated that SIRT1 also plays a critical role 
in the HSR by directly deacetylating HSF1 within its DNA binding domain to promote 
HSF1 occupancy at heat shock promoters (Westerheide, Anckar et al. 2009).  As SIRT1 
is an important metabolic regulator and because HSF1 and SIRT1 function together to 
protect cells from stress, we were interested in examining a direct link between the HSR 
and metabolism.   
C. elegans is a useful model organism for testing the relationship between the HSR and 
metabolism, as these animals can easily be calorically-restricted via bacterial limitation.  
Here, we show that CR and HS synergize to induce the HSR and that this effect depends 
on the C. elegans SIRT1 homolog Sir2.1.   
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Methods 
C. elegans strains and maintenance 
The following C. elegans strains were utilized in this study: wild-type N2, C12C8.1::GFP 
reporter fusion (Morley and Morimoto 2004), sir2.1 (ok434), sir2.3 (ok444), Q0-YFP, 
Q24-YFP, and Q35-YFP (Morley, Brignull et al. 2002).  Wild-type (N2), C12C8.1::GFP, 
Q0-YFP, and Q35-YFP animals were obtained from Dr. R.I. Morimoto.  All other strains 
were provided by the Caenorhabditis Genetics Center, which is funded by the NIH 
National Center for Research Resources (NCRR).  All strains were handled with standard 
procedures (Brenner 1974) and grown on standard NGM agar plates seeded with OP50 E. 
coli and incubated at 23°C.  The Q24-YFP; sir2.1 (ok434) double mutant strain was 
constructed by mating Q24-YFP males with sir2.1 (ok434) hermaphrodites.  F1 cross 
progeny that displayed the YFP reporter were picked to individual plates and allowed to 
have F2 progeny.  Approximately twenty F2 progeny were picked to individual plates 
and allowed to self fertilize.  Once F3 progeny were obtained, the F2 parents were tested 
for the sir2.1 deletion by PCR using primers flanking the deletion (5′-
CAGCGACGCTGTCTCAAAAA, 3′-GATCAAATGAGCATTCGGCT) (Wang and 
Tissenbaum 2006).   
Bleach synchronization 
Animals were bleach synchronized in order to obtain the same developmental time point 
prior to any experimental conditions as previously described (Lewis and Fleming 1995).  
Briefly, a petri dish of C. elegans was washed with M9 buffer to dislodge the animals for 
transfer into a 15mL conical for centrifugation. The pellet was washed with 20% alkaline 
hypochlorite solution to kill all animals except for the eggs, which are resistant to the 
bleach. These were then centrifuged and washed three times with M9 and the final pellet 
was resuspended in 7 mL of M9 and incubated at room temperature at 220 rpm to allow 
the eggs to reach the L1 larva stage.  Synchronized L1 larvae were used for all 
experimental conditions. 
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Caloric Restriction and Heat Shock Conditions 
Synchronized L1 larvae were cultured in S-basal media with OP50 E. coli in either 
ad libitum (AL) or CR conditions, 1.9 x 1010 cells/mL or 2.6 x 109 cells per mL of 
bacteria, respectively (Hansen, Chandra et al. 2008).  Cultures were incubated at 23°C at 
220 rpm.  The life cycle progression of the animals was monitored daily under a 
dissecting microscope until they reached adulthood.  Once the animals reached 
adulthood, each AL and CR flask was equally divided into two flasks (one for control and 
one for HS). HS was performed for 15 minutes or 1 hour in a 33°C circulating water bath 
and worms were allowed to recover at 23°C for 30 minutes or 6 hours as indicated.   
Quantitative RT-PCR 
qRT-PCR was performed to quantify mRNA levels for the hsp70 family members 
C12C8.1, F44e5.4 and F44e5.5 as well as sir2.1 using gene-specific primers.  Animals 
were collected via centrifugation and RNA extracted using TRIzol per standard protocol. 
RNA was reverse transcribed using Applied Biosystem’s High Capacity cDNA Reverse 
Transcription Kit (cat#4368814) according to the manufacturer’s protocol.  The samples 
were diluted to 50 ng/µL and used as a template for qRT-PCR. qRT-PCR was performed 
with Applied Biosystem’s Step One Plus Real-time PCR system using BioRad’s iTaq™ 
Fast SYBR® Green Supermix with ROX (cat#172-5101) according to manufacturer’s 
protocol.  Statistical data analysis and determination of relative fold increase from control 
samples was performed according to standard calculations (Bookout and Mangelsdorf 
2003). 
Fluorescence Microscopy 
Animals were analyzed for GFP expression using an EVOS fluorescence microscope.  
Animals were photographed individually by pipetting onto a layer of 1% agarose on top 
of a glass slide.  Animals were paralyzed prior to microscopy by adding 1-2 drops of 
1mM Levamisole onto the slide. 
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Immunoblotting Analysis 
For each treatment condition, cultured C. elegans were centrifuged at 5,000 rpm for 5 
minutes and the resulting pellet was repeatedly washed in phosphate buffered saline to 
clear bacteria from the extraction.  Animals were lysed in Buffer C (20mM HEPES pH 
7.9, 25% (v/v) glycerol, 0.42 M NaCl, 1.5 mM MgCl2, and 0.2 mM EDT) with the 
addition of Halt™ Protease Inhibitors (Thermo Scientific cat#78430) and sonicated for 
15 minutes, cycling on and off for 30 second intervals, using the Diagenode Bioruptor 
300.  Protein extracts were quantified and run on a 10% SDS-PAGE gel.  Blots were 
probed with anti-GFP (Santa Cruz, cat#SC-9996) at a 1:1000 dilution and anti-Actin 
(Amersham, cat#JLA20-C) at a 1:750 dilution.   
Thermotolerance Assay 
Animals grown in AL or CR conditions were either left untreated or heat shocked for 1 
hour at 33°C in liquid culture in a circulating water bath and allowed to recover overnight 
at 23°C. The next day, 100 animals from each of the 4 liquid cultures were plated to 
separate NGM agar plates without bacteria. These were then exposed to a lethal heat 
shock at 36°C in a circulating water bath for 45 minutes with a 3 hour recovery. 
Survivability of the animals was then manually quantified using a dissecting microscope.  
Animals were scored as alive if they responded to stimuli by poking with a platinum 
wire.   
Thrashing Assay 
After animals were scored in the thermotolerance assay, lethal HS survivors were 
individually transferred to a drop of M9 buffer on a glass slide.  The animals were 
allowed to recover from the transfer for 1 minute.  Thrashing was judged as a mid-body 
bend.  The number of thrashes was counted for 1 minute after recovery from the transfer.   
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Paralysis Assay 
Q24 animals grown in AL or CR conditions were either left untreated or heat shocked for 
1 hour at 33°C in a circulating water bath and allowed to recover overnight at 23°C.  At 
day 4, paralysis was determined by transferring individual animals to a seeded NGM 
plate.  Animals that did not move through the bacterial lawn and create a trail within 5 
minutes were scored as paralyzed.  Animals were scored as alive if they responded to 
stimuli by poking with a platinum wire.  
Polyglutamine Protein Aggregation Assay 
Q35-YFP animals were cultured as described in the paralysis assay.  At day 3, animals 
were visualized to analyze GFP expression.  Animals were photographed as described 
previously and the number of protein aggregates was scored.  
Results 
Caloric Restriction and Heat Shock Synergize to Activate an hsp70 Promoter 
Reporter 
CR has previously been reported to induce hsp70 expression (Heydari, Wu et al. 1993; 
Ehrenfried, Evers et al. 1996).  To verify that our CR conditions induce a HSR in 
C. elegans, we visualized green fluorescent protein expression (GFP) which is under the 
regulatory control of the hsp70 promoter (C12C8.1::GFP) by microscopy (Morley and 
Morimoto 2004).  Animals were maintained under ad libitum (AL) or CR conditions with 
either 1.9 x 1010 or 2.6 x 109 bacterial cells per mL, respectively.  As expected, HS 
treated animals showed induction of HS-responsive GFP expression, as compared to 
untreated animals (Figure 3.1A).  CR also resulted in an increase in expression of the 
HS-responsive reporter, however GFP levels were not as robust as in animals receiving 
HS treatment.  Interestingly, animals subjected to both CR and HS displayed an increase 
in reporter activation as compared to either treatment condition alone.  The increase in 
GFP expression observed by fluorescence microscopy was corroborated by quantification 
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of GFP levels (Figure 3.1B) and by Western analysis using an anti-GFP antibody 
(Figure 3.1C).  While immunoblotting was not sensitive enough to detect GFP expression 
in the animals treated with CR alone, quantitation of GFP fluorescence confirmed that 
animals subjected to CR and HS induced a 2-fold increase in GFP expression over 
animals treated with HS alone.  
Caloric Restriction and Heat Shock Synergize to Activate Endogenous Heat Shock 
Gene Expression 
To get a more accurate quantification of the synergy between CR and HS, endogenous 
heat shock gene expression was measured in the N2 C. elegans strain.  Wild-type N2 
animals cultured in either AL or CR conditions were exposed to a 33°C heat shock for 15 
minutes with a 30 minute recovery.  Induction of C12C8.1 (hsp70) transcripts was 
quantitated by qRT-PCR (Figure 3.2).  As expected, animals maintained under AL 
conditions showed a 40-fold increase in C12C8.1 mRNA levels upon HS (Figure 3.2A).  
Consistent with results shown in Figure 3.1A, N2 animals cultured under CR conditions 
also showed a 20-fold increase in C12C8.1 expression.  Strikingly, animals cultured in 
CR conditions and HS together exhibited a 4,000-fold increase in C12C8.1 mRNA levels, 
indicating a synergistic effect between HS and CR.  To determine whether similar results 
were observed for multiple members of the hsp70 family, we also performed qRT-PCR 
using primers against F44e5.4 and F44e5.5.  Similar to C12C8.1, F44e5.4 and F44e5.5 
expression significantly increased in response to CR and HS treatment, as compared to 
either treatment alone (Figure 3.2B,C).    
sir2.1 is Required for the Synergy between HS and CR on hsp70 Induction 
We have previously established that mammalian cells required the NAD+-dependent 
deacetylase SIRT1 for full transcriptional activity of HSF1 (Westerheide, Anckar et al. 
2009).  As CR stimulates SIRT1 activity by changing the NAD+ to NADH ratio, we 
tested whether the synergistic effect observed between HS and CR was dependent on 
sir2.1. The sir2.1 (ok434) strain possesses a homozygous sir2.1 partial gene deletion that 
encodes for a non-functional protein. To initiate experiments, animals were treated with 
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HS, CR or both as previously described in Figure 3.2 and qRT-PCR was performed to 
evaluate mRNA expression for the hsp70 family members C12C8.1, F44E5.4, and 
F44E5.5 (Figure 3.3). For reasons that are not clear, the hsp70 genes are induced to a 
higher level upon HS treatment in the sir2.1 (ok434) strain than in the N2 strain under 
AL conditions.  Interestingly, though, the sir2.1 (ok434) strain was no longer able to 
upregulate C12C8.1 in response to CR (Figure 3.3A). Furthermore, the ability of CR and 
HS treatments to synergistically upregulate C12C8.1, F44E5.4, and F44E5.5 gene 
expression was lost upon deletion of sir2.1 (Figure 3.3A-C).  
To determine whether the synergistic upregulation of the hsp70 gene family was 
dependent on sir2.1 and not some other sirtuin family member, the sir2.3 (ok444) 
knockout strain was treated with CR, HS, or both CR and HS and C12C8.1, F44e5.4 and 
F44e5.5 expression was measured by qRT-PCR.  As shown in Figure 3.4, animals treated 
with both CR and HS showed a synergistic increase in the expression of the hsp70 gene 
family, indicating the specificity of the response to sir2.1. Thus, expression of the sir2.1 
gene product, but not sir2.3, is required to synergistically upregulate hsp70 genes in 
response to HS and CR in C. elegans.     
CR enhances the ability of HS to induce thermotolerance 
As a prior induction of hsp genes upon mild stress can lead to increased thermotolerance 
upon subsequent exposure to a lethal HS in a variety of organisms (Lithgow, White et al. 
1995; Cypser and Johnson 2002), we investigated whether CR and HS could heighten 
thermotolerance in C. elegans above levels produced with HS alone.  N2 animals were 
exposed to a 33°C conditioning HS with an overnight recovery prior to receiving a 36°C 
lethal heat shock.  After a 3 hour recovery, the animals were scored for survivability.  As 
expected, preconditioning with a mild HS provided thermotolerance to lethal HS 
treatment with a 25% increase in survival rate, compared to animals without HS 
preconditioning (Figure 3.5A).  CR preconditioning prior to lethal HS treatment also 
provided modest thermotolerance, with a 14% increase in survival.  Similar to what we 
observed with hsp70 gene induction, animals preconditioned with both CR and HS 
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displayed heightened thermotolerance.  Animals increased from 48% survival with no 
preconditioning to 94% survival upon preconditioning with both CR and HS together.  
Both sir2.1 (ok434) and sir2.3 (ok444) deletion strains were examined for responses to 
thermotolerance. Consistent with our other data, sir2.1, but not sir2.3, was required for 
thermotolerance.  Therefore, as for the induction of hsp70 genes, the ability of CR to 
enhance HS-induced thermotolerance requires sir2.1. 
CR enhances the ability of HS Preconditioning to Increase the Fitness of Lethal HS 
Survivors 
To measure whether HS and CR preconditioning increased overall fitness after lethal HS 
exposure, thrashing assays were performed immediately after scoring for thermotolerance 
by transporting individual animals into a drop of M9 buffer.  After a 1 minute recovery 
from the transfer, the number of thrashes, or mid-body bends, was scored for 1 minute.  
Similar to survival assays, preconditioning with either HS or CR alone prior to exposure 
to lethal HS increased the number of thrashes per minute (Figure 3.5B).   Moreover, 
animals preconditioned with both CR and HS displayed heightened fitness as compared 
to either treatment alone, in a manner dependent on sir2.1 (Figure 3.5B-E).  Collectively, 
our data indicate that CR works in conjunction with HS to effectively provide increased 
thermotolerance, survival and fitness, a process specifically requiring sir2.1.   
CR increases the ability of HS to preserve movement in a C. elegans model of 
polyglutamine diseases 
C. elegans strains genetically engineered to express a polyglutamine (polyQ) repeat tract 
fused to YFP in the body wall muscle serve as models of polyQ disease where the 
expression of polyQ expansions in body wall muscle cells causes animal paralysis that 
develops in a polyQ length- and age-dependent manner (Morley, Brignull et al. 2002). In 
polyQ models in a variety of organisms, induction of the HSR protects animals from 
polyQ aggregation and aggregation-induced toxicity (Waza, Adachi et al. 2005; Fujikake, 
Nagai et al. 2008; Calamini, Silva et al. 2011).  We were interested in determining 
whether CR would enhance the ability of HS to protect from polyQ aggregation and 
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cytotoxicity. Q35-YFP worms produce aggregates that can be easily visualized by 
fluorescence microscopy by day 3 of adulthood (Morimoto 2008).  Upon testing the 
effect of HS and CR on the Q35-YFP strain, we found a statistically significant decrease 
in the number of aggregates with either CR or HS pretreatment (Figure 3.6A, B).  There 
was no increased effect observed upon treatment with HS and CR together, which could 
perhaps be due to the strong propensity of Q35-YFP to aggregate.  To test whether CR 
could enhance the cytoprotective effect of HS on a more sensitive polyQ strain, we 
assayed polyQ-induced paralysis in Q24-YFP animals.  While this strain does not 
produce visual aggregates, it does result in age-dependent paralysis that is evident at day 
4 of adulthood.  CR was observed to increase the ability of HS to alleviate paralysis in 
this strain (Figure 3.6C). A Q24-YFP; sir2.1 (ok434) strain was created to determine if 
the ability of CR to enhance HS-induced cytoprotection is dependent upon sir2.1.  The 
Q24-YFP; sir2.1 (ok434) double mutant displayed a higher degree of paralysis and 
eliminated the ability of CR to enhance HS-induced movement preservation 
(Figure 3.6C). Therefore, we conclude that CR can increase the ability of HS to preserve 
movement ability in this polyQ model in a sir2.1-dependent manner.   
The transcriptional regulation of the HSR was further evaluated for the Q24-YFP mutant 
to determine if the cytotoxicity of the polyglutamine repeat altered the HS and CR 
synergism observed for the hsp70 genes in N2 animals.  Q24-YFP animals cultured in 
either AL or CR conditions were exposed to a 33°C heat shock for 15 minutes with a 
30 minute recovery.  Induction of hsp70 family transcripts was quantitated by qRT-PCR 
(Figure 3.7A-C).  We found that the Q24 repeats did not impact the synergy between HS 
and CR, although the overall inducibility of the hsp70 genes was reduced.  We tested to 
see if the expression of Q24-YFP influenced sir2.1 expression and found it was decreased 
by 43% (Figure 3.7D).  Thus, we conclude that while Q24-YFP expression dampens 
sir2.1 mRNA expression and the inducibility of the HSR, the ability of CR to synergize 
with HS is maintained. 
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Discussion 
Prior work on mammalian HSF1 has implicated that it may be regulated by metabolism 
due to control by the NAD+-dependent sirtuin SIRT1 (Westerheide, Anckar et al. 2009; 
Donmez, Arun et al. 2012).  SIRT1 activity promotes the HSR, so we therefore reasoned 
that CR, by changing the NAD+ to NADH ratio, would also promote the HSR.  We have 
tested this hypothesis in C. elegans, an organism that is easily amenable to growth in CR 
conditions by limiting the bacterial food source.  The studies presented here demonstrate 
that CR conditions do indeed enhance the HSR as observed in a C12C8.1(hsp70)::GFP 
reporter strain.  Additionally, striking synergy occurs in the HS-induced levels of hsp70 
mRNA in the presence of CR.  This effect is dependent on sir2.1, as evidenced by 
experiments using sir2.1-deletion animals.  The synergy that we observe between CR and 
HS is biologically relevant, as CR can enhance the ability of HS to cause thermotolerance 
and increase thrashing fitness after a lethal HS in a sir2.1-dependent manner.  In addition, 
CR and HS can work together to preserve movement in a C. elegans polyQ cytotoxicity 
model.  To ensure the survival of the organism, it makes sense that stress induced by CR 
would enhance the cytoprotective effects of HS-induced stress. 
HSP70 is the chaperone that is highly induced by the HSR and protects cells from 
cytotoxic stress (Riabowol, Mizzen et al. 1988; Angelidis, Lazaridis et al. 1991; Li, Li et 
al. 1991).  There is an age-related decline in HSP70 levels during aging in many model 
organisms (Deguchi, Negoro et al. 1988; Faassen, O'Leary et al. 1989; Liu, Lin et al. 
1989; Fargnoli, Kunisada et al. 1990; Blake, Fargnoli et al. 1991; Campanini, Petronini et 
al. 1992; Pahlavani, Harris et al. 1995), which correlates with a decline in the ability to 
respond to stress. Interestingly, CR has been shown to restore the ability of cells to mount 
a HSR in aged rat hepatocytes (Heydari, You et al. 1996).  In these cells, CR was found 
to function not by increasing HSF1 levels, but by increasing the ability of HSF1 to bind 
to DNA upon HS.  It was proposed that HSF1 may be post-translationally altered by CR 
to allow it to be more active.  Our studies support a positive influence of CR upon 
induction of the HSR in a second model organism, C. elegans.  The synergy that we 
observe between CR and HS requires sir2.1.   
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A direct interaction between the insulin/IGF-1-like signaling pathway and HSR in 
C. elegans has recently been described.  Upon increased insulin/IGF-1-like signaling, an 
inhibitory complex containing the C. elegans proteins DDL-1, DDL-2, and HSB-1 was 
found to associate with HSF-1 and sequester it (Chiang, Ching et al. 2012).  CR 
conditions, by decreasing insulin/IGF-1-like signaling, may thus enhance the HSR via 
two mechanisms: 1) an increased NAD+ to NADH ratio activates Sir2.1 and thus the 
HSR and 2) the release of HSF-1 from the DDL-1/DDL-2/HSB-1 inhibitory complex 
leads to an increase in free HSF-1 capable of being activated.  Homologs of the DDL-1, 
DDL-2 and HSB-1 proteins are also present in mammals, indicating a possible 
preservation of this pathway.   
A characteristic of various activators of the HSR is that they can often function 
synergistically with each other.  For example, the non-steroidal anti-inflammatory drug 
indomethacin can cooperate with a mild heat stress to induce increased levels of 
chaperone gene expression over treatment with just heat alone (Lee, Chen et al. 1995). 
Other small molecules shown to work synergistically with HS include the inflammatory 
pathway intermediate arachidonic acid, the hydroxylamine derivative bimoclomol, and 
the triterpenoid celastrol (Jurivich, Sistonen et al. 1994; Torok, Tsvetkova et al. 2003; 
Westerheide, Bosman et al. 2004).  We now add CR as another HSR activator that can 
synergize with HS. 
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Figure 3.1.  Caloric restriction synergizes with heat shock to activate the 
C12C8.1(hsp70) promoter.   
A, Epifluorescence (E) and phase contrast (P) images are shown of a 
C12C8.1(hsp70)::GFP reporter strain of C. elegans treated with or without HS and CR, as 
indicated.  B, GFP levels observed by fluorescence microscopy in the worms in (A) were 
quantified by Image J and plotted as fluorescence intensity in arbitrary units.  Statistical 
significance was measured by Student’s t test as compared to AL (*P<0.05,** P<0.01, 
***P<0.001). C, GFP protein levels were determined by Western analysis using protein 
extracts from C12C8.1(hsp70)::GFP reporter animals treated as in (A).  The relative 
intensities of the GFP bands were quantitated by Image J and the fold inductions, relative 
to the untreated animals, are shown. Results are representative of three or more 
experiments.       
 
 
 
 
AL
0 
20 
40 
60 
80 
100 
120 
140 
AL AL+HS CR CR+HS 
in
 A
rb
itr
ar
y 
U
ni
ts
 
 66 
 
 
 
 
 
Figure 3.2.  Caloric restriction synergizes with heat shock to induce the endogenous 
hsp70 genes C12C8.1, F44e5.4 and F44e5.5.   
A, N2 animals were treated with or without HS and CR, as indicated, and mRNA levels 
were determined for C12C8.1 by qRT-PCR.  B, N2 animals were treated as in (A) and 
mRNA levels were determined for F44e5.4.  C, N2 animals were treated as in (A) and 
mRNA levels were determined for F44e5.5.  Results are in technical triplicates and are 
representative of biological duplicates.  Statistical significance was measured by 
Student’s t test as compared to AL (*P<0.05,** P<0.01, ***P<0.001). 
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Figure 3.3.  The synergistic effect between heat shock and caloric restriction on 
hsp70 gene induction is dependent upon sir2.1.  
A, sir2.1 deletion animals (ok434) were treated with or without HS and CR, as indicated, 
and mRNA levels were determined for C12C8.1 by qRT-PCR.  B, sir2.1 (ok434) animals 
were treated as in (A) and mRNA levels were determined for F44e5.4.  C, sir2.1 (ok434) 
animals were treated as in (A) and mRNA levels were determined for F44e5.5.  Results 
are in technical triplicates and are representative of biological duplicates.  Statistical 
significance was measured by Student’s t test  as compared to AL (*P<0.05,** P<0.01, 
***P<0.001). 
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Figure 3.4.  sir2.3 deletion does not alter the synergistic effect between heat shock 
and caloric restriction on hsp70 gene induction.  
A, sir2.3 deletion animals (ok444) were treated with or without HS and CR, as indicated, 
and mRNA levels were determined for C12C8.1 by qRT-PCR.  B, sir2.3 (ok444) animals 
were treated as in (A) and mRNA levels were determined for F44e5.4.  C, sir2.3 (ok444) 
animals were treated as in (A) and mRNA levels were determined for F44e5.5. Results 
are in technical triplicates and are representative of biological duplicates.  Statistical 
significance was measured by Student’s t test as compared to AL (*P<0.05,** P<0.01, 
***P<0.001). 
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Figure 3.5.  Caloric restriction enhances the ability of heat shock to induce 
thermotolerance and thrashing fitness in a sir2.1-dependent manner.   
A, The indicated C. elegans strains were treated with or without HS and CR, as indicated, 
prior to a lethal HS treatment of 36ºC for 45 minutes followed by a 3 hour recovery.  
Percent survival was quantified.  sir2.1 was required for the observed synergistic 
thermotolerance effect, while sir2.3 was not.  B and C, The fitness of the surviving 
animals from (A) was tested by a thrashing assay by quantitating the number of mid-body 
bends per minute.  B, N2 animals exposed to both HS and CR exhibited synergy in 
thrashing activity. C, sir2.1 deletion animals did not show a synergistic effect between 
HS and CR in thrashing fitness. Results for thermotolerance are in biological triplicates.  
Fifty animals were scored for each variable in the thrashing assay, with results 
representative of two experiments.  Statistical significance was measured by Student’s t 
test as compared to AL (*P<0.05,** P<0.01, ***P<0.001).  
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Figure 3.6.  Caloric restriction and heat shock reduce aggregate numbers and 
preserve movement in a C. elegans polyglutamine cytotoxicity model.   
A) Q35-YFP animals show a reduction in aggregate formation when pretreated with HS, 
CR, or HS and CR together.  The numbers refer to the amount of aggregates observed for 
the animal pictured in the panel.  B) Quantitation of the aggregate numbers from (A). At 
least 50 animals were scored for each variable. C) Q24-YFP animals show a preservation 
of movement when pretreated with HS or CR, and CR increases the ability of HS to 
preserve movement in a in a manner dependent on sir2.1.  Q24-YFP or Q24-YFP;sir2.1 
deletion animals were treated with HS, CR, or CR+HS as indicated.  At least 100 animals 
were scored for each variable.  Results for the paralysis assay are in biological triplicates.  
Statistical significance for B-C was measured by Student’s t test as compared to AL 
(*P<0.05,** P<0.01, ***P<0.001). 
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Figure 3.7.  PolyQ cytotoxicity does not alter the synergistic effect between heat 
shock and caloric restriction on hsp70 gene induction.   
A, Q24-YFP animals were treated with or without HS and CR, as indicated, and mRNA 
levels were determined for C12C8.1 by qRT-PCR.  B, Q24-YFP animals were treated as 
in (A) and mRNA levels were determined for F44e5.4.  C, Q24-YFP animals were 
treated as in (A) and mRNA levels were determined for F44e5.5. D, N2 and Q24-YFP 
animals were analyzed for sir2.1 mRNA levels by qRT-PCR.  Results are in technical 
triplicates and are representative of biological duplicates.  Statistical significance was 
measured by Student’s t test as compared to AL (*P<0.05,** P<0.01, ***P<0.001). 
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CHAPTER 4: RPS19, A KNOWN AROS-INTERACTING PROTEIN, IS A 
NEW TRANSCRIPTIONAL TARGET OF HSF1 
Authored by Rachel Raynes, Kevin Nguyen, and Sandy D. Westerheide. 
Unpublished data. 
Experiments were designed, performed, and analyzed by R. Raynes or performed under 
the direction of R. Raynes.  K. Nguyen performed a qPCR replicate for Figure 4.1.   
All data analysis and figures were generated by R. Raynes.  The manuscript was written 
by R. Raynes.   
Abstract 
HSF1 is the master regulator of the heat shock response (HSR) and consequently 
up-regulates heat shock (HS) inducible genes upon stress.  HSF1 activity is determined 
by a number of post-translational modifications (PTMs).  Because acetylation causes 
HSF1 to lose affinity for the DNA, the deacetylase SIRT1 plays a significant role in the 
propagation of heat shock proteins (HSPs).  Recently, SIRT1 regulators DBC1 and 
AROS have also been shown to impact HSF1 activity and regulation of the HSR.  Here, 
we investigate a ribosomal protein, RPS19, which binds to AROS and may play a role in 
the HSR.   We found that RPS19 expression increases upon HS and that HSF1 is 
recruited to the rps19 promoter.  We conclude that rps19 is a new transcriptional target of 
HSF1.   
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Introduction 
The ribosome is a ribonucleoprotein assembly consisting of rRNA strands and multiple 
smaller protein subunits. Eukaryotes possess a small 40S and a large 60S subunit, as 
measured by the Svedberg rate of sedimentation unit.  The 40S subunit is composed of 
18S rRNA and 33 proteins while the 60S subunit is composed of a 5S, 28S, and 5.8S 
rRNA and approximately 49 proteins (Klinge, Voigts-Hoffmann et al. 2011; Rabl, 
Leibundgut et al. 2011).  Ribosomal proteins (RP) are named according to molecular 
weight on a 2D gel and their formation with the small or large subunits, RPS or RPL, 
respectively.   
Some ribosomal proteins, for instance the S. cerevisiae RPL26, have roles in optimizing 
pre-rRNA maturation and are non-essential to the translation of proteins.  An 
rpl26aΔ;rpl26bΔ mutant undergoes identical growth and translation accuracy as 
compared to the wild-type strain, though does result in a slight deficit of 60S r-subunits 
and a delay in pre-rRNA processing (Babiano, Gamalinda et al. 2012).  However, most 
RPs are essential and result in disease or lethality when defective.  Mutations in the 
proteins RPS17, RPS19, RPS24, RPL5, RPL11, and RPL35a are associated with 
Diamond Blackfan Anemia (DBA).  DBA is characterized by decreased erythroid 
progenitors in the bone marrow resulting in anemia that develops in infancy.  Nearly half 
of the individuals diagnosed with DBA also possess congenital abnormalities including 
cardiac defects, craniofacial malformations, limb abnormalities, and cleft palate 
(Freedman 2000; Willig, Gazda et al. 2000).  Approximately 25% of DBA cases have 
been linked to mutations in RPS19 (Draptchinskaia, Gustavsson et al. 1999; Willig, 
Draptchinskaia et al. 1999).  This has led to the hypothesis that a defect in the ribosomal 
machinery may be the underlying cause of DBA.   
In an effort to better understand the cause of DBA, a yeast two-hybrid screen aimed to 
identify novel proteins that associate with RPS19 led to the discovery of a small 15kDa 
protein that localizes to the nucleoli and was subsequently named RPS19 binding 
protein 1 (RPS19bp1) (Maeda, Toku et al. 2006).  RPS19bp1 was later discovered in 
another yeast two-hybrid screen aimed to investigate direct regulators of SIRT1 (Kim, 
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Kho et al. 2007).  It was found that RPS19bp1 binds directly to SIRT1 in order to 
suppress p53 transcriptional activity, thus leading the cell down a non-apoptotic pathway 
and earning the new name Active Regulator of SIRT1 (AROS) (Kim, Kho et al. 2007).  
In addition to regulating p53-mediated apoptosis, SIRT1 is also a known regulator of the 
HSR.  SIRT1 deacetylates HSF1 thus increasing its affinity for DNA and prolonging the 
transcription of hsp genes (Westerheide, Anckar et al. 2009).   
Recently, our laboratory has shown that the SIRT1 interactor AROS regulates HSF1 
activity and the HSR.  We found that AROS has an impact on hsp70 transcription, HSF1 
acetylation status, and HSF1 recruitment to hsp promoters (Raynes, Pombier et al. 2013).  
Given that AROS has been shown to directly interact with RPS19 and because RPS19 
has a critical role in protein translation, we sought to investigate whether RPS19 might 
play a role in the HSR.  Here we show that RPS19 is upregulated upon initiation of the 
HSR and is a new HSF1 target for transcription.   
Methods 
Cell culture and heat shock 
HeLa and HEK293 cells were utilized in this study.  All cell lines were cultured and 
heat-shocked as previously described (Raynes, Pombier et al. 2013) (Studies, Chapter 1).  
Briefly, plates were wrapped in parafilm and submerged in a water bath set to 42°C for 
the designated times prior to collection with 1X PBS. 
Quantitative RT-PCR 
qRT-PCR was performed to quantify mRNA levels for rps19 and gapdh using 
gene-specific primers (Appendix B).  qRT-PCR was performed as previously described 
(Raynes, Pombier et al. 2013) (Studies, Chapter 1).  Briefly, RNA was extracted using 
Trizol and was reverse transcribed using Applied Biosystem’s High Capacity cDNA 
Reverse Transcription Kit (cat#4368814) according to the manufacturer’s protocol.  The 
samples were diluted to 50 ng/µL and used as a template for qRT-PCR.  Statistical data 
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analysis and determination of relative fold increase from control samples was performed 
according to standard calculations (Bookout and Mangelsdorf 2003). 
Immunoblotting Analysis 
HeLa cells were collected in 1X PBS and then extracted using M-PER (Thermo 
Scientific cat#78503) with the addition of Halt™ Protease Inhibitors (Thermo Scientific 
cat#78430).  20 µg of protein was run on a 10% SDS-PAGE gel and immunoblotting was 
performed as previously described (Raynes, Pombier et al. 2013) (Studies, Chapter 1).  
Primary antibodies used include ACTIN (Santa Cruz cat#sc-1616-r) and RPS19 (Sigma 
cat#SAB1404336).  HRP-conjugated secondary antibodies were from Millipore 
(cat#12-349 and 12-348).  Detection was performed using ECL Plus Western Blotting 
Detection System (Amersham™ cat#RPN2132). 
Chromatin Immunoprecipitation 
Chromatin Immunoprecipitation (ChIP) was performed as previously described (Raynes, 
Pombier et al. 2013) (Studies, Chapter 1).  Immunoselection and immunoprecipitation 
were performed using 5 µL of HSF1 (Enzo cat#ADI-SPA-901) or IgG (Cell Signaling 
Technology cat#2729S) antibody. Purified DNA was used for qRT-PCR using primers to 
the rps19 promoter surrounding the proximal HSE (Appendix B).  Statistical data 
analysis and determination of relative fold increase from control samples without heat 
shock was performed according to standard protocol (Bookout and Mangelsdorf 2003). 
Results 
RPS19 mRNA and protein levels increase upon HS 
We first sought to investigate whether rps19 transcription levels were affected by a HS 
time course.  HeLa cells were treated with a 42°C HS from 0 to 6 hours and qRT-PCR 
was performed using primers to rps19.  It is well established, and we have previously 
shown, that hsp70 mRNA levels increase substantially by 2 hours of HS and then begin 
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to decline by 6 hours of HS due to the attenuation of the HSR (Figure 2.1B) (Raynes, 
Pombier et al. 2013).  Similarly, rps19 mRNA levels increased after 30 min of HS and 
began to decline by 6 hours of continuous HS treatment (Figure 4.1).  Western blot 
analysis showed that RPS19 protein is elevated upon 2 hours of HS and remained 
constant at 6 hours of treatment (Figure 4.2).  We therefore conclude that RPS19 
expression is induced by the HSR. 
The rps19 promoter possesses conserved HSF1 binding sites 
We next sought to investigate whether rps19 is a transcriptional target of HSF1 as 
suggested by Figures 4.1-2.  The rps19 open reading is highly conserved from yeast to 
humans (Figure 4.3).  The HSF1 targeted promoters possess evolutionarily conserved 
inverted repeats of heat shock elements (HSEs) composed of the pentamer sequence 
nGAAn (Sorger and Pelham 1987; Amin, Ananthan et al. 1988).  Typically found in 
triplicate, each element is a sequence for one of the three DNA-binding domains of the 
HSF1 trimer to bind to the DNA.   Sequence analysis of the C. elegans rps19 5`UTR 
revealed a putative HSE 367 bps upstream of the ATG start codon (Figure 4.4).  
Sequence analysis of the H. sapiens rps19 5`UTR revealed a putative HSE 150 bps 
upstream of the ATG start codon (Figure 4.5).  This HSE is conserved in S. cerevisiae, 
C. elegans, D. melanogaster, and M. musculus (Figure 4.6).   
HSF1 is recruited to the rps19 promoter 
In order to verify that rps19 is an HSF1 target, we performed chromatin 
immunoprecipitation (ChIP).  HEK293 cells were treated with HS over a 6 hour time 
course followed by ChIP using an antibody to HSF1.  A 2 hour HS resulted in 
recruitment of HSF1 to the rps19 promoter (Figure 4.7).   Unlike the kinetics observed 
for HSF1 recruitment to hsp targets (Figure 2.4B) (Raynes, Pombier et al. 2013), HSF1 
recruitment to the rps19 promoter did not attenuate at 6 hours of HS treatment 
(Figure 4.7).   Therefore, we conclude that rps19 is a transcriptional target of HSF1.   
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Discussion 
Our results indicate that RPS19 is a new transcriptional target of HSF1.  We provide 
evidence that RPS19 is upregulated upon HS and that HSF1 is recruited to the rps19 
promoter.  Upon initiation of the HSR, transcription and translation of most genes is 
reduced in favor of the upregulation of HSPs (Theodorakis and Morimoto 1987).  It is 
therefore interesting that RPS19 interacts with AROS (Maeda, Toku et al. 2006), a 
positive SIRT1 modulator, and that RPS19 is also up-regulated upon HS.  We feel that 
there are two hypotheses that may explain this phenomenon: 1) RPS19 may be a 
component in a SIRT1-AROS complex that positively regulates the HSR or 2) the 
expression of RPS19 is increased during the HSR to manage the elevation of HSP 
translation induced by HS.     
Future Directions 
It is well established that RPS19 interacts directly with AROS and that AROS interacts 
directly with SIRT1 (Maeda, Toku et al. 2006; Kim, Kho et al. 2007).  In order to test the 
hypothesis that RPS19 forms a complex with SIRT1 and AROS, a 
co-immunoprecipitation pulling down SIRT1 should be performed under HS conditions 
and the presence of RPS19 can be confirmed via Western blot analysis.  Additionally, the 
precipitation of RPS19 with HSF1 would provide further evidence of its involvement 
with HSR regulation.  Association with SIRT1-AROS might provide a mechanism to 
recruit translational machinery to hsp promoters in order to rapidly transcribe nascent hsp 
RNA.   
While knockdown studies would traditionally elucidate the role of a protein in the HSR, 
knockdown of RPS19 may be uninformative due to the fact that it is an essential 
ribosomal protein.  Recently, depletion of the proteins RPS6, RPS7, RPS15, RPS16, 
RPS25, RPS28, RPL7, RPL14, and RPL26, in addition to the previously reported 
DBA-associated proteins including RPS19, demonstrated that they are essential for 
translation. Knockdown of individual RPs with siRNA resulted in a decreased production 
of other RPs within the same subunit and a decline in the production of mature 
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ribosomes, thus negatively affecting translation (Robledo, Idol et al. 2008).  Similarly, 
overexpression of RPS19 may merely cause the increased expression of other proteins in 
the small ribosomal subunit and result in a general increase in HSPs, independent of 
RPS19 interaction with a SIRT1-AROS complex.   
However, because the HSE found within the rps19 promoter is conserved in 
S. cerevisiae, the importance of HSF1 induction of RPS19 can be tested via site-directed 
mutagenesis in the yeast model system.  Guanine and cytosine are the most conserved 
nucleotides of the HSE and may abolish HSF1 recruitment if mutated to purines 
(Trinklein, Murray et al. 2004).  Upon mutation of the rps19 HSE, a decline in HS-stress 
resistance compared to the wild-type strain would indicate that the increased expression 
of RPS19 is critical for HSR regulation.  
Additionally, the importance of RPS19 in HSR-regulated stress resistance can be 
measured in a D. melanogaster strain possessing a heterozygous deletion mutation for 
rps19bEY00801 (Bloomington Drosophila Stock Center, Stock#15043).  Loss of one copy of 
the rps19b allele may lead to reduced HS-stress resistance.  Furthermore, a cross between 
an rps19bEY00801 mutant and a polyQ-GFP reporter mutant may result in an increase in 
age-dependent aggregation.  This would demonstrate the importance of rps19 in HSR 
regulation in a multicellular organism.  While this can also be shown in C. elegans using 
RNAi to rps19, complete knockdown of rps19 may be detrimental to protein translation 
as a whole, thus resulting in misleading phenotypic interpretations.   
In addition to the hypothesis that RPS19 is a member in an HSF1 regulatory complex, it 
would be interesting to investigate whether RPS19 may be a sensor of the HSR in regards 
to protein translation. Stress sensing mechanisms are critical for regulation of the HSR 
and are evident for the trimerization of HSF1.  Inactive HSF1 monomers are bound by 
HSP90 and sequestered to the cytoplasm.  Upon denaturing stress, HSP90 releases HSF1 
in order to manage misfolded proteins, allowing HSF1 to trimerize and translocate to the 
nucleus (Ali, Bharadwaj et al. 1998).  HSF1 trimerization is also aided by the eukaryotic 
elongation factor eEF1A and Heat Shock RNA-1 (HSR-1), which are hypothesized to 
recruit translational machinery to the nascent hsp mRNA (Shamovsky, Ivannikov et al. 
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2006).  HSR-1 is thermosensitive RNA that may act in a similar manner as the 
prokaryotic rpoH, which forms an inhibitory secondary RNA structure that can only be 
translated upon melting by denaturing stress (Morita, Kanemori et al. 1999; Morita, 
Tanaka et al. 1999).  Likewise, rps19 may be sensitive to proteotoxic stress in order to 
promote the HSR by interacting with SIRT1-AROS or to prepare for the increased 
translation of HSPs.  Interestingly, in vitro studies have shown that RPS19 binds the 
5`UTR region of its own RNA in a potential feedback mechanism (Schuster, Frojmark et 
al. 2010).   Because RPS19 has RNA binding capabilities and is upregulated upon HS, its 
potential involvement with HSR-1 and eEF1A should be investigated.    
In order to test the independent hypothesis that RPS19 expression is increased during the 
HSR as a global consequence to necessitate the elevation of HSP translation induced by 
HS, the expression levels of other ribosomal proteins upon HS should be evaluated.  
Moreover, evidence of HSEs within the promoter regions of other ribosomal genes would 
indicate that the increased expression of RPs during the HSR is a global reaction to 
increased translation.  However, given that translation of constitutive genes decreases 
upon HS, it may be that the rate of general protein translation does not increase in order 
to compensate for increased HSP expression.  Further confounding the matter is the 
hypothesis that nSB’s sequester protein translational machinery as a method to 
down-regulate translation of non-stress genes (Sandqvist and Sistonen 2004).  Titrating 
away translation factors may not negatively impact HSP protein synthesis if they are 
specifically recruited with HSF1. 
Further research is needed to determine if RPS19 upregulation by HSF1 is a hallmark of 
protein translation or a component of the SIRT1-AROS regulatory complex.  This current 
work expands our knowledge of genes that are transcriptional targets of HSF1 and we 
add RPS19 as a protein that is inducible by HS stress.  
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Figure 4.1.  rps19 mRNA levels increase upon HS.   
HeLa cells were exposed to a 42°C HS from 0 to 6 hours and qRT-PCR was performed 
using primers to rps19.   The kinetics of rps19 transcription is rapid, but does not change 
throughout the initiation of the HSR.  However, similarly to hsp70 induction 
(Figure 2.1A), rps19 levels begin to decrease at 6 hours at 42°C. The qPCR results are in 
technical triplicates and statistical significance was measured by Student’s t test as 
compared to 0 hr HS (*P<0.05,** P<0.01, ***P<0.001).  
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Figure 4.2.  RPS19 protein levels increase upon HS.   
HeLa cells were exposed to a 42°C HS from 0 to 6 hours and RPS19 and ACTIN protein 
levels were determined by Western blot analysis.  RPS19 protein levels begin to increase 
at 2 hours of HS.  Results representative of biological duplicates.   
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Figure 4.3. The sequence alignment of the rps19 open reading frame is evolutionarily conserved. 
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Figure 4.4.  Sequence of a putative HSE within the promoter region of the C. elegans 
rps19 homolog, T05F1.3. 
A putative HSE was found 367 bps upstream of the C. elegans rps19 homolog.  The 
orange bar indicates the ORF.  Analysis was performed using Geneious® DNA sequence 
analysis software. 
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Figure 4.5.  Sequence of a putative HSE within the promoter region of the H. sapiens 
rps19 gene.   
HSF1 binds to HSEs, consisting of variations of the inverted pentamer sequence nGAAn, 
within the promoter region of HS responsive genes. A HSE is 150 bps upstream of the 
rps19 gene.  The orange bar indicates the open reading frame (ORF).  Analysis was 
performed using Geneious® DNA sequence analysis software. 
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Figure 4.6.  Sequence alignment of the rps19 5` UTR for S. cerevisiae, C. elegans, 
D. melanogaster, M. musculus, and H. sapiens.   
A) Conserved nGAAn pentamer.  B) Conserved nTTCn pentamer. Other elements of the 
core promoter have not yet been identified.  Sequence alignment was performed using 
Geneious® DNA sequence analysis software.   
[Nucleotide notations: G= G, guanine; A= A, adenine; T = T, thymine; C= C, cytosine; 
R= G or A, purine; Y= T or C, pyrimidine; M= A or C,  amino; K= G or T, keto; S= G or 
C, strong interaction (3 H bonds); W= A or T, weak interaction (2 H bonds); H= A or C 
or T, not a guanine; B= G or T or C, not an adenine; V= G or C or A, not a thymine; D= 
G or A or T, not a cytosine;  N= any nucleotide.]   
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Figure 4.7. HSF1 is recruited to the rps19 promoter and undergoes an increase in 
recruitment upon HS. 
Hek293 cells were exposed to HS for 0, 2, or 6 hours and chromatin immunoprecipitation 
(ChIP) was performed with an HSF1 antibody. The purified DNA was then analyzed by 
qPCR and DNA levels were determined for the rps19 promoter.  The qPCR results are in 
technical triplicates and statistical significance was measured by Student’s t test as 
compared to 0 hr HS (*P<0.05,** P<0.01).  ChIP was performed in biological 
duplicates. 
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CHAPTER 5. IMPLICATIONS AND FUTURE DIRECTIONS 
Implications for AROS and DBC1 Studies 
HSF1 and Cancer 
Heat shock proteins (HSPs) are elevated in a number of cells and tissues from a variety of 
cancers including prostate (Tang, Khaleque et al. 2005), lung (Zimmermann, Nickl et al. 
2012), pancreas (Gress, Muller-Pillasch et al. 1994), bladder (Syrigos, Harrington et al. 
2003), and breast (Cheng, Chang et al. 2012).  Elevated HSP expression is often used as a 
biomarker for tumor progression and prognosis, though not all cancers (i.e. renal cell 
carcinoma) present this correlation (Ramp, Mahotka et al. 2007).  Tumors take advantage 
of the HSR survival mechanism, which allows the cancer cells to proliferate.  
Overexpression of HSP27 in rat colon adenocarcinoma cells injected into syngenic 
animals increased tumorigenicity resulting in increased tumor size and a delay in tumor 
regression (Garrido, Fromentin et al. 1998).  Furthermore, overexpression of HSP70 in 
primary cell cultures can lead to reversible oncogenic transformation (Volloch and 
Sherman 1999). 
The manner in which increased expression of HSPs promote cancer is not fully 
understood.  In cancer cells, the dysregulation of cell growth is the result of a shift toward 
cell proliferation over cell death.  Therefore, HSPs may have a role in cytoprotection 
against apoptosis and interfere with apoptotic signaling.  In tumor cells, knockdown of 
HSP70 with antisense oligomers led to the induction of apoptosis and the inhibition of 
tumor cell proliferation (Wei, Zhao et al. 1995).  In addition, HSP70 has been shown to 
interfere with the assembly of the apoptosome by preventing the recruitment of 
procaspases 9 and 3 (Beere, Wolf et al. 2000).  The mechanism by which HSP70 is 
cytoprotective against apoptosis may also be through inhibitory binding and sequestration 
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of proapoptotic proteins (Jolly and Morimoto 2000). For instance, HSP70 has been 
shown to stabilize p53 in transformed cell culture (Pinhasi-Kimhi, Michalovitz et al. 
1986).  In addition to HSP70, other HSPs have been found to promote cancer cell 
proliferation, in a chaperone-specific manner that may not be redundant (Richards, 
Hickey et al. 1996).    
Modulation of HSF1 as a Therapeutic Strategy 
As expected, the upregulation of HSPs in cancer correlates with elevated expression of 
HSF1.  Expression of HSF1 is increased in the more malignant human prostate carcinoma 
cells resulting in HSP induction (Tang, Khaleque et al. 2005).  High levels of HSF1 may 
potentially act as a prognostic biomarker for tumor progression.  A Nurses’ Health Study 
initiated in 1976 revealed that an increased level of HSF1 in mammary tumors is 
indicative of a poor prognosis (Santagata, Hu et al. 2011). 
Due to the role of HSF1 in some cancers, the ability to regulate the HSR is an attractive 
avenue for cancer treatment.  Our studies add to the current knowledge base of HSR 
regulation in the cell.  We found that AROS and DBC1 are SIRT1 regulators that impact 
hsp70 transcription (Figure 2.4-5), HSF1 acetylation status (Figure 2.6A), and HSF1 
recruitment to the hsp70 promoter (Figure 2.6D) (Raynes, Pombier et al. 2013).  
Specifically, DBC1 is shown to have a negative impact on hsp induction.  Interestingly, 
through inhibitory binding to SIRT1, DBC1 also stimulates p53 by blocking its 
deacetylation (Kim, Chen et al. 2008).  Acetylation of p53 results in its transactivation 
and the upregulation of p53-mediated function, thus leading cells down an apoptotic 
pathway.  Consequently, a decrease in DBC1 inhibition of SIRT1 may promote cancer 
cell survival.  Contrary to this hypothesis, DBC1 is overexpressed in a number of cancers 
and is associated with a shorter overall survival (Cha, Noh et al. 2009; Lee, Kim et al. 
2011).  However, while both SIRT1 and DBC1 expression is higher in breast cancer, 
their protein interaction is weaker in tumor tissue compared to normal tissue (Sung, Kim 
et al. 2010).  This may be due to inhibitory post-translation modification to residues 
within the binding domains that allow for the SIRT1-DBC1 interaction.  Furthermore, the 
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aberrant regulation of SIRT1 by DBC1 may contribute to cell proliferation in cancer as 
mediated by p53, as well as HSF1.   
Recently, it was shown that DBC1 is phosphorylated at T454 upon genotoxic stress and 
mutation of that residue abolishes the SIRT1-DBC1 interaction (Yuan, Luo et al. 2012).  
DBC1 binds to the SIRT1 catalytic domain via its leucine zipper motif (amino acids 
243-264) (Kim, Chen et al. 2008), but phosphorylation of DBC1 upon DNA damage 
creates a second binding site for SIRT1.  Consequently, T454 phosphorylation of DBC1 
resulted in a stronger DBC1-SIRT1 interaction and enhanced p53 acetylation (Yuan, Luo 
et al. 2012).  The manner in which DBC1 senses DNA damage and becomes 
phosphorylated may involve recruitment of the MRN complex to modified histones at 
double-stranded DNA break sites, ultimately resulting in the activation of the ATM/ATR 
kinase pathway [reviewed in (Aguilera and Gomez-Gonzalez 2008)].  Therapeutic 
strategies aimed to phosphorylate DBC1 may have a dual function in treating cancer by 
1) repressing p53 deacetylation thereby activating apoptosis and by 2) repressing HSF1 
deacetylation resulting in down-regulation of HSPs.   
Future Studies for DBC1 
We have shown that the SIRT1 modulator DBC1 is able to negatively impact the HSR 
and hsp transcription.  DBC1 is a homolog to cell cycle and apoptosis regulator 1 
(CCAR1) in mammalian cells.  While C. elegans does not have a DBC1 homolog, there 
is a CCAR1 ortholog known as LST-3.  Due to the relevance of DBC1 in SIRT1 
regulation and its ability to impact the HSR, current work in our laboratory is aimed to 
investigate the evolutionary significance of lst-3 in sir2.1 regulation of the HSR in 
C. elegans. Our laboratory has recently found that RNAi knockdown of lst-3 results in an 
increase in fluorescence of an Phsp70::GFP reporter C. elegans strain (Figure S8,9) and 
the positive impact that lst-3 knockdown has on the HSR is dependent upon the SIRT1 
ortholog, sir2.1 (unpublished data).  We hypothesize that DBC1 regulation of SIRT1 is an 
evolutionarily conserved mechanism that impacts the HSR and protein homeostasis.  We 
propose to test this hypothesis using aging and age-related disease models in C. elegans 
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to investigate the effect that lst-3 has on sir2.1 regulation of the HSR in C. elegans with 
the following aims: 
Aim 1:  Investigate the effect that lst-3 has on sir2.1 regulation of the HSR in C. elegans. 
1.1: Determine the impact that RNAi knockdown of lst-3 has on the HSR as 
measured by transcription of hsp70 family members and whether this is 
dependent on sir2.1. 
1.2:  Examine whether lst-3 RNAi impacts the acetylation status of HSF-1 by 
utilizing an HSF-1::GFP C. elegans strain, immunoprecipitating HSF-1::GFP, and 
analyzing acetylation of HSF-1 via Western blot. 
1.3:  Perform chromatin immunoprecipitation using an HSF-1::GFP C. elegans 
strain and a GFP antibody to determine the impact the lst-3 knockdown has on 
HSF-1 recruitment to hsp promoters via qRT-PCR. 
Aim 2: Determine if RNAi knockdown of lst-3 is cytoprotective by evaluating 
thermotolerance and rescue of the deleterious phenotype of a polyglutamine C. elegans 
disease model.  
2.1:  Evaluate whether lst-3 knockdown results in thermotolerance and increased 
fitness for N2 (wild-type) animals exposed to lethal heat shock and whether this 
effect is reliant on sir2.1. 
2.2:  Examine the impact and sir2.1-dependency that lst-3 RNAi knockdown has 
on an age-dependent polyglutamine::YFP C. elegans model by assaying for YFP 
aggregation and paralysis.  
Aim 3: Investigate whether RNAi knockdown of lst-3 leads to an increase in C. elegans 
lifespan in a sir2.1-dependent manner.  
3.1:  Evaluate whether lst-3 RNAi knockdown impacts lifespan due to increased 
stress adaptation caused by salvaging the age-related decline of hsp transcription.   
3.2:  Determine if sir2.1 plays a role in lst-3 modulation of lifespan using a sir2.1 
(ok434) deletion mutant, sirtuin inhibitors/activators, and RNAi against sir2.1.  
Together, these proposed aims will provide a basis for demonstrating the evolutionary 
conservation of HSF-1 regulation of the HSR, lst-3 involvement in protein aggregation in  
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a polyglutamine neurodegenerative disease model, and the impact of lst-3 regulation of 
HSF-1 on lifespan.  This work will provide further support of DBC1 as an HSR regulator 
that may be a potential therapeutic target in HSR modulation.  
In addition to the lst-3 studies in C. elegans evaluating the conservation of the impact of 
DBC1 on the HSR, our laboratory has recently found that DBC1 is degraded upon a HS 
time course (Figure S2).  Future studies should evaluate the nature of DBC1 regulation 
and how it becomes degraded throughout induction of the HSR.  The rate of DBC1 
degradation can be determined by standard [35S]-methionine pulse chase radiolabelling 
followed by immunoprecipitation of DBC1 and SDS-PAGE analysis by autoradiography.  
Moreover, inhibition of the proteasome with MG132 may impact the rate of DBC1 
degradation.  Additionally, it would be interesting to determine whether degradation of 
DBC1 upon HS is mediated by chaperone-mediated autophagy, which may be a more 
readily available pathway compared to ubiquitylation and proteolysis by the 26S 
proteasome. 
Furthermore, DBC1 may also be regulated at the mRNA level as indicated by the slight 
decrease of dbc1 transcription observed upon prolonged HS (Figure 2.4A).  The stability 
of the dbc1 mRNA can be evaluated by performing a nuclear run-on assay using HEK293 
cells in the absence and presence of HS.  In short, transcription is halted in the cells with 
actinomycin D treatment and RNA is collected over a 24-hour time course followed by 
qRT-PCR using primers to dbc1.  Determining the method in which DBC1 is regulated 
will provide insight in how to modulate the HSR for therapeutic purposes. 
Future Studies for AROS 
Our studies regarding SIRT1 regulation of the HSR also indicated that the SIRT1 
regulator AROS has a positive impact on hsp induction. However, compared to DBC1, 
AROS has been relatively understudied.  In part, this may be due to the fact that there is 
currently no available commercial antibody for endogenous detection of AROS protein4.  
                                                
4 We have successfully detected overexpressed AROS in transfected cell lysate using an antibody from 
Santa Cruz (cat#SC-86210).  
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Because AROS positively regulates SIRT1 deacetylation activity, it may have a role in 
fostering cell survival by 1) promoting deacetylation of p53 thereby leading cells away 
from a pro-apoptotic pathway and by 2) promoting the deacetylation of HSF1 resulting in 
upregulation of HSPs.  Unlike DBC1, AROS does not possess an ortholog in invertebrate 
models and is therefore an evolutionarily recent mechanism for regulating SIRT1.  It 
would be interesting to investigate whether AROS may play a role in cancer or if its 
activation could relieve polyQ aggregation toxicity in a cell culture model.  In addition, 
the involvement of AROS in HSR regulation should be further investigated.  It is 
tempting to suggest that there may be a dynamic role for AROS and DBC1 as 
competitors for SIRT1 binding and, consequently, HSF1 regulation.  The endogenous 
activity of AROS and DBC1 upon stress would elucidate whether such an antagonistic 
relationship is a hallmark of SIRT1 regulation.   
Final thoughts 
The HSR is an ancient adaptive mechanism that has evolved to help organisms cope with 
stressful insults.  Regulation of the HSR is complex involving redundant mechanisms and 
a number of feedback controls (Figure 5.1).  While HSF1 has been shown to promote 
cytoprotection and cell survival, it has also been demonstrated to have a lethal role in 
cancer proliferation.  In addition, a loss of protein homeostasis is a hallmark of many 
other diseases including heart disease, neurodegenerative diseases, and diabetes.  
Therefore it is of great significance to further understand the intricacies controlling this 
complex survival response.    
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Figure 5.1.  A model for the regulation of the eukaryotic HSR. 
Upon denaturing stress, misfolded proteins compete with HSF1 for binding to HSPs, 
thereby releasing HSF1 to trimerize and translocate to the nucleus where it binds HSEs 
within the promoter of hsp genes.  Trimerization is aided in part by elongation factor 
eEF1A and the open confirmation of HSR-1 RNA, a complex which also serves to recruit 
translational machinery to the nascent hsp mRNA. Transactivation of HSF1 is aided in 
part by phosphorylation of the AD by a number of protein kinases (PK), while DNA 
binding of HSF1 is regulated by acetylation of the DBD by a histone acetyltransferase 
(HAT).  HSF1 DNA-binding affinity is promoted via deacetylation by SIRT1, which is 
positively regulated by AROS and negatively regulated by DBC1.  During recovery of 
cellular homeostasis, an excess of HSPs disassociates HSF1 trimers resulting in 
attenuation of the HSR.   
 94 
 
Implications for Caloric Restriction and Heat Shock Synergy Studies 
Caloric Restriction as a Therapeutic Strategy  
Activation of the HSR and the up-regulation of HSPs are currently under investigation as 
a potential therapeutic to combat aging and protein aggregate diseases, including 
Alzheimer’s and Parkinson’s disease.  Several small molecule activators have been found 
to activate HSF1 and are generally categorized as translation inhibitors, chaperone 
inhibitors, proteasome and protease inhibitors, amino acid analogs, and thiol reactive 
molecules (Westerheide and Morimoto 2005; Neef, Jaeger et al. 2011). Pharmacological 
activation of HSF1 is primarily caused by targeting and dysregulating protein 
homeostasis.  By perturbing protein synthesis, folding, and degradation, an imbalance in 
protein homeostasis occurs, which leads to an increase in misfolded proteins that have the 
potential to oligomerize and aggregate, and thereby necessitate induction of the HSR 
(Salomons, Menendez-Benito et al. 2009; Wilde, Brack et al. 2011).    
Several pharmacological HSR activators have proven effective against phenotypes 
related to neurodegenerative disease models. Celastrol, a plant-derived triterpene, has 
been shown to ameliorate cytotoxicity and inflammation in a rodent Alzheimer’s disease 
model (Allison, Cacabelos et al. 2001).  HSF1A, a benzyl pyrazole derivative, elevates 
HSP expression, reduces protein misfolding and apoptosis in polyQ-expressing neuronal 
precursor cells, and promotes cytoprotection in a polyQ-mediated neurodegenerative fly 
model (Neef, Turski et al. 2010).  Despite several studies that indicate the potential of 
using HSF1 activators therapeutically, the disadvantages of these compounds are too 
severe to apply to clinical trials.  Many of the known HSR activators show hepatotoxicity 
in animal models at the higher concentrations that would be required in human studies.  
Additionally, there is a low degree of specificity regarding target activation, therefore 
signaling pathways independent of the HSR may be activated.  Furthermore, while 
activation of the HSR is desirable in the treatment of protein aggregate diseases and to 
combat the decline of HSPs associated with aging, many cancers exhibit overexpression 
of HSPs and it is unknown if HSR activators could lead to the onset of cancerogenesis  
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later in life (Santagata, Hu et al. 2011).  In order for pharmacological activators of the 
HSR to ever be used in therapeutics, compounds must be engineered to have a higher 
degree of specificity and a lower degree of cellular toxicity.  
Alternatively, caloric restriction (CR) is a relatively innocuous treatment to impose on an 
organism and appears to have no known negative side effects.  CR has been shown to 
increase an organism’s resistance to a number of acute stressors (Sinclair 2005; Brown-
Borg 2006).  While the benefits of CR in model organisms have been demonstrated 
extensively, there have been relatively few studies to investigate the clinical application 
of CR in humans.  The clinical studies that have been done indicate that humans on CR 
show increased metabolic fitness similar to laboratory mammals.  In humans, CR has 
been shown to lower blood pressure, promote glucose homeostasis, and improve blood 
lipid profiles (Heilbronn, de Jonge et al. 2006; Weiss, Racette et al. 2006; Fontana and 
Klein 2007). The void of clinical CR studies is likely due to the impression that CR only 
has long-term benefits and that long-term self-imposed food restriction in humans is 
notoriously difficult.  
Indeed, several studies indicate that long-term CR is required for the maximal effects of 
increased lifespan.  In fruit flies, the effects of CR on longevity, as measured by daily 
mortality rate, depends on their current nutritional status with no apparent effect imparted 
by past nutrition (Mair, Goymer et al. 2003). While the greatest effects on longevity are 
due to long-term CR, short-term restriction has been shown to impart resistance to acute 
stressors.  Mice that are pretreated with 5 and 8 months of CR show increased 
survivability over AL animals when injected with paraquat, a free radical-inducing agent 
(Sun, Muthukumar et al. 2001).  The short-term benefits of CR have also been 
demonstrated using the surgical stress of ischemia reperfusion (IR) injury.  The damage 
that is accrued during IR injury is caused, first, by the lack of blood flow (ischemia) that 
inflicts the targeted organs with oxygen deprivation, ATP depletion, and cellular toxicity 
resulting from the buildup of toxic byproducts; and secondly, by the restoration of blood 
flow (reperfusion) that inappropriately activates cellular oxidases and inflammation 
pathways in response to the initial tissue damage (Friedewald and Rabb 2004).  In rats,  
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preconditioning CR for 12 months reduced myocardial oxidative stress and protected 
animals from the post-ischemic inflammatory response related to IR injury in comparison 
to AL fed control animals (Chandrasekar, Nelson et al. 2001).  Interestingly, the length of 
time for the kinetic onset of CR benefits is shorter than previously anticipated.  Both CR 
for 2-4 weeks and fasting for 3 days were similarly effective in protecting mice from 
renal IR injury when compared to mice on an AL diet (Mitchell, Verweij et al. 2010).  In 
addition to exhibiting benefits as measured by kidney function biomarkers, short-term CR 
and fasted mice demonstrated a striking 60% increase in post-surgical survival.   
The nutritional basis in which CR imparts biologically relevant benefits to mammals is 
poorly characterized.  One hypothesis for the mechanism in which CR confers longevity, 
stress resistance, and hormesis is that the phenomenon is dependent on a reduction of 
amino acids (Segall and Timiras 1976; Ooka, Segall et al. 1988; Orentreich, Matias et al. 
1993; Miller, Buehner et al. 2005; Troen, French et al. 2007; Grandison, Piper et al. 
2009).  Recently, it was found that when mice were pretreated with a protein-free diet for 
1-2 weeks prior to IR injury, kidney function was protected preserving their ability to 
clear waste products from the blood (Peng, Robertson et al. 2012).  Specifically, a 
tryptophan-deficient diet fed AL significantly protected kidney function compared to its 
pair-fed control.  Additionally, at 35% dietary restriction, a protein- and tryptophan-free 
diet were significantly better than a complete diet in promoting hormesis, as measured by 
kidney function (Peng, Robertson et al. 2012).   
Amino acid depletion is sensed by GCN2 (general control nonderepressible 2) kinase, 
which binds uncharged transfer RNAs (tRNAs) and consequently phosphorylates the 
eukaryotic translation initiation factor 2α (eIF2α) (Wek, Zhu et al. 1995; Dong, Qiu et al. 
2000; Wek, Jiang et al. 2006).  Phosphorylation of eIF2α inhibits the formation of the 
43S pre-initiation complex and represses the onset of translation.  Because Gcn2 is 
effectively an essential (EAA) and non-essential (NEAA) amino acid sensor, a Gcn2-/- 
mouse was used to test whether it is necessary for protection against IR injury.  The 
deletion of Gcn2 abrogated the hormesis imparted by the tryptophan-free diet, while 
treatment with halofuginone, an activator of the Gcn2 pathway, was able to reproduce the 
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protective effect of amino acid deprivation (Peng, Robertson et al. 2012).  While these 
studies have yet to be demonstrated in humans, the prospect of benefiting from a 
short-term tryptophan-restricted diet eaten ad libitum versus a traditional CR diet may be 
a feasible additive therapeutic for surgical patients.  
Our C. elegans studies demonstrate that the hormetic effect of CR to protect against a 
lethal HS stressor occurred only in the presence of sir2.1 (Figure 3.5) (Raynes, Leckey et 
al. 2012).  In addition, the ability of CR to protect against the age-dependent paralysis 
resulting from proteotoxicity of a polyglutamine model also required sir2.1 (Figure 3.6) 
(Raynes, Leckey et al. 2012).  As expected, we have also shown that Q24-YFP animals 
have a 40% decrease in sir2.1 mRNA levels (Figure 3.7) (Raynes, Leckey et al. 2012).  
This is consistent with Western blot analysis of tissue samples from Huntington Disease 
patients, for which the polyglutamine repeats are a model (Pallas, Pizarro et al. 2008).  
Taken together, our results indicate that CR hormesis is dependent upon its ability to 
induce the HSR in the presence of stressors that perturb protein homeostasis.  
It has been previously shown that SIRT1 protein levels increase upon CR in rats (Cohen, 
Miller et al. 2004).  Likewise, recent evidence in our laboratory has shown that CR 
significantly increases sir2.1 mRNA levels in C. elegans by 1.6 fold (Figure S7).  
Interestingly, CR in a Q24-YFP background causes a 4.8 fold increase in sir2.1 mRNA.  
While this result seems contradictory, a study of polyglutamine mutants in yeast has 
shown that protein oxidation and catalase activity increases in relation to the length of the 
polyQ tract only in glucose limiting conditions (Sorolla, Rodriguez-Colman et al. 2011).  
The oxidative stress resulting from the polyQ cytotoxicity results in an increase in Sir2 
and subsequent reduction in protein aggregation.  This has led us to hypothesize that 
there may be crosstalk between the HSR and the oxidative stress response (OSR).   
The Oxidative Stress Response 
Under homeostatic conditions, cells are able to balance the production of oxidants and 
antioxidants resulting in redox equilibrium. Oxidative stress occurs when cells are 
subjected to excess levels of reactive oxygen species (ROS) or as a result of antioxidant 
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depletion, resulting in an imbalance of ROS and antioxidants.  Common ROS include 
superoxide (O2), hydrogen peroxide (H2O2), hydroxyl radicals (OH), and reactive 
nitrogen species (NO) (Rutkowski, Pancewicz et al. 2007).  While normal cells require 
low level concentrations of these compounds for signal transduction, increased levels are 
lethal resulting in DNA base modifications, DNA strand breaks, lipid peroxidation, and 
protein aggregation (Burney, Niles et al. 1999; Klaunig, Kamendulis et al. 2010).  
Nuclear Factor Erythroid-derived 2-Related Factor 2 (NRF2) is the major transcriptional 
regulator of the OSR, which results in the induction of detoxification and antioxidant 
proteins.  NRF2 is highly conserved and is known as SKN-1 in C. elegans (Bishop and 
Guarente 2007; Onken and Driscoll 2010) and CncC in D. melanogaster (Sykiotis and 
Bohmann 2008).  Upon induction of the OSR, NRF2 binds to antioxidant response 
elements (AREs) within the promoter regions of target genes.  AREs consist of the motif 
(T/C) TGCTGA (C/G) TCA (T/C), which are bond by the basic leucine zipper (bZIP) 
domain within NRF2 (Andrews, Kotkow et al. 1993).  Modulation of the 
NRF2-mediated OSR involves the cytoplasmic protein Keap1, which sequesters NRF2 
within the cytoplasm in basal conditions (Itoh, Wakabayashi et al. 1999).  Upon oxidative 
stress, NRF2 disassociates from Keap1 and localizes to the nucleus where it forms 
heterodimers with small transcriptional activator Maf proteins and binds to the ARE 
(Sykiotis and Bohmann 2010).  
Several studies have demonstrated that the generation of ROS is linked to hormesis 
(Ristow and Schmeisser 2011).  Administration of antioxidants Vitamin C and E prevent 
the health-promoting effects of exercise in humans (Ristow, Zarse et al. 2009). A study in 
C. elegans has shown that glucose restriction causes increased ROS formation, thus 
promoting mitochondrial metabolism and resulting in an increase in longevity (Schulz, 
Zarse et al. 2007).  A minor oxidative stress results in the upregulation of antioxidant 
genes on the cellular level that may increase the survival response of the organism, which 
is then better prepared to manage potentially lethal oxidative stressors. Similarly, 
induction of the HSR is cytoprotective against subsequent lethal HS stressors.  Crosstalk 
between adaptive stress responses may provide organisms with increased survival and 
would, therefore, be evolutionarily advantageous.   
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Crosstalk between the HSR and the OSR 
Adaptive stress responses are highly conserved in eukaryotes and enable an organism to 
manage a variety of stressors.  In addition to thermal stress, HSF1 is activated by free 
radicals and oxidative damage, which also induce the NRF2-mediated OSR (Westerheide 
and Morimoto 2005).  In addition, SIRT1 deacetylates a number of other transcription 
factors regulated by stress, including NRF2.  In a K562 myelogenous leukemia cell line, 
overexpression of SIRT1 results in NRF2 deacetylation rendering antioxidant gene 
transcription inactive (Kawai, Garduno et al. 2011).  Therefore, the NRF2-mediated OSR 
and the HSF1-mediated HSR are both stress-induced cytoprotective systems regulated in 
part by SIRT1 (Kawai, Garduno et al. 2011; Zhang, Ahn et al. 2011).   Certain 
sulfhydryl-reactive small molecule activators have been found to induce both HSF1 and 
NRF2 transcriptional targets including celastrol and nitro-oleic acid (Westerheide and 
Morimoto 2005; Trott, West et al. 2008; Kansanen, Jyrkkanen et al. 2009).  
Sulfoxythiocarbamate inducers were recently demonstrated to act as dual activators of 
NRF2 and HSF1, though much higher concentrations were required to induce hsp70 
transcription (Zhang, Ahn et al. 2011).  This differential induction of both stress 
responses may indicate that upon oxidative stress, the more rapid kinetics of NRF2 
activation allow cells to respond to immediate stress, while the slower kinetics of HSF1 
activation allow cells to manage the resulting proteomic stress.  Interestingly, SIRT1 has 
been shown to deacetylate NRF2 resulting in a loss of affinity for the ARE element in 
target promoters and a decrease in NRF2-dependent gene transcription (Kawai, Garduno 
et al. 2011).  The role of SIRT1 in the activation and regulation of stress response 
mechanisms may represent a vital evolutionarily conserved function in cellular 
homeostasis.   
Future studies 
Glutathione S-transferase 4 (gst-4) is a transcriptional target for skn-1, the Nrf2 
C. elegans homolog, and can be used as a sensor for OSR induction.  In order to evaluate 
the interplay between the HSR and the OSR, a Pgst-4::RFP strain of C. elegans, in which  
 
 100 
 
the gst-4 promoter is fused to RFP, can be utilized to report transactivation of skn-1.  A 
Pgst-4::RFP;Phsp70::GFP strain could be used in a compound screen for dual inducers 
of the transcription factors skn-1 and hsf-1.  The C12C8.1::GFP strain used in Studies 
Chapter 2 would be a suitable reporter for HSR induction.  However construction of a 
GFP reporter activated by the F44E5.5 promoter, an hsp70 family member, would likely 
give a more robust fluorescence due to the increased number of HSEs present in the 
sequence (Figure 1.2), which results in increased transcriptional activity (Figure 3.3) 
(Raynes, Leckey et al. 2012).   
A number of cytoprotective assays using combinations of oxidative and thermal stressors 
to precondition against lethal oxidative or thermal damage would elucidate crosstalk 
between the HSR and OSR.  For instance, a minor HS preconditioning promotes 
thermotolerance against a lethal HS, but can it also protect against lethal oxidative 
damage by juglone, H2O2, or copper?  Likewise, can a preconditioning treatment with 
ROS reagents protect against lethal HS?  Furthermore, does a minor oxidative stress act 
in an additive or synergistic manner with HS or CR to maximize cytoprotection?  In 
addition, it would be interesting to investigate the sir2.1-dependency of these 
mechanisms with RNAi.   
Final thoughts 
A loss of protein homeostasis is a hallmark of many diseases associated with aging.  As 
lifespan increases in Western civilizations, so does the need to manage the imbalance 
between proteotoxic stress and cytoprotective genes.  By understanding adaptive stress 
responses and how they can be exploited in order to promote hormesis, the treatment of 
age-related disease may be directed toward the broad approach of extending healthspan.  
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APPENDICES 
Appendix A. Supplementary Figures 
 
 
Figure S1.  SIRT1 can interact directly with HSF1.  
SIRT1 interacts directly with HSF1. A TNT-synthesized HSF1 prey protein precipitates 
with SIRT1-GST expressed by E. coli in a GST pull-down assay.   
 
Methods:  SIRT1-GST bait protein was generated using the Gateway Cloning system to 
shuttle full-length SIRT1, lacking a stop codon, in the ORF Express Gateway Plus 
Shuttle clone (Genecopoeia cat#GC-U1443-CF) into the Gateway® pDEST™24 GST 
Destination Vector (Invitrogen cat#12216-016).  A GST pull-down assay was performed 
using Promega’s MagneGST™ Pull-Down System (cat#V8870). The HSF1 prey protein 
was synthesized using the TNT® T7 Master Mix from the full-length Myc-HSF1 plasmid 
(Holmberg, Hietakangas et al. 2001) described above.  SIRT1-GST was transformed into 
BL21 (DE3) competent E. coli cells (NEB cat#C2527) and expression was induced with 
1mM IPTG for 6 hours.  The cells were lysed with MagneGST™ Cell Lysis Reagent and 
the SIRT1-GST fusion protein was immobilized with equilibrated MagneGST™ Particles 
that had been blocked with 10% BSA according to manufacturer’s instructions.  The 
HSF1 prey protein was then captured by the immobilized SIRT1-GST bait protein and 
washed with 400 µL of MagneGST™ Binding/Washing buffer.  The MagneGST™ 
Particles were eluted with SDS sample buffer and bound polypeptides were detected by 
Western blot analysis. 
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Figure S2. DBC1 protein expression decreases over a heat shock time course.  
Protein collected from HeLa cells exposed to 42°C from 0 to 6 hours.  Immunoblotting 
was performed using an antibody against DBC1 and Actin.  The relative intensities of the 
DBC1 bands were quantitated using Image J and the fold intensities compared to the 
background is shown. 
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Figure S3. SIRT1 does not co-localize with HSF1 at nuclear stress bodies upon HS.   
Immunofluorescence of HSF1 and SIRT1 nuclear localizations in HeLa cells. HSF1 
localizes to the nucleus specifically to nuclear stress bodies, as previously described 
(Westerheide, Anckar et al. 2009).  SIRT1 localizes to PML nuclear bodies prior to heat 
shock, also as previously described (Campagna, Herranz et al. 2010).  Upon heat shock, 
SIRT1 does not appear to experience a change in localization. 
Methods:  HeLa cells were cultured on glass coverslips in 30 mm plates at a 1:10 dilution 
in DMEM media (CellGro cat#15-017-CV) supplemented with 10% fetal bovine serum 
(GIBCO cat#10437-028) and 1% Pen-Strep-Glutamine (CellGro cat#30-0090CI).  
Parafilmed plates were heat shocked in a 42°C water bath for 30 minutes with no time for 
recovery.  At 75-90% confluency, cells were fixed in a 4% formaldehyde solution in 
PBS.  The cells were then washed in PBS and blocked in blocking buffer (5% FBS and 
0.3% Triton in 1X PBS) for 1 hour.  After blocking, the cells were incubated overnight at 
4°C with the primary antibodies, both anti-HSF1 (Stressgen cat#SPA-901) and anti-
SIRT1 (Millipore cat#04-1557).  Next, the cells were washed in PBS and incubated with 
the secondary antibodies for 1-2 hours, both Alexa-Fluor #555 and #488 (Invitrogen).  
The cells were then washed with PBS and the coverslips were placed on a slide with a 
drop of Vectorshield® with Dapi (Vector Laboratories).  The coverslips were sealed with 
clear nail polish and observed on the EVOS scope.  
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Figure S4. Knockdown with AROS siRNA reduces hsp70 promoter activity upon 
HSR induction at 42°C. 
HeLa hsp70.1 promoter-luciferase reporter cells were transfected with 50 nM of 
Dharmacon SmartPool DBC1, AROS, HSF1, or non-targeting control siRNA and HS 
was induced via 2 hours at 42°C.  Luciferase activity was measured and compared to that 
of the non-targeting control.  Luciferase assays were performed in biological triplicate.  
Statistical significance was measured by Student’s t test as compared to the non-targeting 
siRNA control with celastrol (5 µM) treatment (*P<0.05,** P<0.01, ***P<0.001).  
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A. 
 
 
B. 
 
 
Figure S5. Generation of the Q24-YFP;sir2.1 (ok434) strain. 
A) The Q24-YFP; sir2.1 (ok434) double mutant strain was constructed by mating 
Q24-YFP males with sir2.1 (ok434) hermaphrodites.  F1 cross progeny that displayed the 
YFP reporter were picked to individual plates and allowed to have F2 progeny.  
Approximately twenty F2 progeny were picked to individual plates and 
allowed to self fertilize.  B) Once F3 progeny were obtained, the F2 parents 
were tested for the sir2.1 deletion by PCR using primers flanking the deletion 
(5′-CAGCGACGCTGTCTCAAAAA, 3′-GATCAAATGAGCATTCGGCT) (Wang and 
Tissenbaum 2006).  
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Figure S6. PCR confirmation of the Q24-YFP;sir2.1 (ok434) strain. 
PCR was performed on genomic DNA from the F2 parents using sir2.1 deletion primers 
flanking the deletion.  The deletion is confirmed by PCR amplification of a 300 bp 
amplicon.     
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Figure S7.  sir2.1 mRNA levels for N2 and Q24-YFP C. elegans strains. 
N2 and Q24-YFP animals were treated with or without HS and CR, as indicated, and 
mRNA levels were determined for sir2.1 by qRT-PCR. Results are in technical triplicates 
and are representative of biological duplicates.  Statistical significance was measured by 
Student’s t test as compared to AL (*P<0.05,** P<0.01). 
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Figure S8.  hsp70 promoter reporter used in Studies, Chapter 2. 
A green fluorescent protein (GFP) reporter driven by the promoter of the HSF-1 target 
gene hsp-70 (C12C8.1) provides a fluorescence-based method for measuring HSF-1 
transcriptional activity in C. elegans.  The expression of GFP is highly inducible with 
heat. 
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Figure S9. hsp-70 promoter induction is significantly increased upon HS in 
C. elegans when fed lst-3 RNAi.   
Bacteria (HT115) containing plasmid constructs made to produce double-stranded RNA 
were grown in LB and ampicillin and then spread onto fresh NGM agar plates containing 
100µg/ml ampicillin and 1mM IPTG (Isopropyl β-D-1-thiogalactopyranoside).  Bacterial 
lawns were induced overnight at room temperature.  A C12C8.1::GFP strain was bleach 
synchronized and placed onto plates with either empty vector (pL4440), hsf-1, or lst-3 
RNAi.  Upon adulthood, animals were heat-shocked at 33̊C for 15 minutes.  
(Experimental designed by R. Raynes and J. Brunquell and performed by J. Brunquell.) 
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Appendix B. Supplementary Tables 
 
Table S1.  List of primer sets used for mammalian cell culture samples. 
Gene name Sequence* Amplicon (bp) 
aros F: 5’- GAAGGCAATTCAGGCCCAGAAACT- 3’ 
R: 5’- TCGTCCTGGTCAGAAACTTCAGGT- 3’ 
131 
dbc1 Primer mix from GeneCopoeia, Inc. 
Cat # HQP015872 (KIAA1967) 
Not provided 
gapdh F: 5’- CCACTCCTCCACTTTGAC - 3’ 
R: 5’- ACCCTGTTGCTGTAGCCA - 3’ 
102 
gapdh promoter1 F: 5’- TACTAGCGGTTTTACGGGCG - 3’ 
R: 5’- TCGAACAGGAGGAGCAGAGAGCGA - 3’ 
166 
hsp272 F: 5’- CAAGTTTCCTCCTCCCTGTC - 3’ 
R: 5’- GGCAGTCTCATCGGATTTTG - 3’ 
156 
hsp703 F: 5’- AGAGCGGAGCCGACAGAG - 3’ 
R: 5’- CACCTTGCCGTGTTGGAAC - 3’ 
110 
hsp70  promoter 13 
(HSE site) 
F: 5’- GGCGAAACCCCTGGAATATTCCCGA - 3’ 
F: 5’- AGCCTTGGGACAACGGGAG - 3’ 
191 
hsp70  promoter 2 
(NS site) 
F: 5’- CCTCCCGAGGAGCTGGGACT - 3’ 
R: 5’- CGAGGCGGGCGGATCACTTA - 3’ 
134 
hsp904 F: 5’- GGCAGTCAAGCACTTTTCTGTAG - 3’ 
R: 5’- GTCAACCACACCACGGATAAA - 3’ 
199 
rps19 F: 5’- GGCGTCATGCCCAGCCACTT - 3’ 
R: 5’- TTTGCGGCCGCCATCTTGGT- 3’ 
111 
rps19 promoter F: 5’- GACCCCTTGGCCCTCCCCTT- 3’ 
R: 5’- GGTTTCCCGGGCGCACAAGT- 3’ 
170 
sirt13 F: 5’- TCCTGGACAATTCGAGCCATCTCT - 3’ 
R: 5’- TTCCAGCGTGTCTATGTTCTGGGT - 3’ 
103 
 
*F: forward, R: reverse 
1Primers from Folz et al. Am. J. Respir. Cell Mol. Biol. 2008 39:2, 243 
2Primers from Yao et al. Journal of Biomedical Science 2010 17:30. 
3Primers from Westerheide et al. Science 2009 323, 1063. 
4Primers from McLean et al. Biochemical and Biophysical Research Communications 
2006 351:3. 
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Table S2. List of primer sets used for C. elegans samples.  
Gene name Sequence* Amplicon (bp) 
C12C8.1 F: 5’- CCCGTTGTTGAGGTTGAAGT- 3’ 
R: 5’- CAGCTTCAGCCGTTTCTTTC- 3’ 
100 
gapdh F: 5’- GGAACTGTTACCTACGATGGAGA - 3’ 
R: 5’- AAACTCCAGTAGACTCGACAACG - 3’ 
148 
F44E5.4 F: 5’- CTCGGTACTACGTACTCGTGTGTT - 3’ 
R: 5’- GAATGCCACGTATGATGGAGT - 3’ 
102 
F44E5.5 F: 5’- GTTGAAGTGAAAGGAGAAAAGAGG - 3’ 
R: 5’- GATAACTGCATCTTTCACGGTATG - 3’ 
120 
sir2.1 F: 5’- GGGAATGAGATTCGTGAGGA - 3’ 
R: 5’- TCCGAGATCCTCTCCAAAGA - 3’ 
105 
sir2.1 deletion F: 5′- CAGCGACGCTGTCTCAAAAA -3’ 
R: 5’- GATCAAATGAGCATTCGGCT - 3’ 
304/1072^ 
 
*F: forward, R: reverse 
^ The amplicon is 304 bp if a deletion occurs within the sir2.1 gene and 1072 bp if one 
does not occur.   
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Table S3.  Antibodies for Western blot (WB) analysis, immunoprecipitation (IP), 
and immunocytochemistry (ICC).   
Antibody Manufacturer Catalog # Dilution Application 
Acetyl-K Cell Signaling Technology 9441 1:1000 WB 
ACTIN Santa Cruz SC-1616-R 1:1000-1:5000 WB 
ACTIN (C. elegans) Amersham JLA20-C 1:750 WB 
Alexa-Fluor #488 Invitrogen A11008 2 µg/0.5 mL ICC 
Alexa-Fluor #588 Invitrogen A21422 2 µg/0.5 mL ICC 
AROS (S19bp) Santa Cruz SC-86210 1:200 WB 
BETA-TUBULIN Cell Signaling Technology 2128 1:1000 WB 
DBC1 Abcam AB 70242 1:2500-1:5000 WB 
GFP Santa Cruz SC-9996 1:1000 WB 
ANTI-FLAG Sigma F3165 1:500 WB 
HA Convance MMS-101P 1:2500 WB 
HRP-Mouse Millipore PA43009V 1:2500 WB 
HRP-Rabbit Millipore PA45011V 1:2500 WB 
HRP-Rat Jackson Immuno Research 112-035-062 1:10,000 WB 
HSF1 Assay Design SPA-950 1:750 WB 
HSF1 Stressgen SPA-901 5 µL/0.5 mg, 10 µL/1 mL 
IP,  
ICC 
HSP27 Stressgen SPA-803 1:5,000 WB 
HSP70 Stress Marq SMC-100B 1:1000 WB 
Normal Rabbit IgG Cell Signaling Technology 2729 5 µL/0.5 mg IP 
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Table S3 continued from previous page. 
Protein A-HRP Thermo Scientific (Pierce) 32400 1:5000 WB (post IP) 
RPS19 Sigma SAB1404336 1:1000 WB 
SIRT1 Abcam AB 32441 1:5000 WB 
SIRT1 Millipore 07-131 5 µL/0.5 mg IP, ICC 
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Appendix C. Published review: Westerheide SD, Raynes R, et al. Current Protein 
and Peptide Science, 2012. 
 
HSF Transcription Factor Family, Heat Shock Response, and Protein Intrinsic Disorder.   
 
Sandy D. Westerheide, Rachel Raynes, Chase Powell, Bin Xue and Vladimir N. Uversky 
 
Published in Current Protein and Peptide Science, 2012, 13, 86-103. 
 
Authors contributed equally to the text.  Figures 1 and 7 were created by R. Raynes.  See 
Appendix E for copyright permission.  The format differs from the publication style due 
to copyright restrictions. 
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Appendix D.  Published review: Raynes R, Brunquell J, Westerheide SD. Genes & 
Cancer, 2013. 
 
Stress-inducibility of SIRT1 and its role in cytoprotection and cancer. 
 
Rachel Raynes, Jessica Brunquell, and Sandy D. Westerheide  
 
Published in Genes & Cancer: doi: 10.1177/1947601913484497.  Epub before print 
April 3, 2013. 
 
Written by R. Raynes and S.D. Westerheide, with contribution from J. Brunquell. All 
figures were created by R. Raynes.  See Appendix E for copyright permission.  Much of 
the text has been formatted from the Introduction and Implications of this dissertation.   
 
 
 
 
 
 
 
 
  183 
Abstract 
Cells must continuously respond to stressful insults via the upregulation of cytoprotective 
pathways.  The longevity factor and deacetylase SIRT1 plays a critical role in 
coordinating this cellular response to stress.  SIRT1 activity and levels are regulated by 
cellular stressors, including metabolic, genotoxic, oxidative, and proteotoxic stress.  As a 
stress sensor, SIRT1 impacts cell survival by deacetylating substrate proteins to drive the 
cell towards a cytoprotective pathway.  Extreme stress conditions, however, can cause 
SIRT1 to lead cells down an apoptotic pathway instead. SIRT1 is frequently dysregulated 
in cancer cells and has been characterized to have a dual role as both an oncogene and a 
tumor suppressor, likely due to its pivotal function in regulating cytoprotection. Recently, 
the ability of SIRT1 to regulate HSF1-dependent induction of the heat shock response has 
highlighted another pathway through which SIRT1 can modulate cytoprotection.  
Activation of HSF1 results in the production of cytoprotective chaperones that can 
facilitate the transformed phenotype of cancer cells.  In this review, we discuss the stress-
dependent regulation of SIRT1.  We highlight the role of SIRT1 in stress management 
and cytoprotection and emphasize SIRT1-dependent activation of HSF1 as a potential 
mechanism for cancer promotion.   
An Introduction to Sirtuins  
The sirtuin family is evolutionarily conserved from prokaryotes to eukaryotes (1).  Sir2 
(silent information regulator 2), the original sirtuin to be characterized, was first observed 
in yeast during an extensive screen for silencing factors (2).  Sir2 is a Class III 
NAD+-dependent histone deacetylase that causes transcriptional silencing due to the 
removal of histone acetyl groups resulting in the tighter packaging of chromatin (3).  
Mammalian cells contain seven sirtuin family members, SIRT1-7 [reviewed in (4, 5)].  
The mechanism of sirtuin deacetylation is unique, in which the SIRT protein binds to a 
NAD+ molecule, thus cleaving nicotinamide and transferring the acetyl group from a 
substrate protein onto the NAD+ backbone (6).  The result is a 1:1:1 ratio of 
nicotinamide, O-acetyl-ADP-ribose, and the deacetylated substrate protein as measured 
by HPLC quantification (6).  In the absence of enzyme or acetylation of the substrate 
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protein, no ADP-ribose or nicotinamide is generated from available NAD+, thus 
establishing the necessity of NAD+ hydrolysis in the catalysis of SIRT1 deacetylation 
activity (6).  Additionally, SIRT3, SIRT4, and SIRT6 possess ADP-ribosyltransferase 
activity capable of transferring the O-acetyl-ADP-ribose onto acceptor protein residues 
(5).  
Interest in sirtuins has grown with their association with longevity. It was found that an 
extra copy of Sir2 transformed into yeast resulted in a reduction in recombination of 
ribosomal DNA and a subsequent 30% increase in lifespan of the yeast mother cell (7).  
The Sir2 homolog Sir2.1 was later discovered to extend lifespan in C. elegans, suggesting 
that Sir2 homologs and the NAD+/NADH ratio may also be responsible for extending 
lifespan in higher eukaryotes such as mammals (8).  While several studies have supported 
the role of Sir2 in longevity, recently the impact of sirtuins in fly and worm lifespan 
extension has been questioned due to confounding issues with genetic background (9).  
However, while new experiments using C. elegans with identical genetic backgrounds 
show that the original effect on lifespan by Sir2 overexpression was overestimated, there 
is still a 10-14% lifespan extension observed by increased Sir2 levels, thus continuing to 
support a role for SIRT1 as a longevity factor (10).  
As might be expected for a factor that can extend lifespan, SIRT1 has been characterized 
to promote cytoprotection upon exposure to stressful conditions.  Here, we review the 
regulation of SIRT1 activity and levels by stress and the role of SIRT1 in facilitating 
cytoprotection.  We discuss the dual role of SIRT1 as both an oncogene and a tumor 
suppressor.  Finally, we speculate on the role of SIRT1 in the induction of the heat shock 
response and molecular chaperones as a mechanism for cancer promotion. 
Regulation of SIRT1 activity by stress 
The deacetylase activity of SIRT1 has been well-documented in the regulation of several 
stress-induced transcription factors including p53 (11, 12), HSF1 (13-15), NF-κB (16-
18), PGC-1α (19, 20), and the FOXO family of transcription factors (21-23).  The 
activation of SIRT1 upon stress may therefore be an evolutionarily conserved process to 
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drive cellular homeostasis by invoking a variety of stress response pathways.  As a 
critical stress sensor, it follows that SIRT1 activity and levels are modulated by multiple 
cellular stresses, thus allowing for the coordination of the appropriate cellular response.   
Regulation of SIRT1 activity by metabolic stress 
Sirtuins are linked to metabolism based on their unique ability to breakdown NAD+ 
during protein deacetylation, resulting in the formation of nicotinamide and O-acetyl-
ADP-ribose (24).  Therefore, a prime mode of SIRT1 activity regulation is through 
metabolic stress. SIRT1 depends on NAD+ as a critical cofactor for enzymatic activity, 
therefore indicating SIRT1 as an energy sensor.  Changes in levels of NAD+, NADH, or 
their ratio, resulting from changes in diet or metabolic status, can lead to changes in 
SIRT1 activity.   
Various enzymes in the NAD+ salvage pathway have also been implicated in the 
regulation of SIRT1 activity (Figure S10).  Nicotinamide phosphoribosyltransferase 
(NAMPT) is an enzyme that converts nicotinamide to nicotinamide mononucleotide 
(NMN), which then reacts with ATP to regenerate NAD+ (25).  Increased NAMPT 
activity has been shown to activate SIRT1 activity in human vascular smooth muscle 
cells (26).  Interestingly, NAMPT is induced after some forms of stress including 
complete serum removal, thus linking metabolic stress pathways with other stress 
pathways (26).  NAMPT levels decrease as cells age, and the resulting decline in 
NAD+ levels may contribute to the lowered SIRT1 activity observed upon aging (26).   
In yeast, worms, and flies nicotinamide is recycled back to NAD+ in 4 steps that compose 
the NAD+ biogenesis pathway.  The first step is nicotinamide catalysis by PNC1 to 
produce nicotinic acid.  PNC1 is upregulated by environmental stressors, leading to 
increased stress resistance and lifespan in worms and flies (27-29).  Thus, PNC1 can 
promote cell survival in response to environmental stress. 
Caloric restriction (CR) is a 30-40% decrease in dietary intake with maintained nutrition 
that has been shown to increase longevity and protect against age-related disease (30). 
The life extension effects of CR were first established as early as 1935 using 
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calorically-restricted rats (31) and have now been extended to yeast (32, 33), nematodes 
(34, 35), flies (36, 37), and mice (38).   In fasted mice, an increase in NAMPT activity 
correlates with an increase in NAD+ levels and enhances SIRT1 transcriptional activity 
(39).  Interestingly, it has been reported that a 10-fold change in cellular NAD+ 
concentration is required to affect Sir2 activity in yeast (40).  However, caloric restriction 
studies in yeast have shown that Sir2 activity is regulated by a reduction of NADH, a 
competitive inhibitor of Sir2 (41, 42).  CR was found to increase the replicative lifespan 
of budding yeast by Sir2 activation due to decreasing the NADH levels resulting in an 
increase in the NAD+/NADH ratio (41).  Furthermore, the deletion of Sir2 blocks the 
beneficial effects of CR on yeast lifespan (43).  
AMP-activated protein kinase (AMPK), activated in response to increasing amounts of 
AMP, functions as an energy sensor that responds to cellular metabolic stress including 
CR (44).  SIRT1 and AMPK are therefore two evolutionary conserved energy sensing 
molecules that are vital in the regulation of energy homeostasis, with SIRT1 sensing 
change to the NAD+/NADH ratio and AMPK sensing change in the AMP/ATP ratio (45).  
AMPK increases the NAD+/NADH ratio in skeletal muscle after exposure to an AMPK 
activator (AICAR) (45) proving AMPK to be an indirect activator of SIRT1.  The role of 
AMPK as an energy sensor and regulator of metabolism led to the investigation of its 
function in the lifespan extension effects observed in a low glucose environment.  A 
change in AMPK activity coupled with increased NAD+ levels was found 18-24 hours 
and 30-36 hours after glucose restriction, respectively, in skeletal muscle.  This indicates 
that AMPK activity precedes the change in NAD+ levels in mammalian cells resulting in 
an increase in SIRT1 activity in a low glucose environment (46). Together, AMPK and 
SIRT1 may lead to improved fitness in C. elegans, as AMPK and SIRT1 homologs are 
important regulators of lifespan (47, 48).  
Not only is SIRT1 regulated in part by metabolism, but SIRT1 is also required for the CR 
phenotype.  CR produces complex behavioral changes in mammals, including increased 
physical activity and an increase in distance coverage, which is most likely associated 
with foraging behavior (49).  Moreover, wild-type mice and SIRT1 knockout (KO) mice 
demonstrate vastly different phenotypes upon CR, with the SIRT1 KO mice exhibiting a 
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phenotype very similar to wild-type control mice that are not on a restricted diet (50).  
Recently, it was shown that CR can synergize with heat shock stress to promote increased 
thermotolerance and fitness in a sir2.1-dependent manner (51).  sir2.1, the mammalian 
SIRT1 homolog, is also necessary for the cytoprotection conferred by CR and heat shock 
to preserve movement in a C. elegans polyglutamine neurodegenerative disease model 
(51).  SIRT1, therefore, is an energy sensor that can coordinate the response to metabolic 
stress at both the cellular and the organismal level. 
Regulation of SIRT1 activity by protein modulators  
As SIRT1 is a critical coordinator of cellular stresses, including metabolic stress, its 
activity must be  finely regulated.  Two proteins that are known to function as SIRT1 
modulators are Deleted in Breast Cancer 1 (DBC1) and Active Regulator of SIRT1 
(AROS). DBC1 was initially cloned from a region homozygously deleted in 3.5% of 
breast cancers (52).  DBC1 has been found to directly interact with SIRT1 and inhibit 
deacetylase activity both in vivo and in vitro (53).  DBC1-mediated down-regulation of 
SIRT1 deacetylates p53 and inhibits p53 transcriptional activity.  The repression of 
SIRT1 activity by DBC1 leads to an increase in p53 acetylation, and therefore an 
upregulation of p53-dependent apoptotic activity.  Likewise, the RNA interference of 
DBC1 results in an increase of SIRT1-mediated deacetylation, thus inhibiting p53-
dependent apoptosis (54). In a similar manner, DBC1 has also been shown to regulate the 
acetylation status of the SIRT1 targets PPARγ and HSF1 (14, 55).  Interestingly, the 
DBC1-SIRT1 interaction increases following DNA damage and oxidative stress. The 
stress-induced DBC1-SIRT1 interaction requires ATM-dependent phosphorylation of 
DBC1 at Thr454, thus creating a second binding site for SIRT1 (56).  Therefore, stressful 
conditions do not only activate SIRT1, but can also blunt SIRT1 activity, suggesting that 
the cell has the ability to fine-tune the control of this factor. 
AROS, a small ribosomal binding protein, has been shown to interact with SIRT1 and 
modulate its activity.  In contrast to DBC1, AROS increases the deacetylase function of 
SIRT1.  AROS enhances SIRT1-mediated deacetylation of p53, thus inhibiting p53-
mediated transcriptional activity (57).  Recently, it was shown that AROS, like DBC1, 
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also has an impact on HSF1 acetylation status and the heat shock response (14).  The 
AROS-SIRT1 interaction is likely another way in which the cell can fine-tune stress-
induced SIRT1 activity.  It will be interesting to investigate which cellular stresses can 
regulate the AROS-SIRT1 interaction. 
Regulation of SIRT1 activity by stress-inducible post-translational modifications  
SIRT1 is highly modified by post-translational modifications and these modifications are 
regulated by cellular stress.  Mass spectrometry has identified 13 phosphorylation sites 
within SIRT1 (58). One of the kinases identified to phosphorylate SIRT1 is the c-Jun N-
terminal kinase (JNK).  JNK inducibly binds to and phosphorylates SIRT1 upon 
oxidative stress at Ser27, Ser47, and Thr530, resulting in increased nuclear localization of 
SIRT1 (59).  JNK belongs to the mitogen-activated protein kinase family and is 
responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and 
osmotic shock (60).  This could explain, in part, how these various stress stimuli lead to 
an increase in SIRT1 activity on its nuclear targets.   
Mammalian target of rapamycin (mTOR) is another stress-inducible kinase that has been 
identified to phosphorylate SIRT1. mTOR phosphorylates SIRT1 on Ser47, thus 
inhibiting SIRT1 activity (61).  mTOR is a key cellular sensor of nutrient and energy 
levels as well as redox status, and is activated by increased levels of insulin, growth 
factors, amino acids, and oxidative stress (62).  SIRT1 physically interacts with the 
mTOR-Raptor complex, and a single amino acid substitution in the TOR signaling motif 
in SIRT1 prevents Ser47 phosphorylation (61).  Under conditions of caloric restriction, 
mTOR activity is inhibited, thus leading to enhanced SIRT1 activity.   
Casein Kinase II (CK2) is another stress-activated kinase implicated in SIRT1 regulation.  
Four CK2 phosphorylation sites have been identified in murine SIRT1 at Ser154, Ser649, 
Ser651, and Ser683 (63). Two of these sites are also phosphorylated in human SIRT1 at 
the corresponding amino acids Ser659 and Ser661 (64).  Ser659 and Ser661 lie within the 
Essential for SIRT1 Activity (ESA) region of human SIRT1 (65).  The ESA region 
interacts with the catalytic domain of SIRT1, thus activating its catalytic activity and 
increasing the affinity for SIRT1 substrates. Phosphorylation at Ser659 and Ser661 has 
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been proposed to enhance the interaction of the ESA region with the catalytic core.  It is 
possible that this would affect DBC1 binding to SIRT1, as the binding site for ESA in the 
catalytic domain is also the binding site for DBC1 (53). Therefore, the control of SIRT1 
function by its own C-terminal domain and the regulation of this interaction by CK2 may 
be an important regulatory mechanism for SIRT1 activity. 
Aside from phosphorylation, SIRT1 can be modified by sumoylation, methylation, and 
transnitrosylation.  SIRT1 is sumoylated at Lys734, and SUMO1/Sentrin-Specific 
Peptidase 1 (SENP1), a nuclear desumoylase, removes this modification (66).  
Sumoylation of SIRT1 increases its catalytic activity as measured by p53 deacetylation 
and desumoylation by SENP1 reduces its deacetylase activity (66). Stress-inducing 
agents, including UV radiation and hydrogen peroxide, were found to promote the 
association of SIRT1 with SENP1 (66).  Therefore, certain stress-inducing agents may 
counteract the anti-apoptotic activity of SIRT1 by recruiting SENP1 to SIRT1, resulting 
in the desumoylation and inactivation of SIRT1.   
SIRT1 is methylated via the methyltransferase Set7/9, which methylates SIRT1 at 
Lys233, Lys235, Lys236, and Lys238.  SIRT1 interacts with Set7/9 both in vitro and in 
vivo, and the interaction is increased upon DNA damage.  SIRT1 methylation may inhibit 
SIRT1 deacetylation activity, as DNA damage inhibits the interaction of SIRT1 and p53, 
leading to an increase in p53 acetylation levels (67).   
SIRT1 has also been found to be transnitrosylated by nitrosylated GAPDH (68).  
Transnitrosylation of SIRT1 inhibits SIRT1 deacetylase activity, as measured by an 
increase in levels of acetylation of the SIRT1 target PGC-1α.  Cys387 and Cys390 within 
the catalytic core of SIRT1 are targeted by nitrosylation.  These cysteines are involved in 
the coordination of Zn2+ binding and nitrosylation of these sites may result in SIRT1 
protein misfolding. Multiple types of post-translational modifications, therefore, are 
involved in fine-tuning SIRT1 activity in response to stress. 
  190 
Regulation of SIRT1 levels by stress 
Stress-responsive regulation of SIRT1 expression levels by transcription factors 
In addition to regulation of SIRT1 at the activity level, SIRT1 can also be regulated at the 
expression level. SIRT1 expression is altered by various stress-inducible transcription 
factors including p53, c-Myc, FOXO family members, and certain PPAR family 
members. p53 is inducible by a myriad of stresses, including DNA damage and oxidative 
stress.  p53 has been shown to regulate SIRT1 expression by binding to the sirt1 
promoter at two binding sites to repress sirt1 mRNA expression (69).  As p53 is a SIRT1 
deacetylation target, this provides a feedback loop to regulate SIRT1 expression by 
modulating the acetylation status and thus the activity state of this protein. Consistent 
with a negative role for p53 in regulating SIRT1 expression, p53 null mice show 
increased basal expression of SIRT1 in certain tissues (70).  The negative regulation of 
SIRT1 by p53 could also be an explanation for why SIRT1 levels can be higher in tumors 
that have lost p53.   
The proto-oncogene c-Myc is activated through the mitogen-activated protein kinase 
(MAPK) pathway, and is responsive to various mitogenic and stress signals.  c-Myc 
induces SIRT1 expression by binding to the sirt1 promoter and activating transcription 
(71). As SIRT1 deacetylates c-Myc, resulting in decreased c-Myc stability, a c-Myc-
SIRT1 feedback loop likely exists that may be relevant in cancer. 
FOXO transcription factors are SIRT1 targets that can also increase SIRT1 expression.  
FOXO1, which can be regulated by insulin levels and is thus under metabolic control, can 
increase SIRT1 expression by binding to FOXO1 binding sites in the sirt1 promoter (70, 
72).  SIRT1-mediated deacetylation of FOXO1 leads to an increase in the transcriptional 
activity of FOXO1, thus indicating a positive feedback loop between SIRT1 and FOXO1 
(72). FOXO3, on the other hand, translocates into the nucleus in the absence of nutrients 
and interacts with p53, inhibiting its suppressive activity on SIRT1 transcription, and thus 
leading to increased SIRT1 levels (70).  FOXO3 is also a deacetylase target of SIRT1, 
but unlike FOXO1, SIRT1 can either activate or inhibit the transcriptional activity of this 
factor depending on the circumstances (22). 
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Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that are also 
regulated by metabolic state. The three subtypes, PPARα, PPARγ, and PPARβ/δ, are 
expressed in multiple organs and regulate different physiological functions such as 
energy metabolism, insulin action, and inflammation. Fasting can induce PPARα activity 
in mice and induce SIRT1 expression through a PPARα binding site in the sirt1 promoter 
(39).  While PPARα may not be a direct target of SIRT1, SIRT1 can regulate the activity 
of its coactivator PGC-1α, thus creating a positive feedback loop (73).  PPARβ/δ can also 
induce SIRT1 expression by inducing Sp1 binding to the sirt1 promoter (74).  PPARγ, in 
contrast to PPARα and PPARβ/δ, represses SIRT1 expression through direct interactions 
with the sirt1 promoter (55).  As PPARγ is a deacetylation target of SIRT1, this suggests 
the presence of a negative feedback loop.  
Hypermethylated in cancer 1 (HIC1) is a transcriptional repressor that can bind to the 
sirt1 promoter and negatively regulate sirt1 mRNA expression (75).  The repressive 
effect of HIC1 is dependent on carboxyl-terminal-binding protein (CtBP), an 
NAD+/NADH redox sensor (76).  Nutrient deprivation decreases the interaction of CtBP 
with HIC1, thus decreasing the repressor function of HIC1 and increasing SIRT1 
expression (76).  HIC1 is also a deacetylase target of SIRT1, thus providing another 
negative feedback loop mechanism (77).  Therefore, multiple stress-responsive 
transcription factors can regulate SIRT1 levels and thus influence the ability of SIRT1 to 
deacetylate target proteins. 
Stress-responsive regulation of SIRT1 expression levels by RNA stability and translation 
control 
Regulation of RNA stability and translation are other ways in which stress can regulate 
SIRT1 levels. A stress-regulated mRNA binding protein, as well as specific miRNAs, 
have been demonstrated to regulate SIRT1 expression levels.  HuR, a ubiquitously 
expressed mRNA binding protein, increases SIRT1 levels by binding to the 3’ UTR of 
p53 mRNA, thus stabilizing it (78).  Oxidative stress triggers the dissociation of the 
HuR-SIRT1 mRNA complex, thereby promoting SIRT1 mRNA degradation, decreasing 
SIRT1 transcriptional levels, and lowering cell survival.  The cell cycle checkpoint kinase 
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Chk2 is implicated in this process, as it is activated by hydrogen peroxide, interacts with 
HuR, and is predicted to phosphorylate HuR at residues Ser88, Ser100, and Thr118. 
Mutation of these residues reveals a complex pattern of HuR binding, with Ser100 
appearing to be important for HuR dissociation from SIRT1 mRNA after hydrogen 
peroxide treatment (78).   
Several stress-regulated miRNAs control SIRT1 expression by binding to sirt1 mRNA 
and suppressing translation or reducing mRNA stability.  The first miRNA described to 
regulate SIRT1 was miR-34a (79).  This miRNA was first discovered as a tumor 
suppressor in neuroblastoma (80).  miR-34a is regulated by metabolism, as its levels were 
shown to increase in mice fed a high-fat diet (81).  miR-195, also regulated by 
metabolism, has been shown to regulate SIRT1 expression in cardiomyocytes (82).  miR-
199a, induced by hypoxia, targets both SIRT1 and the hypoxia-inducible factor HIF-1α 
(83).  Therefore, interactions with RNA binding proteins and miRNAs can influence 
SIRT1 expression levels and thus the cellular response to stress. 
SIRT1, stress, and cellular fitness 
SIRT1 can function in either a cytoprotective manner or a pro-apoptotic manner by 
activating stress response pathways through a number of factors including p53 (11), 
FOXO (22), HSF1 (13, 15), Nrf2 (84), and various DNA damage repair factors (85-91) 
(Figure S11).  Under moderate stress, the result of modulation of these pathways is to 
promote metabolic homeostasis, prevent apoptosis, and repair oxidative cellular damage 
and damaged DNA.  Under chronic or extreme stress conditions, however, SIRT1 can 
promote cell death by inducing apoptosis.  
SIRT1 promotes cytoprotection upon moderate stress 
Under moderate stress conditions, SIRT1 promotes cytoprotection via modulation of a 
number of cell survival regulators, including p53, FOXO, HSF1, NF-κB and DNA 
damage response proteins.  p53 is a well-characterized substrate of SIRT1 that is critical 
in cell cycle checkpoint regulation, apoptosis, and tumor suppression (11, 12).  p53 is 
transcriptionally activated by a number of protein kinases including ATM (92), ATR 
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(93), and the MAPK  family (94).  The activity of p53 is mediated by its acetylation 
status, where deacetylation reduces activity, thus allowing cells to bypass p53-mediated 
apoptosis (75, 95, 96).  SIRT1 null mice show that p53 is hyperacetylated when 
compared to wild-type mice (97), while overexpression of SIRT1 in cell lines suppressed 
p53-dependent apoptosis and increased cell survival after exposure to oxidative stress 
(12).  In addition, the p53 family member p73 is also deacetylated by SIRT1, resulting in 
suppression of apoptosis (98).   
The FOXO family of transcription factors has proven to be important in many biological 
functions, implicating it as an essential factor in cellular fitness and protection.  These 
functions include checkpoint regulation (99) and detoxification (100).  In response to 
oxidative or genotoxic stress, FOXO proteins translocate to the nucleus and activate 
target genes involved in cytoprotection and DNA repair (22, 101).  FOXO interactions 
with SIRT1 are controlled during stress stimuli.  Specifically, FOXO3 and SIRT1 have 
been shown to form a complex upon stress, allowing for SIRT1-mediated deacetylation 
of this transcription factor (22).  FOXO3 deacetylation potentiates cell cycle arrest and 
induces the transcription of DNA repair target genes while simultaneously attenuating 
FOXO-mediated apoptosis, thus allowing the cell to avoid apoptosis and maintain stress 
resistance.  Deacetylation of FOXO family members leads to an increase in DNA binding 
affinity of this transcription factor, resulting in the transcription of cytoprotective target 
genes (102, 103), thereby allowing for cytoprotection and cell survival (22, 104, 105).  
The heat shock response regulator HSF1 has recently been established as a SIRT1 
substrate (13, 15). The heat shock response is the cell’s cytoprotective response to protein 
damaging stress that results in the induction of molecular chaperones to restore 
proteostasis and promote cell survival.  SIRT1 deacetylates HSF1 and thus promotes 
DNA binding (13).  The interaction of SIRT1 with HSF1 has been shown to be induced 
by heat shock (15).  Induction of the heat shock response by SIRT1, therefore, is another 
way to promote cytoprotection.  The regulation of HSF1 by SIRT1 and implications in 
cancer will be discussed later in this review. 
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In addition to the regulation of transcription factor activity, SIRT1 has an established role 
in interactions with DNA damage response proteins. Deacetylation of the DNA repair 
proteins NBS1, Werner syndrome protein (WRN), xeroderma pigmentosum group A 
protein (XPA), and Ku70 by SIRT1 have all been shown to control genomic stability (86-
91). The MRE11-RAD50-NBS1 (MRN) complex is a conserved nuclease complex that 
can sense damaged DNA and regulate the cellular response to DNA double-strand breaks 
(106). The regulatory subunit of this complex, NBS1, is mutated in the human genetic 
disease Nijmegen breakage syndrome, a chromosomal instability disorder that results in 
multiple symptoms including microcephaly, radiation sensitivity, and predisposition to 
lymphoid malignancy (107).  SIRT1 maintains NBS1 in a hypoacetylated state, thus 
allowing it to be responsive to DNA damage-induced phosphorylation by the ATM 
kinase (91).  Phosphorylation activates NBS1, leading to the initiation of DNA damage 
repair (91).   
WRN, a RecQ DNA helicase family member, helps to maintain genome stability and is 
another target of SIRT1 (107).  Werner syndrome, an autosomal recessive disorder 
associated with premature aging and cancer predisposition, is caused by mutations in the 
WRN gene (108). SIRT1 interacts with WRN in a manner that is enhanced after DNA 
damage (89). The acetylation of WRN decreases its helicase and exonuclease activities, 
while deacetylation by SIRT1 reverses this effect (89).  
SIRT1 also interacts with XPA, a nucleotide excision repair (NER) factor that is essential 
for the NER process (109). The interaction occurs in a UV irradiation-inducible fashion 
(87).  Complementation experiments using XPA null cells with an acetylation mimic of 
XPA shows that SIRT1-mediated deacetylation of XPA is required for optimal NER (87).  
Ku70 is another DNA repair factor that can interact with SIRT1.  Upon exposure to 
radiation, SIRT1 enhances both the DNA repair capacity of the cell and the deacetylation 
of Ku70 (88). Overexpression of SIRT1 increases the repair of DNA strand breaks 
induced by radiation, while SIRT1 siRNA decreases this repair activity (88).  SIRT1 
forms a complex with Ku70 leading to deacetylation, suggesting that SIRT1 may 
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modulate DNA repair activity through regulating the acetylation status of repair protein 
Ku70 following DNA damage (88).   
Interestingly, in addition to its function in DNA repair, Ku70 is one of several proteins 
that inhibit apoptosis by sequestering the pro-apoptotic factor BAX, a BCL-2 family 
member, from the mitochondria (110). SIRT1 has been implicated in promoting 
cytoprotection through Ku70 deacetylation, thus strengthening its ability to sequester the 
pro-apoptotic BAX protein (86). Upon non-stress conditions, BAX is localized in the 
cytosol complexed with Ku70 (85, 111).  Upon DNA damage-inducing stress, Ku70 
becomes acetylated, which breaks the interaction with BAX, allowing it to translocate to 
the mitochondria (85).  SIRT1, through deacetylation of Ku70, can strengthen the 
interaction of Ku70 with BAX, thus preventing apoptosis and promoting cytoprotection 
(85). Therefore, SIRT1 can lead to enhanced cytoprotection through deacetylating 
transcription factors, DNA repair factors, and a factor directly involved in preventing 
apoptosis. 
SIRT1 as a pro-apoptotic factor  
While SIRT1 has been well-established as a cytoprotective factor upon moderate stress, 
in certain cases SIRT1 can induce apoptosis.  High levels of reactive oxygen species 
(ROS), for instance, can cause SIRT1 to activate apoptosis through a number of different 
routes including Nrf2, NF-κB, and p53-controlled pathways.  The transcription factor 
Nuclear Factor Erythroid-derived 2-Related Factor 2 (Nrf2) is a central regulator of the 
cellular response to oxidative stress (112).  High ROS levels cause Nrf2 to bind to 
antioxidant response elements (ARE) within promoter regions of phase II detoxification 
enzymes, allowing for upregulation of superoxide dismutase (SOD) and glutathione S-
transferase (gst) genes, among other antioxidant gene targets (113).  Acetylation of Nrf2 
promotes DNA binding and target gene transcription, while deacetylation of Nrf2 
disengages it from the ARE resulting in transcriptional termination (114).  Therefore, 
SIRT1 is a negative regulator of Nrf2 and consequently down-regulates this adaptive 
response to oxidative stress (84).  
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NF-κB is another transcription factor that can be activated by ROS and other cellular 
stress conditions.  As NF-κB transcriptionally upregulates a number of survival genes, 
such as the IAP family of apoptotic inhibitors, the over-activation of NF-κB is common 
in tumorigenesis and chemotherapy resistance [reviewed in (115)].  SIRT1 has been 
shown to form a complex with the RelA/p65 subunit of NF-κB, deacetylating Lys310 
(116).  This decreases NF-κB activity and down-regulates survival genes, thus resulting 
in increased apoptosis (116).   
As a distinct mechanism to induce apoptosis at the mitochondrial level, high ROS can 
direct cytosolic p53 to induce apoptosis via the SIRT1-induced targeting of p53 to this 
organelle (117).  In this pathway, deacetylated p53 binds to the outer-membrane of the 
mitochondria and outcompetes BAX for binding to BCL-2 proteins.  The subsequent 
activation of BAX then leads to the release of cytochrome c from the mitochondria and 
the induction of apoptosis (118).  SIRT1, therefore, has dual functions of both promoting 
cytoprotection and apoptosis, depending on the nature and severity of the stress. 
Activation of the heat shock response by SIRT1 and implications in cancer  
As certain conditions can cause SIRT1 to be cytoprotective while others can cause SIRT1 
to induce cell death, SIRT1 has been implicated both as an oncogene and as a tumor 
suppressor [reviewed in (119, 120)].  Here a role for SIRT1 as an oncogene through 
activation of HSF1 and the cytoprotective heat shock response is explored. 
SIRT1-dependent regulation of HSF1 
As mentioned earlier, HSF1 has recently been established as a SIRT1 substrate (13, 15) 
and is the master regulator of the heat shock response, the cell’s cytoprotective molecular 
reaction to protein damaging stress (Figure S12).  While the classic inducer of this 
adaptive stress response is heat shock, other stressors can also induce this response, 
including oxidative stress, heavy metals, and various pathophysiological states (121).  
The heat shock response results in the induction of molecular chaperone genes, called 
heat shock proteins (HSPs), which function to restore proteostasis and promote cell 
survival.  In non-stressed cells HSF1 exists in a monomeric form. Upon stress, HSF1 
  197 
forms trimers that accumulate in the nucleus and bind to heat shock elements in the 
promoters of target genes (122).  Hyperphosphorylation leads to transcriptional activity 
and hsp genes are induced (123).   
SIRT1 regulates the heat shock response through deacetylation of HSF1 (13).  HSF1 can 
be acetylated at multiple sites, and the acetylation of Lys80 within the DNA-binding 
domain inhibits DNA binding ability (13).  Activation of SIRT1 leads to the 
deacetylation of HSF1, resulting in prolonged binding of HSF1 to the hsp70 promoter 
and induction of the heat shock response.  Conversely, down-regulation of SIRT1 
promotes the attenuation of the heat shock response via increased HSF1 acetylation and 
decreased HSF1 DNA binding ability.  Interestingly, the interaction of SIRT1 with HSF1 
has been shown to be regulated by stress, as endogenous SIRT1 co-immunoprecipitates 
with HSF1 only upon heat shock in mouse embryonic fibroblasts (MEFs) (15). 
The regulation of HSF1 and the heat shock response by SIRT1 has been shown to be 
biologically significant in a number of ways.  As expected for a cytoprotective factor, the 
overexpression of SIRT1 was found to confer increased tolerance to high temperature 
heat shock in 293T cells (13).  As HSF1 and SIRT1 are both aging factors, it is 
interesting to note that WI-38 human fibroblast cells at late passage numbers show a 
decreased heat shock response and reduced activation of HSF1 DNA binding by heat 
shock that correlates with a reduced abundance of SIRT1 (13).   
SIRT1 has also been shown to work together with HSF1 to protect against α-synuclein 
pathology, an aging-related disorder (15).  In this study, a transgenic mouse was used 
bearing the human α-synuclein gene with the A53T mutation, which causes familial 
early-onset Parkinson’s disease (15).  When the A53T mice were crossed with SIRT1 
transgenic mice, SIRT1 was found to prolong the lifespan of the mice and to decrease α-
synuclein aggregates in the mouse brain.  SIRT1 was found to deacetylate HSF1 and 
increase HSP70 levels in the brains of the A53T mice, but not in brains of mice not 
expressing α-synuclein A53T.  Therefore, these combined results suggest that SIRT1 
deacetylates HSF1 and activates chaperone expression only under stress conditions, 
including heat shock stress or aggregation-induced stress.   
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Association of HSPs and HSF1 with cancer 
Heat shock proteins (HSPs), the transcriptional targets of HSF1, are elevated in a number 
of cells and tissues from a variety of cancers including prostate (124), lung (125), 
pancreas (126), bladder (127), and breast (128).  HSPs comprise several distinct classes 
of molecular chaperones that maintain proper protein function in the cell by facilitating 
the folding, translocation, and proteolytic turnover of many critical regulators of cell 
growth and cell death (129-131).  Multiple studies have shown the upregulation of HSPs 
in cancers and its association with increased aggression and lower survival rates (132-
135).  Consequently, elevated HSP expression is associated with poor prognosis and 
resistance to chemotherapy (136) and is often used as a biomarker for tumor progression 
and prognosis, though not all cancers (i.e. renal cell carcinoma) present this correlation 
(137).  In particular, overexpression of HSP27, HSP70, and HSP90 seems to play crucial 
roles in cancer cell survival (138, 139).  For instance, overexpression of HSP27 in rat 
colon adenocarcinoma cells injected into syngeneic animals increased tumorigenicity 
resulting in increased tumor size and a delay in tumor regression (140).  Overexpression 
of HSP70 in Rat-1 fibroblasts can lead to reversible oncogenic transformation (141).   In 
tumor cells, knockdown of HSP70 with antisense oligomers led to the induction of 
apoptosis and the inhibition of tumor cell proliferation (142).  The inhibition of HSP90 
by small molecule inhibitors has also shown promising anti-cancer results [reviewed in 
(143)].  These combined results suggest that tumors may take advantage of chaperone-
based cell-survival mechanisms, thus allowing the cancer cells to proliferate. 
The manner in which increased expression of HSPs promotes cancer is likely to occur 
through multiple cytoprotective mechanisms, including effects on maintaining 
proteostasis, preventing apoptosis, and facilitating growth-promoting signaling pathways.  
Rapidly proliferating tumor cells have increased dependency on protein folding for 
survival, due in part to an increase in expression of multiple proteins for oncogenic 
signaling pathways (144).  In addition, the mutagenic nature of tumor cells results in an 
increase in polymorphic variants of essential proteins that may have folding difficulties, 
thus requiring increased assistance with protein folding for cell survival (143).  HSPs, 
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through their effects of promoting protein folding and maintaining proteostasis, are 
therefore likely to assist cancer cells in this regard.   
In addition to effects on proteostasis, HSPs can act at several points in the apoptotic 
pathway to inhibit apoptosis, including preventing cytochrome c release, regulating the 
apoptosome, and preventing caspase activation (139).  HSP70 has been widely studied 
with regard to apoptosis, and has been shown to interfere with the assembly of the 
apoptosome by preventing the recruitment of procaspases 9 and 3 (145).  The mechanism 
by which HSP70 is cytoprotective against apoptosis may also be through inhibitory 
binding and sequestration of pro-apoptotic proteins  
Facilitating growth-promoting signaling pathways is another key way in which HSPs 
may aid in tumor progression.  HSP90 is highly relevant in this regard due to its 
oncogenic client proteins, including mutant p53, NF-κB, HER2, B-Raf and AKT (131).  
In fact, certain tumors have been found to be dependent on HSP90, and HSP90 inhibitors 
can selectively target these cancer cells (146).  The overexpression of multiple HSPs in 
cancer cells could therefore help promote cell survival and aid cancer progression 
through multiple mechanisms. 
HSF1, the master regulator of chaperones, has itself been implicated in cancer in a 
number of experiments. For instance, HSF1 was found to promote Ras-induced 
transformation, as HSF1 null MEFs produced fewer Ras-induced foci than wild-type 
MEFS (147).  HSF1 is also required for transformation induced by HER2 in MCF-10A 
cells (148) and was shown to cooperate with HER2 to promote mammary tumorigenesis 
and metastasis (149). In addition, HSF1 promotes lymphomas in p53-deficient mice 
(150). Oncogenesis has in fact recently been shown to be an inducer of the heat shock 
response due to activation of HSF1 through unknown mechanisms (151).  It may be that 
the variety of stresses common to cancer, such as hypoxia, lack of nutrients, ATP 
depletion, and acidosis, combine to promote HSF1 activity. HSF1 genome occupancy in 
cancer cells was found to include genes involved in cell-cycle regulation, signaling, 
metabolism, adhesion and translation, as well as known hsp target genes (151).  This set 
of gene targets could all be significant in promoting oncogenesis. 
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Implications of SIRT1-induced activation of the heat shock response in cancer 
It is possible that the upregulation of SIRT1 observed in many cancers may facilitate 
HSF1 activation that is commonly observed in tumorigenesis.  It is interesting that 
DBC1, the negative regulator of SIRT1, has been found to be homozygously deleted in 
certain breast cancers.  DBC1 has been shown experimentally to inhibit HSF1 activity 
and the heat shock response (14).  Therefore, deleting this inhibitor of SIRT1 may 
indirectly promote HSF1 activity in cancer as well as promote the deacetylation of p53, 
thus enabling cancer cell survival.  Developing an understanding of how HSF1, SIRT1, 
and SIRT1 modulators influence cancer may lead to the discovery of new cancer 
therapies. 
Final thoughts  
The role of SIRT1 in the activation and regulation of stress response mechanisms may 
represent a vital evolutionarily conserved function in cellular homeostasis.  A better 
understanding of the role of SIRT1 in stress may provide insight into diseases marked by 
a dysfunction in critical adaptive stress responses including cancer.  
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Figure S10.  Model of SIRT1-dependent deacetylation of substrate proteins.   
SIRT1 binds to NAD+ and an acetylated substrate protein in order to catalyze the transfer 
of the acetyl group to the NAD-backbone, thus resulting in the deacetylated substrate 
protein, nicotinamide (NAM), and O-acetyl-ADP-ribose in a 1:1:1 ratio.  Upon triggering 
of the NAD+ salvage pathway, nicotinamide phosphoribosyltransferase (NAMPT) 
catalyzes the conversion of NAM to nicotinamide mononucleotide (NMN).  NMN is then 
converted back to NAD+ by nicotinamide mononucleotide adenylyltransferase 1-3 
(NMNAT1-3). Caloric restriction has been shown to trigger the NAD+ salvage pathway 
by activating NAMPT and AMPK promotes an intracellular increase in NAD+ levels. 
  202 
 
 
Figure S11. SIRT1 is activated and inhibited by stress-responsive factors, and plays 
a dynamic role in regulating cytoprotection, and apoptosis.   
SIRT1 levels and activity are mediated by metabolism and interactions with various 
stress-responsive regulators.  SIRT1 activation by caloric restriction, HuR, NAD+, and 
AROS influences the activity of several targeted factors including HSF1, nuclear p53, 
FOXO, and DNA repair proteins. Deacetylation of these substrate proteins results in a 
decrease of apoptosis and an increase in stress adaptation.  Conversely, SIRT1-mediated 
deacetylation of Nrf2, NF-κB, and cytoplasmic p53 can lead to a pro-apoptotic 
environment due to increased reactive oxygen species and decreased p53 activity.  These 
dynamic processes of SIRT1 may be inhibited by its interactions with DBC1, NAM, 
HIC-1, and miRNAs. (1 nuclear, 2 cytoplasmic). 
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Figure S12.  SIRT1-dependent regulation of HSF1 and the heat shock response.   
HSF1 exists as an inactive monomer in the cytoplasm.  Upon induction of the heat shock 
response by denaturing stress, it trimerizes and translocates to the nucleus where it binds 
to heat shock elements (HSEs) found in the promoter regions of HSP genes.  
Transcription of hsp genes is promoted by the hyperphosphorylation of HSF1, while the 
attenuation of the heat shock response is regulated by a dual mechanism involving 
negative feedback inhibition from HSPs and acetylation at a critical lysine residue within 
the DNA-binding domain of HSF1 causing loss of affinity for DNA. SIRT1 is a 
NAD+-dependent HDAC that deacetylates HSF1, thus promoting stress-induced HSF1 
DNA binding ability and increasing HSP expression.  Protein modulators AROS and 
DBC1 have recently been shown to impact hsp70 transcription, HSF1 acetylation status, 
and HSR1 recruitment to the DNA (14).   
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Appendix F.  Protocols 
In addition to the methods provided in each study, at the request of my committee (and in 
dedication to the members of the Westerheide lab) I have included my commonly used 
protocols in this dissertation.   
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Tissues culture and biochemistry protocols used in these studies 
 
1. Counting cells, pg. 223 
2. RNA isolation for tissue culture, pg. 224 
3. Reverse transcription reaction, pg. 225 
4. Quantitative PCR with sybr green + rox (cat # 172-5101), pg. 226 
5. Western blot analysis, pg. 228 
6. Flag pull-down using anti-flag m2 affinity gel beads (sigma f2426), pg. 231 
7. Co-immunoprecipitation (co-IP), pg. 233 
8. NAD/NADH quantification, pg. 234 
9. Chromatin immunoprecipitation (CHIP), pg. 236 
10. Protein expression using bl21(de3) competent E. coli (NEB, cat#c2527h), pg. 240 
11. GST pull-down assay, pg. 241 
12. Immunocytochemistry, pg. 244 
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1. COUNTING CELLS 
 
! Aspirate off the old media from the plate and add half as much 1X PBS. 
! Gently rotate the plate and aspirate off 1X PBS. 
! Add Trypsin and gently swirl around the plate.  (For a 60 mm plate, add 100 µL 
of Trypsin.  For a 100 mm plate, add 250 µL of Trypsin. 
! Swirl around the plate and place in 37°C CO2 incubator for about 5 min. 
! Add media to the trypsinized plate (5 mL to a 60 mm plate; 10 mL to a 100 mm 
plate) and transfer the trypsinized cells to a 15 mL conical. 
! Pipette 100 µL of cells and 100 µL trypan dye to a 1.5 mL tube and vortex briefly. 
! Add 10 µL of trypan mixture to a hemocytometer slide. 
! Count 2 boxes of 4x4 squares. 
 
 
 
 
 
Figure S13. Counting cells using a hemocytometer.    
 
! Determine the appropriate dilution to achieve the desired concentration of cells.  
If the total of the 2 boxes is 52, then the cell count is 0.52 x 106 cells/mL.  Use 
dimensional analysis to calculate the number of desired cells per well.  
! Transfer to a reservoir and pipet 100-200 µL to a 96 well plate. 
! Let cells grow ON prior to transfection or drug exposure. 
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2. RNA ISOLATION FOR TISSUE CULTURE 
 
Use appropriate sterile molecular techniques for RNA extraction.  Pipets and bench 
should be cleaned with RNase Away and sterile filter pipet tips should be used. 
 
! Add 1 mL Trizol reagent to previously harvested cell pellet (from a 100 mm plate 
of cells).  (If cell pellets are freshly collected, a freeze/thaw in the -80°C may aid 
in lysis.) 
! Pipet up and down until viscous. 
! Place tubes on a nutator at RT for 5 min. 
! Let sit at RT for 2-3 min. 
! Add 200 µL of chloroform. 
! Shake tubes vigorously for 10-15 sec. (DO NOT VORTEX.) 
! Let sit at RT 2-3 min. 
! Add 200 µL of chloroform.  
! Centrifuge at 12,000 x g at 4°C for 15 min. 
! Transfer the supernatant (500-550 µL) to a new tube.  (The RNA will be contained 
in the upper clear aqueous layer and is approximately 60% the volume of Trizol 
added.) 
! Add 500 µL of isopropanol and vortex briefly. 
! Let sit at RT for 10 min.  Precipitate at -80°C for 30 min.  (Alternatively, this can 
be a stopping point.) 
! Centrifuge at 12,000 x g at 4°C for 10 min.  (A white pellet will form.) 
! Aspirate the supernatant. 
! Wash pellet with 1 mL cold 70% EtOH (made with RNase-free H20). 
! Centrifuge at 9,000 x g at 4°C for 2 min. 
! Aspirate, but leave about 200 µL.  (Do not touch the pellet!  Remove the rest of 
the liquid with a P200 or stretched glass pipet!) 
! Invert tubes to dry, but be careful not to overdry. 
! Depending on the size of pellet, resuspend in 15-30 µL of RNase-free H2O. 
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3. REVERSE TRANSCRIPTION REACTION USING ABI’S HIGH 
CAPACITY REVERSE TRANSCRIPTION KIT(CAT # 4368814) 
 
Table S4. Reverse transcription master mix recipe. 
Recipe 1 rxn 
10X RT buffer 2.0 
25X dNTPs 0.8 
10X RT random primers 2.0 
RT enzyme 1.0 
dH2O 4.2 
Total= 10 µL 
 
! Make up MM in 0.1 or 0.2 mL tube.  (Make a half reaction more than needed.) 
! Transfer 10 µL of MM to 0.1 mL tubes. 
! Add 10 µL of the appropriate RNA plus RNase-free dH2O to all sample tubes.  
(RNA should not exceed 2µg.) 
! Vortex and short spin.  
Cycle conditions: 
1. 25°C for 10 min 
2. 37°C for 120 min 
3. 85°C for 5 min 
4. 4°C for ∞ 
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4. QUANTITATIVE PCR WITH SYBR GREEN + ROX (CAT # 172-5101) 
 
! Make a working stock of 50 ng/µL for your template DNA.  (For ChIP 
experiments, it is usually best to not dilute the template due to the low yields of 
most ChIP DNA.) 
! Add 35 µL of ROX (cat # 172-5858) to 1 mL of iTaq fast SYBR Green Mix 
before starting. 
Table S5. Quantitative PCR master mix recipe. 
Recipe 1 rxn (1 well) 
3.3 rxn 
(3 wells) 
x 7  lanes 
(pre-MM)^ 
x        lanes 
(pre-MM) 
SYBR green (with ROX) 10.0 33.0 231  
F primer (0.9 µM) 0.2 0.66 4.6  
R primer (0.9 µM) 0.2 0.66 4.6  
DNA template 
(50 ng/ µL) 
1.0 3.3 (23.1)  
dIH2O 8.6 28.38 198.7  
Total = 20 µL 66 µL 462 µL  
 
^One pre-MM for each primer set (i.e. GOI & endogenous control).  There should be 
enough left over for a 20 µL negative control.  Generally make 0.5-1 rxn more than 
needed to ensure precision pipetting.   
*Primer amounts are based on 10 µM working stocks. 
! Make up a pre-MM in a 1.5 mL tube.  (This is the reaction cocktail.)  
  
! Transfer 63 µL of the pre-MM to 0.5 mL tubes for each triplicate set. 
! Add 3.3 µL of the appropriate cDNA or ChIP DNA to each tube. 
! Vortex and short spin. 
! Transfer 20 µL to three vertical wells to obtain triplicates. 
! Cover plate with adhesive and short spin.  Seal the plate well to avoid 
evaporation.  
! Set cycle parameters: 
o 95°C for 45 sec 
o 95°C for 3 sec 
o 55-60°C for 30 sec** 
o Perform melting curve according to instrument instructions 
**Data collection.  The annealing and extension phase is performed concurrently, which 
is why small amplicons of 80-200 bps are necessary when designing primers.   
x 35-45 cycles 
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*Record the primers and temperature settings used.  Use the 96 well plate template to 
record sample location.   
A. 
Primers Temperature (°C) 
  
  
  
  
  
  
  
B.  
  1 2 3 4 5 6 7 8 9 10 11 12 
A                        
B                         
C                         
D                         
E                         
F                         
G                         
H                         
 
Figure S14. A) Recipe template for qPCR.  B) Plate layout template for qPCR.    
 
Tips: 
*The SYBR green mix can be very viscous.  It is best to avoid mixing by pipetting up and 
down so as not to lose volume.  Due to the viscosity, it is good practice to pause 3 or so 
seconds before going to the second stop while pipetting so that all the volume can be 
expelled from the tip. 
*When pipetting 20 µL into the plate, it is best to NOT go to the second stop in order to 
avoid a possible bubble that may interfere with data collection. 
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5. WESTERN BLOT ANALYSIS 
 
Making the gels: 
! Make up the separating gel and stacking gel mix.  Do not add TEMED or 10% 
APS until each gel is ready to be poured. 
Table S6. SDS-PAGE separating and stacking gel recipes by percent acrylamide. 
Separating Gel  Stacking Gel 
Component 6% 8% 10% 12% 15%  Component 4% 
1.5 M Tris (pH 
8.8) 2.5 mL 2.5 mL 2.5 mL 2.5 mL 2.5 mL 
 1 M Tris (pH 6.8) 1.25 mL 
40% Acrylamide 1.5 mL 2.0 mL 2.5 mL 3.0 mL 3.8 mL  40% Acrylamide 1.25 mL 
10% SDS 100 µL 100 µL 100 µL 100 µL 100 µL  10% SDS 100 µL 
10% APS 100 µL 100 µL 100 µL 100 µL 100 µL  10% APS* 100 µL 
TEMED 4 µL 4 µL 4 µL 4 µL 4 µL  TEMED* 10 µL 
dH2O 5.8 mL 5.3 mL 4.8 mL 4.3 mL 3.5 mL  dH2O 7.3 mL 
kDa Range: 60-200  16-70  12-45    
 
! Cast the separating gel by pipetting into the Biorad gel apparatus using a P1000 
and quickly overlay with 1 mL of hydrated Butanol.  (Leave ¼ space for the 
stacking gel.) 
! Let sit for 30 min. 
! After polymerization, remove the Butanol overlay via gravity and rinse with 
dIH2O. 
! Make up the stacking gel and pipet over the separating gel. 
! Insert the comb and let sit to polymerize for at least 30 min. 
! Place the gel in the electrophoresis chamber, cover with running buffer, remove 
the comb, and rinse the wells with buffer to remove unpolymerized acrylamide. 
Preparing the samples: 
! Add Laemmli buffer to aliquoted samples. 
! Incubate the sample at 95°C for 5 minutes to denature the proteins. 
! Mix by vortexing, short spin, and load onto the gel.  Load from left to right. 
! Add Laemmli buffer into all empty wells for an even dye front 
! Run the gel at 180V until the dye front has emerged from the gel (about 1 hour).  
(If smaller kDa proteins are being analyzed, the gel may be stopped before the 
dye front has run off.) 
Blotting: 
! Remove the stacking layer from the gel. 
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! Activate a PVDF membrane in 100% methanol or wet a nitrocellulose membrane 
in a tray filled with dH2O. 
! Fill a large tray with transfer buffer and assemble the blot.  (Place the gel so that 
the marker is on the right.  Use 1 piece of thick blotting paper or 2 pieces of thin 
blotting paper. ) 
Blotting paper 
Membrane 
Gel 
Blotting paper 
 
! Flip the blot assembly over and place in a semi-dry blotter membrane-side down. 
! Set to 300 mA.  Blot for one hour.  (Add more time to transfer large kDa proteins 
or for multiple gels on the blotter.) 
! Stain with 0.1% Ponceau S (in 1% glacial acetic acid) for a few seconds in order 
to visualize protein bands. 
! Rinse the blot with dIH2O to remove background staining. 
! Scan or photograph the blot to confirm equal loading in each lane.  (The Ponceau 
rinses off of nitrocellulose membranes with TBST.  For PVDF membranes, add 
NaOH dropwise into TBST until staining dissipates.  It should only take 1-2 
drops.) 
Blocking: 
! Block in 5% non-fat dry milk in TBST at RT for 30 min.  Rinse briefly in TBST 
and proceed to immunostaining.   
Immunochemical Staining: 
Note the primary antibody, species, and antibody dilution.   
! Incubate the blot at 4°C ON with primary antibody diluted in 1% milk or BSA.  
(The next day, recover the antibody solution in a 15 mL conical. Add 0.02% 
NaAzide to stem bacterial growth.  Freeze at -20°C and reuse 5-15 times.  Do not 
recover HRP-conjugated antibodies as NaAzide acts as an inhibitor to the 
reaction.] 
 
! Wash the blot with TBST for 5 min x 3. 
! Incubate the blot with secondary antibody diluted in 5% milk in TBST for 1 ½ to 
2 hours at RT. 
! Wash the blot with TBST for 5 min x 3. 
 
Antibody detection: 
 
! Prepare ECL Plus/Prime reagents (2 mL solution A + 50 µL solution B). 
! Remove the blot to a transparency sheet in a cassette and quickly pipette 1 mL 
ECL Plus per blot.  
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! Incubate for 5 minutes at RT. 
! Sandwich the blot between a second transparency and expose to film.  (A good 
exposure should capture any subtle differences in expression between samples.  
Start with a 30 sec and 1 min exposure and proceed from there, adding more or 
less time as needed.  The ECL will begin to wear off within 45 min-1 hr.) 
 
Table S7.  Western Blot stock solutions. 
10X Tris/glycine buffer (2L, pH 8.3) 
1.92 M Glycine  288 g 
250 mM Tris   60.6 g 
 
10X TBS (2 L, pH 8.0) 
1.5 M NaCl   175.32 g 
0.5 M Tris   121.14 g 
 
*Autoclave or filter.  Fungus grows in this in Florida! 
 
10% Ammonium Persulfate 
Make up a 1 g APS in 10 mL sterile dIH20 and divide into 0.5 mL aliquots.  Store at -20°C. 
 
As APS degrades, it begins to acidify. To test the integrity of the APS aliquot, spot onto pH 
indicator paper. If the solution soaking into the paper does not change the color to acid past the 
initial spot, then the APS has not degraded.  
 
Ponceau S Dye 
(0.1% Ponceau in 10% acetic acid)  
Dissolve 0.5 gram of Ponceau in 400 mL dIH2O 
Add 50 mL of glacial acetic acid 
dH2O to 500 mL 
 
Ponceau may be reused by pouring back into the original bottle. 
 
Table S8.  Western Blot working solutions. 
1X SDS Running Buffer 1X Transfer buffer 1X TBST (0.5% Tween) 
100 mL 10X tris/glycine 
buffer 
100 mL 10X tris/glycine 
buffer 100 mL 10X TBS 
895 mL dIH20 100 mL methanol 890 mL dIH2O 
5 mL 20% SDS 800 mL dIH2O 5 mL 10% Tween-20 
(Final SDS is 0.1%)  (Final Tween is 0.05%) 
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6. FLAG PULL-DOWN USING ANTI-FLAG M2 AFFINITY GEL BEADS 
(SIGMA F2426) 
 
Make sure to use a FLAG empty vector as a control in overexpression transfection 
experiments.   
 
Protein extraction: 
! Lyse cell pellets in 250-500 uL of M-PER buffer (Thermo Scientific, catalog # 78501) 
+ protease inhibitors. 
! Rotate for 15 min at 4°C. 
! Centrifuge at 13,000 rpm for 10 min at 4°C. 
! Quantitate protein via Bradford assay. 
! Assess the highest amount of protein to use so that each sample is normalized. 
! Save the excess as input and prepare tubes containing 20 ug of total protein for WB 
analysis. 
 
 
Preclear: 
! Add 20 uL mouse IgG agarose beads (Sigma, cat#A0919). 
! Rotate 30 min 4°C. 
! Spin 1 min at 4°C at 1000 rpm 
! Transfer supernatant to new tubes 
 
 
Immunoprecipitate: 
! Equilibrate beads by washing 40 uL/IP of anti-Flag M2 affinity gel beads (Sigma, 
cat#F2426) in 500 uL TBS 2X.   
! Add 40 uL of equilibrated beads to normalized cell lysates. 
! Rotate overnight at 4°C. 
 
Wash beads: 
! Centrifuge at 1000 rpm for 1 min at 4°C.  
! Transfer supernatant to new tubes labeled “flow through” to test for pull-down 
efficiency.   
! Add 500 uL of 1X PBS, vortex briefly, and rotate for 5 min at 4°C.  
! Centrifuge at 1000 rpm for 1 min at 4°C and remove the supernatant.  Repeat 3 times. 
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Elution with FLAG peptide: 
! Add 3 uL of 5 mg/mL 3X FLAG peptide (Sigma, cat#F-4799) to 100 uL PBS for 
FLAG elution solution. 
! Add 25 uL FLAG elution solution to each sample. 
! Incubate shaking for 30 min at 4°C.  (Do not rotate or the small volume will cause the 
beads to stick to the sides.)  
! Centrifuge at 1000 rpm for 1 min at 4°C.  
! Transfer the supernatant to a new tube, being careful not to pipet up the beads. 
! Add 7 uL 5X SDS loading dye.  (Store at -80°C.) 
 
Western blot analysis: 
Follow standard Western blot protocol.  After initial Western blot analysis, strip the blot 
and immunostain using a FLAG antibody.  The signal is robust, so abbreviated 
incubations should be utilized. 
 
! Primary Antibody:  anti- FLAG M2 (Sigma, cat#F3165) 1:500 for 30 min at RT 
! Secondary Antibody:  anti-mouse HRP 1:10,000 in 5% milk for 30 min at RT 
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7. CO-IMMUNOPRECIPITATION (CO-IP) 
 
Collect cells: 
 
! Aspirate media and rinse the cells two times with ice-cold 1X PBS. 
! Scrap cells in 1 mL 1X PBS and pipet to a 1.5 mL eppendorf tube. 
! Centrifuge at 2,000 rpm for 5 minutes at 4°C.  Aspirate and discard the 
supernatant. 
! Lyse cell pellets in 250-500 uL of M-PER buffer (Thermo Scientific, catalog # 
78501) + protease inhibitors. 
! Rotate for 15 min at 4°C. 
! Centrifuge at 13,000 rpm for 10 min at 4°C. 
! Quantitate protein via Bradford assay. 
! Assess the highest amount of protein to use so that each sample is normalized. 
! Save the excess as input and prepare tubes containing 20 ug of total protein for 
WB analysis. 
! Retain 20 µg of the cell lysate for the input sample. 
 
Immunoselection: 
 
! Preclear normalized samples with 20 µL of washed antibody-binding beads (see 
wash procedure below).   
! Rotate at 4°C for 30 min. 
! Centrifuge at 2000 rpm for 1 min at 4°C to pellet the beads. 
! Transfer the cell lysate to a fresh tube. 
! Add 5-10 µL of primary antibody to the precleared cell lysate. 
! Rotate at 4°C ON. 
 
Immunoprecipitation: 
  
! Wash the antibody-binding beads.  Make sure to pipette using a cut P1000 tip. 
o Transfer protein G Sepharose 4B beads to a 1.5-2 mL tube.  (Use 40 µL of 
beads per IP.) 
o Add 500-1000 µL 1X PBS  
o Invert the tubes twice to mix 
o Centrifuge at 2000 rpm for 1 min 4°C at to pellet the beads. 
o Aspirate the supernatant 
! Add 40 µL antibody-binding beads to each IP and rotate ON at 4°C. 
! Centrifuge at 2000 rpm for 2 min at 4°C. 
! Retain supernatant for “flow through” analysis. 
! Wash beads 1x with lysis buffer and 2 times with ice-cold 1X PBS.  Vortex briefly 
and rotate for 5 min between washes.  
! Elute beads with 50 µL of 5% SDS sample buffer.  Heat beads at 95°C for 5 
minutes prior to loading on an SDS-PAGE gel. 
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8. NAD/NADH QUANTIFICATION   
(CELL TECHNOLOGY, FLUORESCENT NAD/NADH DETECTION KIT 
CATALOG # FLNADH 100-2) 
 
This experiment is LIGHT sensitive.  You must have two plates of cells for each variable 
(i.e. one for the NAD extraction and one for the NADH extraction).  The pellets can be 
combined when collected as long as they are  
 
Sample preparation: 
 
! Heat shock the cells at 42°C or treat as desired. 
! Wash a 100 mm plate of cells with 1X PBS. 
! Collect in 0.5-1 mL of 1X PBS using a cell scraper. 
! Centrifuge at 2000 rpm for 5 min at 4°C. 
! Remove the supernatant and add 200 µL NAD or NADH Extraction Buffer (Part# 
3046 and 3047). 
! Gently vortex, then add 200 µL NAD/NADH Lysis Buffer (Part# 3045) and 
homogenize by pipetting up and down. 
! Gently vortex the samples and heat them at 60°C for 15 min. 
! Cool on ice and add 100 µL of NAD/NADH Reaction Buffer (Part # 3044). 
! Add 200 µL of the OPPOSITE extraction buffer and vortex, to neutralize the 
homogenates. 
! Centrifuge at 5000-8000 x g for 5 min.  (Use immediately or freeze at -80°C; 
freezing may lead to slight loss of NAD/NADH.) 
 
! Make up the reaction cocktail and put on ice: 
 
Table S9.  NAD/NADH reaction recipe. 
Reaction cocktail 10 rxns 
NAD/NADH reaction buffer (Part # 3044) 1 mL 
Enzyme mix (Part# 6021) 10 µL 
NADH detection reagent (Part# 4018) 10 µL 
 
 
NAD/NADH Standard Curve: 
 
! Label tubes 1-8. 
! For tube 1, add 997 µL of NADH Standard Diluent (Part# 3051) and 3 µL of 
reconstituted NADH standard (Part# 7013, 3000 nM). 
! For tubes 2-8, add 250 µL of NADH Standard Diluent.  
! Add 250 µL of tube 1 to tube 2. 
! Vortex well and add 250 µL of tube 2 to tube 3, and so on to tube 7. 
! Tube 8 is the blank control. 
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Table S10. Serial dilution for the NADH standard. 
 
 
 
NAD/NADH Assay: 
 
! Add 50 µL of the standard or sample to a 96 well, black plate in triplicate.  (In 
order to ensure that the samples NADH levels fall within the range of the 
standard curve, it is a good idea to make a set of triplicates consisting of 25 µL of 
the sample + 25 µL NADH Standard Diluent.) 
! Pipette 100 µL of the Reaction Cocktail to all the wells. 
! Incubate at RT in the DARK for 1-1.5 hours.  (It is helpful to create an aluminum 
foil lid and store the plate in a drawer.) 
! Take a reading at excitation 530-570 nm and emission 590-600 nm.  Use the 
NADH standard to make a standard curve of RFU vs NADH (nm).  Solve for x to 
determine the concentration of NADH.  (For the NAD samples, the NAD was 
reduced to NADH and a fluorescent detection regent at a 1:1 ratio.) 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A                        
B                         
C                         
D                         
E                         
F                         
G                         
H                         
 
Figure S15.  Plate layout template for NAD/NADH assay  
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9. CHROMATIN IMMUNOPRECIPITATION (CHIP) 
 
Cell collection: 
 
*Grow up, treat, and harvest 1X107 total cells per condition to be tested.  This 
corresponds to about two 80% confluent 100 mM plates of HeLa cells and will allow for 
5 IP’s per sample.  This can equate to combining the pellets of duplicate experiments. 
 
! Add formaldehyde at a 1% concentration (270 µL of 37% formaldehyde) to each 
100mm plate (10 mls of cell culture media). 
! Incubate for 10 min at RT with occasional swirling. 
! Add glycine at a 125mM concentration (500 µL of 2.5M glycine). 
! Incubate for 5 min at RT with occasional swirling. 
! Aspirate media an wash cells 2X with ice-cold 1X PBS. 
! Scrape cells in 1mL 1X PBS and collect in a 1.5mL tube 
! Centrifuge at 4°C at 2000 rpm for 5 min. 
! Aspirate the supernatant.  (This may be a stopping point.  Store pellets at -80°C.) 
 
*WORK AT 4°C UNTIL IMMUNOPRECIPITATION IS COMPLETED! 
 
Cell lysis: 
 
! Add 1mL of Cell Lysis Buffer with protease inhibitors to each tube and pipet up 
and down to resuspend the pellet. 
! Incubate the tubes on ice for 10 min with occasional tapping or on a nutator at 
4°C.  
! Centrifuge at 4°C at 2000 rpm for 5 min to pellet the nuclei. 
! Aspirate or decant supernatant 
! Add 300 µL of Nuclei Lysis Buffer to each tube containing the nuclear pellet and 
resuspend by pipetting up and down.  
! Incubate the tubes on ice for 10 min with occasional tapping or on a nutator at 
4°C.  
 
Chromatin shearing (via a Diagenode Bioruptor): 
 
*Do not tilt the Bioruptor tank! 
*Check that the temperature in the bath stays below 10°C throughout the sonication 
time!  This machine will break if over heating occurs. 
*Empty the tank after each use by using a hand held water pump! 
*Change water after every 15 min of sonication! 
 
! Fill the Bioruptor tank with cold water layered with 0.5 cm of crushed ice 15 min 
prior to sonication. 
! Place the 1.5 mL tubes into the tube holder, filling any empty spots with blank 
tubes. 
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! Sonicate tubes on HIGH for a total of 45 minutes, cycling 30 sec on and 30 sec 
off.  (The Bioruptor needs a 20 min break for every hour of use!) 
! Spin at 13,000 rpm for 10-15 min and transfer the supernatant to a new tube.  
(Use sheared chromatin immediately or aliquot and store at -80°C.) 
 
Optional step to test sonication: 
 
! Add 75 µL of Crosslink Reversal Buffer to 25 µL of sonicated sample.  (Crosslink 
Reversal Buffer:  100 mM Tris-HCL pH 8.0, 10 mM EDTA, 1% SDS.) 
! Incubate in a heat block ON at 65°C  
! Next day: Phenol/chloroform extract the samples by adding 400 µL of 
phenol/chloroform, vortexing, and centrifuging at 14,000 rpm at 4°C for 10 
minutes. 
! Transfer the top clear phase to a new tube, avoiding the white interface. 
! EtOH precipitate the samples by adding one-tenth volume (40 µL) of 3M NaOAc, 
pH 5.2  and two volumes (800 µL) of cold 95% ethanol. 
! Place at -80°C for at least 30 minutes or ON. 
! Resuspend in 40 µL of TE and add 8 µL of 6X dye. 
! Analyze different amounts (1 µL to 10 µL) of sheared chromatin by 1% agarose 
gel.  (Run the gel slowly at 70V or less for the best separation.) 
! Note the sonication conditions that produce heavy DNA smearing between 200-
500 bp 
 
 
Immunoselection: 
 
! To 300 µL of sonicated chromatin, add 2.7 mL of ChIP dilution buffer plus 
protease inhibitors.  (The chromatin suspension must be diluted at least 1:10 to 
reduce the concentration of SDS.) 
! Aliquot 0.5 mL to six 1.5 mL tubes.  (Each tube can be used for 1 IP.) 
! Preclear by adding 15 µL Salmon Sperm DNA/protein A agarose-50% slurry.  
(This reduces non-specific background.) 
! Rotate for 30 min at 4°C. 
! Centrifuge for 1 min at 4°C at 1000 rpm. 
! Transfer the 500 µL of supernatant to fresh tubes. 
!  Add 5-10 µL of antibody to the samples and vortex for 5 sec.  (Make sure to 
include an IgG negative control.  It may also be useful to include a positive 
control using a histone antibody if this is a new ChIP experiment.) 
! Rotate overnight at 4°C.  
 
! Next day:  Add 30 µL Salmon Sperm DNA/protein A agarose-50% slurry. 
! Rotate for 1 hour at 4°C (or ON). 
! Centrifuge for 1 min at 4°C at 1000 rpm. 
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! Carefully remove 500 µL of the supernatant and save as “input”.  (The input 
samples are used as an endogenous control for the qPCR.) 
 
! Perform the following series of washes with 1 mL of each buffer for 10 min at 
RT. 
o Low salt buffer 1 time 
o High salt buffer 1 time 
o LiCl was 1 time 
o 1X Tris EDTA 2 times 
 
Immunoprecipitation: 
 
! Add 250 µL of IP elution buffer. 
! Vortex for 30 sec. 
! Rotate for 15 min at RT. 
! Centrifuge for 5 min at 5000 rpm. 
! Transfer the supernatant to a new tube. 
! Repeat the elution with another 250 µL of IP elution buffer and then pool with the 
first eluate. 
! Add 20 µL of 5M NaCl to IP sample and input samples. 
! Incubate at 65°C for 4 hours to ON. (Set another heat block to 45°C.) 
 
! Next day: Add 10 µL 0.5 M EDTA, 20 µL 1M Tris (pH 6.5), and 2 µL of 10 
mg/mL proteinase K. 
! Incubate at 45°C for 1 hour. 
 
DNA purification: 
 
! Add 300 µL of phenol/chloroform/isoamyl alcohol (25:24:1). 
! Vortex and centrifuge for 5 min at 13,000 rpm. 
! Transfer aqueous phase to a new tube. 
! Add 15 µL 5M NaCl and 1 µL glycogen. Vortex briefly. 
! Add 1 mL 95% ethanol. 
! Precipitate at -80°C for 1 hour or ON. 
! Centrifuge for 20 min at 4°C at 13,000 rpm. 
! Remove ethanol and wash pellets with 1 mL 75% ethanol. 
! Centrifuge for 10 min at 4°C at 13,000 rpm. 
! Remove 75% ethanol and dry the pellets briefly. 
! Resuspend with 30 µL of sterile dH2O. 
! Add sterile dH2O µL of sterile water to new tubes labeled “input 1:150”  
! Transfer 1 µL from the input tubes to new 1:150 tubes.  (Use diluted input for 
qPCR.) 
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Table S11. Chromatin Immunoprecipitation buffers. 
Cell Lysis Buffer (100 mL)   
5 mM PIPES pH 8.0   1M PIPES- 0.5 mL  
85 mM KCl    1M KCl- 8.5 mL 
0.5% NP40    10% NP-40- 5 mL 
 
Nuclei Lysis Buffer (100 mL)  
50 mM Tris-HCl pH 8.1  1M Tris- 5 mL   
10 mM EDTA    0.5 M EDTA- 2 mL 
1% SDS    20% SDS- 5 mL 
 
ChIP dilution buffer (100 mL)   
0.01% SDS    10% SDS- 0.1 mL 
1.1% Triton X 100   1.1 mL 
1.2 mM EDTA    0.5 M EDTA- 0.24 mL 
16.7 mM Tris-HCl pH 8.1  1M Tris-HCl (pH 8)- 1 mL 
167 mM NaCl    5M NaCl-  3.34 mL 
 
Low salt wash (50 mL)   
0.1% SDS    10% SDS- 0.5 mL 
1% Triton X-100   0.5 mL 
2 mM EDTA    0.5M EDTA- 0.2 mL 
20 mM Tris-HCl pH 8.1  1M Tris-HCl (pH 8)- 1 mL 
150 mM NaCl    5M NaCl- 1.5 mL 
 
High salt wash (50 mL)   
0.1% SDS    10% SDS- 0.5 mL 
1% Triton X-100   0.5 mL 
2 mM EDTA    0.5M EDTA- 0.2 mL 
20 mM Tris-HCl pH 8.1  1M Tris-HCl (pH 8)- 1 mL 
500 mM NaCl    5M NaCl- 5 mL 
 
LiCl/Detergent Wash Buffer (50 mL) 
0.25 M LiCl    0.529g LiCl salt 
1% NP-40    10% NP-40- 5 mL  
1% deoxycholate   10% deoxycholate- 5 mL 
1 mM EDTA    0.5 M EDTA –0.1 mL 
10 mM Tris-Hcl pH 8   1 M Tris-HCl – 0.5 mL 
 
ChIP elution buffer (50 mL)  
50 mM NaHCO3   1M NaHCO3- 2.5 mL 
1% SDS    10% SDS- 5mL 
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10. PROTEIN EXPRESSION USING NEB BL21(DE3) COMPETENT E. COLI 
(CAT # C2527H) 
 
Transformation: 
 
! Thaw the cells on ice for 10 min.  As little as 50 µL of cells may be used for 
transformation and may be aliquoted to multiple tubes using a wide (or cut) 
pipette tip. 
! Add 1 pg - 100 ng of plasmid DNA (not to exceed 5 µL) to the cells.  Tap the tube 
gently to mix.  Do not vortex or mix by pipetting.   
! Incubate the mixture on ice for 30 min.  Expect a 2-fold loss in transformation 
efficiency for every 10"minutes you shorten this step.  
! Heat shock the cells in a heat block at exactly 42°C for 10 sec and place the tube 
on ice for 5 min. 
! Add 250 µL of room temperature SOC to the cell mixture. 
! Incubate the tube at 250-300 rpm at 37°C for 1 hr.  Warm selection plates to 37°C 
for 20-30 min prior to plating. 
! Invert the cells to mix and tap on the bench to bring the volume to the bottom of 
the tube. 
! Using a sterile spreader, spread a series of volumes on at least 3 plates and 
incubate at 37°C ON (i.e. 25 µL, 50 µL, 100 µL). Alternatively, incubate at 30°C 
for 24–36 hours or at 25°C for 48 hours. 
 
Protein expression: 
 
! After antibiotic selection, pick one colony from the plate and resuspend in 10 mL 
of liquid culture with antibiotic.  Ideally, try to have 90% air in the liquid culture 
flask/conical.   
! Incubate at 37°C until OD600 reaches 0.4–0.8.  A culture started in the morning 
should be ready for induction 6 hours later. 
! Induce expression with 1 mM IPTG for 2 to 6 hours at 37°C. 
! For expression analysis, lyse a cell pellet with SDS sample buffer and run on a 
10% SDS-PAGE gel.  Expression can be verified by by Coomassie staining to 
verify induction of proteins at the appropriate molecular weight.  (If this is the 
first time these plasmids are used, multiple induction times are beneficial.) 
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11. GST PULL-DOWN USING PROMEGA’S MAGNEGST™ PULL-DOWN 
SYSTEM (PART# TM249) 
 
TNT synthesis of Prey Protein: 
The TNT® T7 Quick Coupled transcription/translation reaction can be performed using 
any plasmid with a T7 primer sequence.  Qiagen preps typically result in suitable 
purification for plasmids used in this application. 
Table S12. Recipe for the TNT® T7 Quick Coupled transcription/translation 
reaction. 
Components 1 Reaction 
TNT® T7 Quick Master Mix 40 µL 
Methionine, 1mM 1 µL 
plasmid DNA template(s) (0.5 µg / µL) 2 µL 
Nuclease-Free Water 7 µL 
Total= 50 µL 
 
! Thaw the TNT® T7 Quick Master Mix by hand-warming or on ice. The other 
components can be thawed at room temperature and stored on ice. 
! Assemble the reaction components in a 1.5 mL tube. 
! Incubate the reaction at 30°C for 60–90 minutes.  
 
Expression of GST-fusion protein in bacterial cells: 
Verify that plasmids are appropriate for expression in bacteria. 
! Inoculate 5 mL of LB with either the GST control plasmid or the GST-fusion 
protein(s) of interest.  (Make sure to use an appropriate strain of E. coli that is 
ideal for protein expression (i.e. BL21).  Once your plasmids are transformed, 
this experiment may be started from glycerol stocks.) 
! The next day, induce plasmid expression with 1mM IPTG for 4-6 hours. 
! Collect 1-2 mL of culture for expression analysis and 1-2 mL of culture for pull-
down assay. 
! For expression analysis, lyse a cell pellet with SDS sample buffer and run on a 
10% SDS-PAGE gel.  Expression can be verified by by Coomassie staining to 
verify induction of proteins at the appropriate molecular weight.  (If this is the 
first time these plasmids are used, multiple induction times are beneficial.) 
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Cell Lysis: 
! Pellet 1-2 mL of induced bacterial culture at 8,000 rpm for 3 min. 
! Remove supernatant and incubate at -80°C for 30 min. 
! Thaw pellet and add 200 µL of the MagneGST™ Cell Lysis Reagent and 
resuspend by pipetting. 
! Add 2 µL of RQ1 RNase-free DNase. 
! Incubate at RT for 20-30 min on a rotating platform. 
 
Particle Equilibration: 
! Pipet 20 µL of MagneGST™ Particles into a 1.5 mL tube. 
! Place the tube in the magnetic stand and remove supernatant.  (Magnetic capture 
takes only a few seconds.) 
! Remove the tube from the stand, add 250 µL of MagneGST™ Binding/Washing 
buffer, and resuspend by inverting. 
! Remove supernatant and repeat wash x3. 
 
Binding of the GST-fusion protein(s) to magnetic beads: 
! Resuspend the particles in 90 µL of MagneGST™ Binding/Washing buffer and 
10 µL of 10% BSA. 
! Add 200 µL of cell lysate containing the GST-fusion protein of interest. 
! Incubate with CONSTANT mixing for 30 min at RT on a rotating platform. 
! Place the tube in the magnetic stand and remove supernatant.  Save for gel 
analysis. 
! Remove the tube from the stand, add 250 µL of MagneGST™ Binding/Washing 
buffer, and resuspend by inverting.  Incubate at RT on a rotating platform for 5 
min. 
! Place the tube in the magnetic stand and remove supernatant.  Repeat wash 
(without 5 min incubation) x5. 
! After the last wash, resuspend the particles in 20 µL of MagneGST™ 
Binding/Washing buffer.  Aliquot 5 µL to four 1.5 mL tubes. 
 
Capture of Prey protein: 
! To each 5 µL aliquot add 20 µL of TNT reaction. 
! Add 155 µL of MagneGST™ Binding/Washing buffer and 20 µL of 10% BSA. 
! Incubate for 1 hr at RT on a rotating platform. 
! Vortex briefly and place the tube in the magnetic stand and remove supernatant.  
Save for gel analysis. 
! Add 400 µL of MagneGST™ Binding/Washing buffer and mix by inverting.  
Incubate at RT on a rotating platform for 5 min. 
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! Place the tube in the magnetic stand and remove supernatant.  Save for gel 
analysis. 
! Add 400 µL of MagneGST™ Binding/Washing buffer and mix by inverting.   
! Place the tube in the magnetic stand and remove supernatant.  Repeat wash x5. 
 
Elution: 
! Add 20 µL of SDS sample buffer. 
! Incubate at 5 min at RT. 
! Place the tube in the magnetic stand and remove eluate for analysis by 10% SDS-
PAGE.  Use 50% of sample for analysis. 
 
Stronger signals in the experimental samples compared to the GST control lanes indicate 
that the prey is specifically pulled down by the bait protein.  Some background is 
expected. 
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12. IMMUNOCYTOCHEMISTRY 
 
Culture cells: 
 
! In the fume hood, soak glass cover slips in a dish filled with 100 % ethanol. 
! Touch to sterile gauze and air dry. 
! Place a cover slip at the bottom of each well in a 6 well plate. 
! Split cells 1:2 with a total volume of 2 mL and incubate ON.   
  
Fix Cells: 
 
! Aspirate the media then, cover cells to a depth of 2-3 mm with 4% formaldehyde 
in PBS. 
! Allow cells to fix for 15 min at RT with occasional swirling. 
! Aspirate fixative and rinse 3x in 1XPBS for 5 min each. 
 
Immunostaining: 
 
! Block specimen in Blocking Buffer for 1 hr. 
! While blocking, prepare primary antibodies by diluting in Antibody Dilution 
Buffer.  If using two different antibodies, make sure they are hosted in different 
species. 
! Aspirate blocking solution and apply diluted primary antibody.  Incubate at 4°C 
ON. 
! The next day, rinse 3x in 1X PBS for 5 min each. 
! Incubate specimen in Alexa Fluoro secondary antibodies diluted in Antibody 
Dilution Buffer for 1-2 hours at room temperature.  Cover with aluminum foil!  
Dilute at 1-10 µg antibody/mL buffer (2µg/mL works well). 
o Alexa Fluoro #555 (red)  (Species: Rabbit)    
o Alexa Fluoro #488 (green)  (Species: Mouse)    
! Rinse 3X in PBS for 5 min each 
! Remove the coverslips from the wells with tweezers and place upside down onto 
a slide into Vector Shield + DAPI. 
! Seal slides by painting around edges of coverslips with clear nail polish. 
! For best results, examine specimens immediately using the appropriate excitation 
wavelength.  For long-term storage, store slides flat at 4°C protected from light. 
Table S13. Immunocytochemistry buffers. 
Blocking buffer:     Antibody Dilution buffer: 
2.5 mL 10X PBS    4 mL 10X PBS 
1.25 mL FBS     36 mL dH2O 
21.25 mL dIH2O     
*stir, then add 75 µL Triton   *stir, then add 0.4 g BSA and 120 µL Triton 
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C. elegans protocols used in these studies 
 
13. Spectrophotometer calibration, pg. 246 
14. Making nematode growth media plates, pg. 247 
15. Freezing and thawing C. elegans, pg. 249 
16. Synchronization of C. elegans via bleaching, pg. 250 
17. RNA isolation for C.elegans, pg. 253 
18. Genomic DNA Extraction for C. elegans, pg. 254 
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13. SPECTROPHOTOMETER CALIBRATION 
 
! Inoculate LB with OP50 and incubate at 250-300 rpm at 37°C ON. 
! Measure and record the OD at 600 nm with the spectrophotometer. 
! Label 1.5 mL tubes 1-7. 
! Pipette 900 µL of fresh LB or 1X PBS to each tube.  
! Add 100 µL of cell culture to tube 1 and serially dilute to each of the following 
tubes.  (Briefly vortex tube 1 and pipette 100 µL of tube 1 to tube 2.  Continue 
through tube 7.  Tube 1 is a 10-1 dilution, tube 2 is a 10-2 dilution, etc.) 
! Label three LB agar plates (without antibiotic) as samples 5-7. 
! Pipette 100 µL from tubes 5, 6, and 7 to the corresponding plate, spread, and 
incubate at 37°C ON. 
! Count the number of colonies per plate and calculate the number of cells per mL.  
For example, for plate 7, 15 colonies per 10-7 equates to 1.5 x 108 cells/mL.  You 
may choose to average the results for plates 5-7.  This corresponds to the original 
OD600 measurement and the number of cells/mL for 1 OD600 can be calculated.   
 
 
 
Figure S16.  Bacterial serial dilution for spectrophotometric calibration.    
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14. MAKING NEMATODE GROWTH MEDIA PLATES 
 
Table S14. NGM plate recipe. 
Recipe Standard Rich 
NaCl 1.5 g 1.5 g 
Bacto-peptone 1.25 g 3.75 g 
Agar 10 g 10 g 
dIH2O 500 mL 500 mL 
 
         
! Make up NGM agar in a 1 L flask. 
! Autoclave for 45 minutes on a liquid setting. 
! Cool to 55°C, then add the following: 
• 0.5 mL cholesterol (5 mg/mL) 
• 0.5 mL 1M CaCl2 
• 0.5 mL 1M MgSO4 
• 12.5 mL KH2PO4, pH 6.0 
 
Pouring NGM plates: 
 
! Pipette 10 mL of NGM agar per 60 mm plate or 25 mL per 100 mm plate.  Plates 
should be less than half full.  (Thick agar results in escaping worms.) 
! Once plates have solidified, turn them upside down to continue drying.  Let plates 
dry on the bench at RT for ideally 2 days.  (Once plates are dry, they may be 
seeded with bacteria or stored at 4°C for 1 month.) 
 
Seeding NGM plates: 
 
! On the day before the plates finish drying, inoculate LB broth with OP50 (or an 
RNAi bacteria) from a glycerol stock.  (1 mL of culture is required per 60 mm 
plate.  If contamination is a reoccurring issue, streak the bacteria onto a plate 
and inoculate cultures from an isolated colony.  This method is preferred for 
making RNAi plates.) 
! Let shake at 250-300 rpm at 37°C ON.   
! Pellet the bacteria by centrifuging at 3,500 g for 10 minutes. 
! Create a 10X concentration of bacteria by removing 90% of the supernatant.  
! Resuspend the pellet in the remaining 10% of broth.  Resuspension may also be 
done in S-basal in lieu of LB.   
! Pipette 100 µL of bacteria per 60 mm plate or 200 µL of bacteria per 100 mm 
plate. 
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! Create a circular, symmetrical bacterial lawn that is central to the plate allowing a 
border of no bacterial growth.  The best way to do this is to use the bottom of an 
autoclaved 1.5 mL tube or a small spreader that can be made from a bent glass 
pipet.   
! Let the plates dry at RT ON.  (Plates may be stored at 4°C for 1 month.) 
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15. FREEZING AND THAWING C. ELEGANS 
 
Freezing: 
! Transfer 20-25 adults to a 10 cm plate that has been seeded with 200 µL of 10X 
OP50 bacteria. 
! Let grow for 3-4 days at 22-25°C.  (Worms should now be starved with eggs 
present and lots of L1’s and L2’s.  The early larval stages survive upon freezing.) 
! Wash the plate with 5-10 mL of S buffer. 
! Swirl plates and then tilt on the lid to allow pooling to one side. 
! Collect the worms in a 15 mL conical. 
! Pellet the worms for 1 minute at full speed in a swing bucket centrifuge. 
! Aspirate buffer and perform at least one more 5 mL wash.  If the liquid is cloudy 
due to uptake of OP50 bacteria, do one or more 10 mL washes until clear. 
! Aspirate all but 2 mL of S buffer. 
! Resuspend and distribute 0.5 mL to four 1.8 mL cryovials. 
! Add an equal amount (0.5 mL) of S buffer + 30% glycerol. 
! Put the tubes in a rack and place in a Styrofoam container at -80°C ON. 
! The next day, the cryovials may be transferred to a destination box in the -80°C 
freezer. 
 
Thawing: 
 
Test thaw the worms to ensure a successful freeze. A successful freeze should have a 
few worm survivors that are capable of producing progeny. This is also the protocol 
for thawing for experimental use. 
 
! Remove a cryovial from the freezer and sit on a bench to thaw completely at room 
temperature. 
! Allow worms to collect at the bottom of the tube and pipette them with as little 
liquid as possible.   
! Transfer to the edge of the bacterial lawn on a 60 mm plate.  (A good method is to 
pipet the worms in a circle around the bacterial lawn.)   Worms should be active 
after just a few minutes. 
! After 2-3 days, transfer the surviving animals to separate plates and ensure that 
they can produce progeny.   
Table S15. S buffer recipe. 
S buffer  
K2HPO4 0.05 M  
KH2PO4  0.05 M  
NaCl    5.85 g 
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16. SYNCHRONIZATION OF C. ELEGANS VIA BLEACHING 
 
Bleach Synchronization: 
 
! Chunk worms onto a seeded 100 mm NGM plate.  (Allow the worms to grow 2-3 
days so that there are lots of eggs and gravid adults on the plate.) 
! Add 5mL of M9 onto the plate and gently swirl to dislodge the worms.  
! Transfer the worms to a 15mL conical tube. 
! Centrifuge for 1 minute at 5,000 rpm to pellet the worms. 
! Aspirate most of the M9 without disturbing the worm pellet. 
! Add 15mL of 20% alkaline hypochlorite solution to the tube.  (8.25 mL dH2O + 
3.75 mL 1M NaOH + 3 mL bleach) 
! Mix the tube gently by inverting (or on a rotating platform) for approximately 5 
minutes or until you see a decrease in the number of intact adult worms.  (Do not 
bleach for much longer than this or you will kill the eggs.) 
! Centrifuge for 1 minute at 5,000 rpm.  
! Aspirate the 20% alkaline hypochlorite solution without disturbing the worm 
pellet. 
! Add 15mL of M9 to the tube and mix by inverting. 
! Centrifuge for 1 minute at 5,000 rpm.  
! Aspirate most of the M9 without disturbing the worm pellet. 
! Repeat M9 wash 2x. 
! Add 7mL of fresh M9 and pipet up and down to resuspend the pellet. 
! Transfer to a 50 mL flask and place on the shaker at RT. 
! Let the eggs hatch ON with gentle rocking (24-34 hours).  (Since there is no food, 
the larvae should be halted at the L1 stage.)  
! Collect in a 15 mL conical. 
! Centrifuge for 1 minute at 5,000 rpm and remove all but 200 µL.  (For liquid 
culture, remove all but 4 mL and split between AL and CR flasks.) 
! Distribute 200 µL onto seeded NGM plates (around the bacterial lawn) or 2 mL 
into liquid culture. 
 
Liquid Culture: 
Table S16. C. elegans liquid culture components. 
S-Basal complete 100 mL mix 
S-basal 96.4 mL 
1M MgSO4 300 µL 
1M CaCl2 300 µL 
100X trace metals 1 mL 
1M potassium citrate 1 mL 
 
*For ad libitum (AL) cultures, use 1.9 x 1010 cells/mL.  For caloric restriction (CR) 
cultures, use 2.6 x 109 cells/mL.  Subtract the volume of bacteria to be added from the 
total volume of S-basal. 
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! Inoculate 100-200 mL of LB broth with OP50 the previous day and shake t 250-
300 rpm at 37°C ON. 
! Measure optical density at OD600.  (Each spectrophotometer should be calibrated 
to obtain a conversion factor for cells/mL of E. coli.)   
! Add the appropriate amount of bacterial culture to 100 mL S-basal complete 
medium in order to achieve the desired level of food source. 
! Add the synchronized worms to the prepared volume of complete S-basal medium 
+ OP50. 
! Shake the inoculated cultures at 200 rpm at 22-24°C. 
! Take a sample each day to monitor worm development. 
*AL worms reach adulthood in ~3 days.  CR worms may be delayed.  Depending 
on the experiment, it may be better to start the CR worms one day early.  
 
 
 
Figure S17.  C. elegans life cycle at 22°C. 
Aartwork by Altun and Hall, © Wormatlas. 
Table S17. C. elegans solutions for synchronization. 
S-basal (1 L)  
NaCl     5.9 g   
1 M KH2PO4, pH 6.0   50 mL  
cholesterol (5 mg/mL in ethanol) 1 mL 
ddH2O to 1L 
 
M9 (1 L)  
Na2HPO4•7H2O       5.8 g 
KH2PO4    3.0 g 
NaCl     5.0 g 
MgSO4•7H2O   0.25 g 
ddH2O to 1L 
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Table S17 continued from previous page. 
 
Trace Metals Solution (500mL) 
FeSO4•7H2O    0.346 g 
Na2EDTA    0.93 g 
MnCl2•4H2O    0.098 g 
CuSO4•5H2O    0.012 g 
ddH2O to 500mL 
*Store in the dark. 
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17. RNA ISOLATION FOR C.ELEGANS 
 
Use appropriate sterile molecular techniques for RNA extraction.  Pipets and bench 
should be cleaned with RNase Away and sterile filter pipet tips should be used. 
 
! Wash at least one 100 mm plate with 10 mL of M9 buffer. 
! Swirl the plates and then tilt on the lid to allow pooling to one side. 
! Collect the worms in a 15 mL conical. 
! Pellet the worms for 1 minute at 5,000 rpm in a swing bucket centrifuge. 
! Aspirate the buffer and do at least one more 10 mL wash.  (If the liquid is cloudy 
due to uptake of OP50 bacteria, do one or more 10 mL washes until clear.  
Alternatively, bacteria can be completely filtered out using 30 µm spin columns 
from Thermo Scientific cat 69725.) 
! Aspirate all but 0.5 mL of M9 buffer. 
! Transfer to a 1.5 mL tube. 
! Centrifuge at 12,000 x g at 4°C for 2 min. 
! Remove most of the supernatant. 
! Add 1 mL Trizol reagent. 
! Pipet up and down with a P200 until viscous. 
! Vortex by hand for about 30 seconds. 
! Vortex at 4°C for 20 min until the worms dissolve.  
! Place on a nutator at RT for 10 min. 
! Add 200 µL of chloroform. 
! Shake tubes vigorously for 10-15 sec. (DO NOT VORTEX.) 
! Let sit at RT 2-3 min. 
! Add 200 µL of chloroform.  
! Centrifuge at 12,000 x g at 4°C for 15 min. 
! Transfer the supernatant (500-550 µL) to a new tube.  (The RNA will be contained 
in the upper clear aqueous layer and is approximately 60% the volume of Trizol 
added.) 
! Add 500 µL of isopropanol and vortex briefly. 
! Let sit at RT for 10 min.  Precipitate at -80°C for 30 min.  (Alternatively, this can 
be a stopping point.) 
! Centrifuge at 12,000 x g at 4°C for 10 min.  (A white pellet will form.) 
! Aspirate the supernatant. 
! Wash pellet with 1 mL cold 70% EtOH (made with RNase-free H20). 
! Centrifuge at 9,000 x g at 4°C for 2 min. 
! Aspirate, but leave about 200 µL.  (Do not touch the pellet!  Remove the rest of 
the liquid with a P200 or stretched glass pipet!) 
! Invert tubes to dry, but be careful not to overdry. 
! Depending on the size of pellet, resuspend in 15-30 µL of RNase-free H2O. 
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18. GENOMIC DNA EXTRACTION FOR C. ELEGANS 
 
If synchronized populations are desired, culture five plates of worms.  If unsynchronized 
populations are desired, worms can be propagated further by supplementing the plate 
with additional 10X OP50 every few days. Optional: The Morimoto lab recommends 
overlaying the NGM media with 1% agarose to avoid potential inhibition of subsequent 
enzymatic manipulations. 
 
! Culture two 100 mm plates of worms on NGM plates.   
! Add 5mL of M9 onto the plate and gently swirl to dislodge the worms.  
! Transfer the worms to a 15mL conical tube. 
! Centrifuge for 1 minute at 5,000 rpm to pellet the worms. 
! Aspirate most of the M9 without disturbing the worm pellet. 
! Repeat M9 wash 2x or more as needed. 
! Flash freeze the pellet at -80°C or in liquid N2. (Stopping point.) 
! Add five volumes of worm genomic DNA lysis buffer and incubate at 65°C for 1-
2 hours. 
! Incubate at 95°C for 20 min to deactivate the proteinase K. 
! Add RNAse A to 0.1mg/mL and incubate at 37°C for 1 hour.  
! Add 1 volume of phenol/chloroform. 
! Mix gently and spin at 4,000 rpm for 5 min at RT.  (Do not perform at 4°C to 
avoid precipitation of SDS.) 
! Transfer the supernatant (aqueous phase) to a new tube.  
! Repeat the phenol/chloroform extraction until the white precipitate at the 
aqueous/organic interface is no longer visible.  
! Add 0.1 volume of 3M sodium acetate and 2 volumes of 100% ethanol. 
! Incubate at -80°C for 1 hour. (Stopping point.)  
! Centrifuge at 14,000 rpm at 4°C for 15 min. 
! Aspirate the supernatant. 
! Wash pellet with 1 mL cold 70% EtOH. 
! Centrifuge at 14,000 rpm at 4°C for 2 min. 
! Repeat 70% EtOH wash 2X. 
! Aspirate, but leave about 200 µL.  (Do not touch the pellet!  Remove the rest of 
the liquid with a P200 or stretched glass pipet!) 
! Invert tubes to dry, but be careful not to overdry. 
! Depending on the size of pellet, resuspend in 30 µL of RNase-free H2O or TE. (If 
the white precipitate does not dissolve, let the suspension sit for 15 min at 37°C 
and 
! then remove the supernatant, leaving the white pellet.) 
! Prep should yield an OD260/OD280 ratio of approximately 1.8.  
Table S18. C. elegans solutions for genomic DNA extraction. 
M9 (1 L)  
Na2HPO4•7H2O       5.8 g 
KH2PO4    3.0 g 
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Table S18 continued from pervious page. 
 
NaCl     5.0 g 
MgSO4•7H2O   0.25 g 
ddH2O to 1L 
 
Worm Genomic DNA Lysis Buffer  
NaCl     200 mM     
Tris-HCl (pH 8.5)   100mM 
EDTA (pH 8.0)    50mM 
ddH2O to 10 mL 
*Aliquot at -20°C 
*Add 0.1 mg/mL of proteinase K (10 mg/mL) and 0.5% SDS (from 20%) before  
use. 
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Worm humor 
 
Cytoprotection!  
 
 
 
 
No Preconditioning. 
 
 
